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Schizophrenia is a chronic, debilitating mental disorder characterised by positive, negative and 
cognitive symptoms. Current treatment regimens fail to adequately address the cognitive and 
negative symptoms of the disorder. Social isolation rearing (SIR) is a well-established 
developmental adversity paradigm which is used as an animal model of schizophrenia and usually 
studied in male rats. Previous SIR studies have found attentional abnormalities in isolated rats in 
behavioural tests which correspond to the results of studies investigating the cognitive symptoms of 
schizophrenia in patient trials. Isolated rats also display abnormal social responses which may be of 
relevance to the negative symptoms of schizophrenia. The primary aim of this study was to build 
on existing SIR literature by performing behavioural tests in socially isolated rats to address 
attentional function. Neurochemical investigations were performed on projections of the locus 
coeruleus norepinephrine system, known to be involved in attentional function, as research on this 
system is surprisingly sparse. The secondary aim of the study was to address the negative 
symptoms of schizophrenia using ultrasonic vocalisation recording to investigate the calling 
behaviour of isolated rats in response to a novel context. The study included both male and female 
rats so that sex differences could be studied in the context of social isolation. 
Methodology 
Sprague-Dawley rats were weaned at postnatal day (p) 21 and randomly allocated to one of four 
housing groups; female socialised (n=50), female isolated (n=50), male socialised (n=38) and male 
isolated (n=38). Socialised animals were housed 4 per cage (single sex) and isolated animals were 
housed alone. Animals were weighed and cages cleaned weekly as part of a minimal handling 
protocol required for SIR. After 8 weeks in their housing conditions (p78-82) rats underwent one of 
two behavioural paradigms: three phase novel object recognition or ultrasonic vocalisation 
recordings. Between p90-94 animals were rapidly decapitated and the hippocampus and prefrontal 
cortex were dissected out for use in one of two neurochemical analyses. For in-vitro superfusion 
experiments the tissue was used immediately to quantify functional release of radioactively-
labelled norepinephrine when stimulated with glutamate under varying conditions. Enzyme linked 
immunosorbent assays (ELISA) and bicinchoninic acid (BCA) protein assays was performed to 
quantify norepinephrine and glutamate concentrations expressed in relation to the wet weight of the 
tissue and amount of protein in the tissue. 
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Results 
Behavioural and neurochemical changes were induced by the SIR model. Isolated animals were 
found to respond to novel objects abnormally compared to control animals. During initial exposure 
to a novel environment in the first phase of the novel object recognition test isolated animals 
demonstrated hypoactivity. An overall reduction in the fractional release of norepinephrine when 
stimulated with combinations of glutamate and gamma-aminobutyric acid (GABA) was 
demonstrated in the hippocampus of isolated rats. Sex differences were evident in a number of 
experiments. Female rats were found to be hyperactive in the three phases of the novel object 
recognition test compared to males and also had elevated hippocampal norepinephrine activity as 
well as an increased concentration of norepinephrine in this area. Male rats on the other hand had 
an elevated prefrontal cortex norepinephrine activity and concentration. 
Conclusion 
The SIR paradigm is able to induce behavioural and neurochemical changes in both female and 
male rats. The results of this study reinforce the usefulness of SIR as a model for schizophrenia as 
the way in which isolated animals responded to novel objects was different to their socialised 
counterparts. This difference implies an abnormal attentional response which corresponds to the 
cognitive symptoms described in schizophrenia. Furthermore, the neurochemical experiments 
performed in this study are the first of their kind and provide preliminary evidence for the 
GABAergic mechanisms underlying attentional abnormalities associated with SIR. The prevalence 
of sex differences throughout testing also provides strong evidence for the inclusion of both sexes 
in future studies to avoid the omission of potentially important findings. Future studies to refine and 
build on neurochemical analyses in developmental models of schizophrenia, such as SIR will 
potentially provide a mechanistic understanding of cognitive dysfunction as well as useful 
translational information for treating the human disorder.  
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 1.1 BACKGROUND ON SCHIZOPHRENIA 
1.1.1 DEFINITION, SYMPTOMS AND DIAGNOSIS  
Schizophrenia is a highly complex and debilitating neuropsychiatric disorder which typically 
persists chronically once an initial diagnosis is made. The disorder is cyclical and characterised by 
psychotic episodes interspersed with periods of remission and accompanied by a progressive 
deterioration in mental function (Millier, Schmidt et al. 2014). Psychosis refers to an impairment of 
thought so severe that contact is lost with reality (Gaebel and Zielasek 2015). Formalised 
definitions of schizophrenia can be found in diagnostic manuals DSM-V (American Psychiatric 
Association 2013) and ICD-10 (World Health Organization 1992), the criterion for diagnosis 
specified in these manuals are subject to ongoing update and review (Biedermann and 
Fleischhacker 2016). Diagnoses are based on the patient’s reported experience as well as the 
observations of the practitioner. The symptoms of schizophrenia fall in three broadly defined 
categories. 
The positive symptoms of schizophrenia are so-called as they are additive to normal experience. 
Delusions, hallucinations (usually auditory) and disorganised thoughts, speech and movements are 
the most typical positive symptoms. These symptoms contribute to what is known as ‘active phase’ 
schizophrenia or psychosis where the patient experiences a severe disconnection with reality. Often 
the delusions and hallucinations are persecutory or paranoia inducing (Mueser, Bellack et al. 1990). 
This active-phase is what the public typically associate with schizophrenia, however positive 
symptoms are rarely experienced continuously and tend to fluctuate in severity (Erritty and Wydell 
2013). In reality it is the negative and cognitive symptoms which make up the majority of the 
individual’s experience of the disorder meaning that these other symptoms are the most debilitating 
(Carbon and Correll 2014). Positive symptoms are largely understood to be mediated by 
dysfunction of the dopamine (DA) system. Antipsychotic medications are used to manage positive 
symptoms and reduce active-phases of the disorder (Bruijnzeel, Suryadevara et al. 2014). 
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The negative symptoms of schizophrenia are deficits in function and include apathy (emotional 
blunting) evidenced in body language, facial expression and tone of voice, avolition (loss of 
motivation), anhedonia (inability to experience pleasure), alogia (poverty of speech) and societal 
withdrawal (An der Heiden, Leber et al. 2016). Decreased social function can be apparent before a 
diagnosis of the disorder and often becomes increasingly problematic and debilitating with time 
(Hansen, Torgalsbøen et al. 2009). Negative symptoms are often apparent before a diagnosis is 
made. They are known as the residual or prodromal phase of schizophrenia as they persist even 
when positive symptoms are not present (Gourzis, Katrivanou et al. 2002). This indicates that 
negative symptoms have their own distinct underlying mechanism. This theory is strengthened by 
the fact that most pharmacological interventions for schizophrenia do little to address the negative 
symptoms (Tsapakis, Dimopoulou et al. 2015). 
The cognitive symptoms of schizophrenia have a detrimental impact on numerous higher functions. 
At present, an increased research focus is being directed towards these cognitive symptoms in order 
to provide a more complete understanding of schizophrenia. Initiatives such as MATRICS – 
(Measurement and Treatment Research to Improve Cognition in Schizophrenia) (Marder and 
Fenton 2004, Lustig, Kozak et al. 2013) have attempted to systematically address these symptoms 
and provide novel therapeutic targets for their relief (Lin, Tsai et al. 2014). Cognitive symptoms 
include the weakening of declarative and working memory faculties. The attentional system is also 
often found to be dysregulated in sustained attention and attention orienting tasks (Shen, Popescu et 
al. 2014). This implies an overarching abnormality in salience processing (Andersen, Campbell et 
al. 2016). An overall decrease in processing speed is also typically experienced, this may stem from 
a dependence on non-typical neural pathways of executive function (Knowles, Weiser et al. 2015). 
These deficits contribute to difficulties in absorbing and interpreting information and the enacting 
of an appropriate response (Heinrichs and Zakzanis 1998). This means that day to day activities and 
engagement with society becomes increasing difficult even if a medication regime is adhered to 
(Marder 2006). 
The DSM-V details five core symptoms for diagnostic purposes, these being delusions, 
hallucinations, disorganised thoughts and speech, abnormal motor behaviour and negative 
symptoms. A diagnosis of schizophrenia requires the presence of at least two of the five core 
symptoms in one month, with one of these being delusions, hallucinations or disorganised speech. 
In addition to this, evidence of decreased life skills and other disturbances and symptoms over a six 
month period are required to rule out acute psychoses. Features of anxiety and depression are also 
often concurrent with schizophrenia. This wide array of clinical features of the disorder means that 
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schizophrenia is notoriously heterogeneous which can complicate diagnosis (Tandon, Gaebel et al. 
2013). There may also be difficulty in differentiating between schizophrenia and bipolar in certain 
cases (van Os and Kapur 2009).  
1.1.2 PREVALENCE AND AETIOLOGY 
Schizophrenia is commonly reported in the literature as affecting 1% of the global population 
(Chen, Cao et al. 2015). Recent reviews have made attempts to demystify this value and found that 
the prevalence is likely to be slightly lower than 1% depending on the criterion of inclusion 
(McGrath, Saha et al. 2008, Simeone, Ward et al. 2015). The disorder forms a huge burden to the 
individual, their families, society as a whole (Millier, Schmidt et al. 2014), and the economy (de 
Silva, Hanwella et al. 2012). This is due to the disabling features of the disorder meaning that one’s 
ability to lead an independent life is severely compromised. The ratio of male to female incidence 
is approximately 1.4:1, yet prevalence between the sexes is roughly equal (Aleman, Kahn et al. 
2003), this disparity has been attributed to the worsened life expectancy of males with the disorder 
(Leung and Chue 2000). The diagnosis of schizophrenia typically occurs during late adolescence or 
early adulthood, notably diagnosis in females is often slightly later than in males (Häfner, an der 
Heiden et al. 1998). Schizophrenia does not ‘begin’ at this age, however this is the time at which 
the positive symptoms of the disorder most often reach the threshold required for a clinical 
diagnosis, having persisted for at least 6 months. The time prior to a diagnosis is known as the 
prodromal phase of the disorder and negative and cognitive symptoms are often already present at 
this stage (Fisher, Loewy et al. 2013).  
Schizophrenia is notoriously elusive in its origins, and once a diagnosis of the disorder has been 
made there are many other factors which add to its complexity. Assessing and improving the 
quality of life of individuals represents a major challenge to health professionals (Awad and 
Voruganti 2012). The World Health Organisation listed schizophrenia in the top 6 of the leading 
worldwide causes of global disease burden (World Health Organisation 2008). Societal 
stigmatisation of individuals experiencing schizophrenic symptoms is common and due to a lack of 
understanding of the disorder and the misconception that schizophrenia makes people violent and a 
threat to the public. The truth is that the risk posed to the individuals themselves is far greater. 
Suicide is rife in schizophrenic patients with 2-10% choosing to end their own lives (Gómez-
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Durán, Martin-Fumadó et al. 2012, López-Moríñigo, Ramos-Ríos et al. 2012) and up to 50% 
making attempts (Bolton, Gooding et al. 2007). Other associated issues are unemployment, 
homelessness, poor diet, drug and alcohol abuse, thus the life expectancy of those with a diagnosis 
of schizophrenia has been found to be reduced by 12-15 years (McGrath, Saha et al. 2008, van Os 
and Kapur 2009). These issues are often be exacerbated by the progressive social withdrawal of the 
individual contributing to feelings of loneliness and hopelessness (Shrivastava, Bureau et al. 2013). 
In South Africa, the administration of effective treatment is particularly challenging, especially in 
‘at risk’ individuals of lower socio-economic status bracket (Lund and Flisher 2002). There are 
many people living with a diagnosis of schizophrenia and many more who are undiagnosed. Access 
to medication and support is often limited and may be accompanied by low levels of education 
which translate to poor health-related practices. Further complications are the fact that people living 
with HIV/AIDS are more likely to be develop disorders such as schizophrenia but health 
professionals are not as well equipped to identify and deal with the latter (Mall, Sorsdahl et al. 
2012). There are differences in understanding of the disorder amongst different cultural groups, 
witchcraft and possession by spirits are believed by some to be the cause of the disorder (Mbanga, 
Niehaus et al. 2002) and stigmatisation by communities is common (de Wet, Swartz et al. 2015). In 
these instances individuals are less likely to seek treatment and adhere to their medications, which 
results in high psychotic relapse. This is especially the case in South African populations where 
methamphetamine abuse and hence, methamphetamine-induced psychosis is common (Akindipe, 
Wilson et al. 2014), these individuals are highly difficult to treat due to drug seeking behaviour 
occluding their desire to be treated. This increases the number of those living untreated with 
schizophrenia and other psychotic disorders. Limited access to health care services and associated 
costs are also a preventative factor for patients. Time spent waiting in clinics as well as distances 
needed to be travelled in order to reach clinics push the perceived benefit versus cost ratio much 
towards the cost side. Lack of funding for specialist training of health care professionals and other 
communities members is also problematic (Lund and Flisher 2002), particularly when language 
barriers are taken into consideration (Asmal, Mall et al. 2011). This research has the potential to 
increase our understanding of schizophrenia and in doing so will allow for more effective education 
of the abovementioned ‘at risk’ individuals in this country as well as associated carers.  
The causative agents of schizophrenia are largely unknown, both genetic and environmental factors 
have been investigated and implicated. A meta-analysis of data from twin studies found that genetic 
similarity does increase the likelihood for a diagnosis (heritability estimates are around 80%) and 
reinforced the idea the schizophrenia is complex and multifactorial disorder (Sullivan, Kendler et 
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al. 2003). In recent years, genome wide association studies have shed light on a large number 
candidate genes which in combination may contribution to the development of the disorder (Chen, 
Cao et al. 2015). As with many psychiatric disorders, in the absence of a clear-cut genetic 
contribution, research focus has moved towards studying other factors which bring about the 
disorder in those with a genetic predisposition. Epigenetic processes are receiving increasing focus 
to elucidate the mechanisms underlying gene expression and regulation and what part this may 
have to play in the disorder (Dempster, Viana et al. 2013). Environmental risk factor studies have 
revealed that the prevalence of schizophrenia is increased in urbanised individuals (Mortensen, 
Pedersen et al. 1999), immigrants (Eaton and Harrison 2000) and those living in countries high 
levels of income inequality (Burns, Tomita et al. 2014). What may link these commonly reported 
risk factor is the likelihood for social exclusion (Morgan, Kirkbride et al. 2008). The conditions of 
birth and pregnancy are also thought to play a role in the development of the disorder (Cannon, 
Jones et al. 2002). The comorbidity of substance abuse disorders and schizophrenia is relatively 
high, around 50% (Addington and Addington 2007). A common perception of the public is that the 
use of illicit substances (particularly cannabis) can cause schizophrenia. While it is certainly true 
that some drugs can induce effects that mimic the disorder in the short term, it is difficult to prove a 
longer-lasting effect (Murray, Paparelli et al. 2013). The interpretation of studies investigating this 
relationship is highly complex. The age at which drug abuse typically begins often coincides with 
the prodromal phase of the disorder (Henquet, Krabbendam et al. 2005). Possible explanations for 
this relationship are that drug-taking is a form of self-medication for cognitive symptoms prior to a 
diagnosis or that substance abuse can induce psychosis in genetically-predisposed individuals 
which precipitates a diagnosis (Bizzarri, Rucci et al. 2009, Sara, Burgess et al. 2014). Studies to 
identify gene-environment interactions are being conducted to integrate increasingly large data sets. 
Though there are many methodological challenges which needed to be accounted for, these 
collaborative efforts may shed new light on the complexities of schizophrenia’s aetiology (van Os, 
Rutten et al. 2014).  
1.1.3 TREATMENT AND NEUROCHEMICAL HYPOTHESES 
Though schizophrenia is most often intractable, it can be managed with pharmacological and 
psycho-social interventions. Pharmacological interventions for schizophrenia target the positive 
symptoms of the disorder and are known as the antipsychotics. Antipsychotic medication falls into 
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two broad categories, ‘typical’ (first generation) antipsychotics and ‘atypical’ (second generation). 
Typical antipsychotics antagonise the dopaminergic system D2 receptors in the mesolimbic area of 
the brain (Carlsson 1978). These drugs may be very effective in reducing length, frequency and 
severity of psychotic episodes, so much so that after their serendipitous discovery in the 1950s they 
were hailed as a miracle cure. However, extra-pyramidal side-effects of the motor system are 
common from the dopaminergic antagonism in the mesolimbic area (Tandon 2007). The newer 
atypical antipsychotics act on the dopaminergic system, though with reduced affinity for D2 
receptors, as well as antagonising the serotonergic system 5-HT2A receptors. These drugs do not 
induce extra-pyramidal side-effect to the same extent as their predecessors (Dazzan, Morgan et al. 
2005). Despite the reduction of side-effects atypical medications have been found to be only 
‘inconsistently more effective’ in addressing negative symptoms and cognitive symptoms and are 
also considerably more costly than first generation alternatives (Tandon, Belmaker et al. 2008). It is 
also known that up to 30% of individuals are treatment-resistant, given that they continue to 
experience positive symptoms even after adhering to antipsychotic regimes (Hasan, Falkai et al. 
2012). The existence of this subgroup strongly suggests that there is more than just DA dysfunction 
underlying psychotic states and demonstrates a crucial need for increased mechanistic 
understanding of the disorder. Aside from those who are treatment-resistant there are many more 
individuals who are undiagnosed, do not have access to, or are not prescribed appropriate treatment 
(Kennedy, Altar et al. 2014). Another factor which complicates the treatment of schizophrenia is 
patient compliance. Given the profile of symptoms, particularly cognitive memory deficits, it is 
difficult to ensure patients remain on course with their medication. It has been found that 74% of 
patients stop taking their medication within 18 months (Lee, Kane et al. 2011). Nowadays, in 
developed countries, pharmacological treatments are most often given in tandem with psycho-
social therapies. There are a diverse range of treatments available, from community counselling 
groups and family therapy through to art and yoga therapies (Cormac, Jones et al. 2002, Asmal, 
Mall et al. 2011, Crawford, Killaspy et al. 2012, Cramer, Lauche et al. 2013). Effectiveness of these 
therapies is highly variable, though they have been shown to facilitate adjustment to living with 
residual symptoms and reintegrating into society once active phase symptoms have subsided. 
Given its heterogeneity there is no single neurotransmitter system which can account for all the 
symptoms of schizophrenia. The effects of different drug types on the profile of symptoms of 
schizophrenia have however led to the development of various neurochemical hypotheses. The 
‘dopamine hypothesis’ of schizophrenia is well established given the efficacy of DA antagonism as 
an antipsychotic treatment. DA is a monoamine neurotransmitter which acts on G-protein coupled 
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receptors (D1- D5) (Beaulieu, Espinoza et al. 2015). It states that hyperactivity at the D2 receptor, 
especially in the mesolimbic region of the brain gives rise to psychotic aspects of the disorder 
(Carlsson 1977, Iversen and Iversen 2007). This theory is corroborated by the fact that the there is a 
positive correlation between the affinity of a drug for the D2 receptor and its clinical efficacy 
(Seeman, Chau-Wong et al. 1975, Madras 2013). Whilst DA antagonists serve to ameliorate 
positive symptoms, DA agonists are known to cause induction of psychotic states in both affected 
and non-affected individuals (Angrist, Sathananthan et al. 1974, Featherstone, Kapur et al. 2007). It 
is theorised that sensitisation of the dopaminergic system may underlie the induction of psychotic 
states in the disorder (Seeman, Weinshenker et al. 2005). The evidence underlying the dopamine 
hypothesis of schizophrenia’s positive symptoms is compelling whereas the mechanisms behind the 
negative and cognitive symptoms are less clear cut. It is suggested that dopaminergic hyperactivity 
in the mesolimbic system is accompanied by dopaminergic hypofunction in the mesocortical 
region. This ‘hypofrontality’ thought to account for some of the negative and cognitive symptoms 
of schizophrenia and evidenced by reduction function of the frontal cortex (Andreasen, O'Leary et 
al. 1997) as evidenced in imaging studies during mental tasks (Callicott, Mattay et al. 2003).  
Glutamate is the major excitatory neurotransmitter in the brain and acts on ionotropic receptors 
(AMPA, NMDA and kainate) as well as on metabotropic glutamate receptors (mGluRs 1 - 8) 
(Niswender and Conn 2010). More recently research has moved towards glutamate hypotheses of 
schizophrenia given the ability of dissociative anaesthetics phencyclidine (PCP) and ketamine to 
induce states that are clinically indistinguishable from the disorder in unaffected individuals, as 
well as exacerbating symptoms in affected individuals (Javitt and Zukin 1991, Newcomer, Farber 
et al. 1999). PCP and ketamine are both ionotropic glutamate NMDA receptor antagonists. It is 
thought that decreased functioning of NMDA receptors also contributes to hypofrontality in 
schizophrenia. Despite these findings, the glutamate system remains untargeted for treatment given 
that it is the major excitatory neurotransmitter in the body. The pharmacological upregulation of the 
glutamate system by the direct stimulation of NMDA receptors would likely lead to the induction 
of seizures and neurotoxicity. For this reason attempts have been made to upregulate NMDA 
function by bypassing glutamate and increasing the availability of co-agonists, such as glycine 
(Möhler, Boison et al. 2011) and D-serine (Heresco-Levy, Javitt et al. 2005). This line of enquiry 
has been strengthened by findings that levels of D-serine in patients with schizophrenia are reduced 
(Hashimoto, Engberg et al. 2005). Where there is a glutamate dysfunction an accompanying 
disturbance in GABA function is highly likely given the synergistic relationship of excitation and 
inhibition between the two. GABA neurons often serve as interneurons in brain for example in the 
25 
hippocampus and regulate glutamatergic transmission via feedback inhibition (Andreasen and 
Lambert 1991), this reciprocal relationship may be impacted in schizophrenia. Recent studies have 
attempted to address this relationship and a number of studies have found genetic GABA 
alterations in schizophrenia (Schubert, Föcking et al. 2015) as well as in in-vivo imaging studies 
(Frankle, Cho et al. 2015). 
Literature on the dopamine and glutamate hypotheses is abundant and investigation into other 
neurotransmitters is required to provide a fuller picture of the multisystem dysfunction which is 
likely to bring about schizophrenia. Given the importance of dopamine function in schizophrenia 
this warrants the study of other monoaminergic neurotransmitters. Norepinephrine (NE) is 
synthesized directly from dopamine and is thought to play role in many cognitive functions; 
attention, memory, arousal and behavioural response to stress (Berridge and Waterhouse 2003). All 
of these processes are in some way or another implicated in schizophrenia and yet to be targeted 
successfully for treatment. NE binds to α1 and α2 as well as β1, β2 and β3-adrenoceptors (Haggerty, 
Glykos et al. 2013). All adrenoceptors can be found post-synaptically with α2 receptors also 
localising to the presynaptic terminal of noradrenergic neurons where they serve as autoreceptors 
regulating negative feedback (Berridge and Waterhouse 2003). NE release can be triggered by the 
excitatory action of glutamate on AMPA and NMDA receptors on presynaptic NE neurons 
(Howells and Russell 2008). Glutamate release may also be triggered by adrenoceptor activation 
(Chen, Li et al. 2006). The reciprocal relationship between these two neurotransmitter systems may 
be altered in a schizophrenic context. The elevated NE hypothesis of schizophrenia is a relative 
newcomer in the literature. Previous studies on NE levels in cerebrospinal fluid and blood have 
revealed increased concentrations associated with schizophrenia as well as positive correlations to 
psychotic symptoms (Kemali, Del Vecchio et al. 1982, Dajas, Barbeito et al. 1983). Attempts to 
link the function of the monoamine neurotransmitters have posited that in the frontal cortex 
dopamine is transported by NE uptake transporters due to relatively low concentrations of 
dopamine transporters (Morón, Brockington et al. 2002). This work is predominately framed in the 
context of attention deficit hyperactivity disorder but may well have relevance to schizophrenia. 
Additionally in certain cases dopamine can activate α and β-receptors (Yang, Zhang et al. 2014) 
given the strong evidence for dopamine dysfunction in schizophrenia it follows that the closely 
related NE system may also be impacted. Recent work has investigated the therapeutic effect of 
targeting the NE system in patient trials. Reboxetine, a NE reuptake inhibitor which increases the 
availability of NE at the synapse, is being trialled to quantify amelioration of cognitive function. 
Reboxetine seems to be well tolerated but has not been able to consistently produce benefit in 
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schizophrenia (Poyurovsky, Faragian et al. 2009, Bruno, Zoccali et al. 2014). Given its posited role 
in schizophrenia, studies have been conducted to explore whether there are differences in the 
synthesis of NE. The majority of NE is made in a small nucleus of the brain; the locus-coeruleus 
(LC) (Grzanna and Fritschy 1991). Investigations into the anatomical abnormalities of the 
noradrenergic LC tissue post mortem found no differences when staining for tyrosine hydroxylase, 
the rate limiting enzyme responsible for the conversion of dopamine to NE, between samples from 
schizophrenia patients and controls (Craven, Priddle et al. 2005). In another post mortem study, cell 
number and volume were quantified revealing an increase in the volume of LC neurons in 
schizophrenia patients but no differences in cell number (Marner, Søborg et al. 2005).  
As previously stated, one of the cognitive symptoms of schizophrenia is attentional dysfunction. In 
the healthy brain attention processing is facilitated by activation of the LC-NE system (Clark, 
Geffen et al. 1987, Schwarz and Luo 2015), this has been confirmed by work done in our lab 
(Howells, Stein et al. 2012). LC neurons fire in two different patterns; tonic firing which is regular 
discharge during wakefulness and phasic firing which increases on presentation of task relevant 
stimuli (Howells, Stein et al. 2012). Its activation by salience, stressors or novelty increases NE 
release in its multiple target regions. Its connections are well characterised, particularly to the 
prefrontal cortex and hippocampus (Moore and Bloom 1978). These areas are associated with 
attentional processing (Kõiv, Zobel et al. 2011) and pathological processes of schizophrenia have 
been described in both of these regions. It has been repeatedly demonstrated that hippocampal 
volume is decreased in post mortem tissue from schizophrenia patients and there is also evidence of 
decreased cell proliferation (Allen, Fung et al. 2016). As previously mentioned, there is also a 
wealth of data relating to prefrontal cortex dysfunction in schizophrenia, notably the hypofrontality 
hypothesis. Preliminary anatomical investigations revealed that bilateral lesioning of the LC 
noradrenergic bundles resulted in an inability to ignore task irrelevant stimuli (Mason and Lin 
1980). This is of particular interest in the context of schizophrenia since deficits are commonly 
found in selective attention studies utilising distractors, for example the Stroop task (Mayer, 
Hanlon et al. 2015). Schizophrenia patients have also been shown to exhibit deficits in tests for 
other types of attentional processing. In orienting attention studies impairments in the visual 
tracking of stimuli has been described (Mather and Putchat 1984). More recently this has been 
visualised during in-vivo brain imaging studies as a reduction in the amplitude of an event related 
potential known as P3 or P300 which is concurrent with the presentation of salient stimuli in 
healthy individuals (Laurens, Kiehl et al. 2005). Deficits are also evident in attention switching 
studies of schizophrenia (Smid, Martens et al. 2013). These tests provide information not only on 
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attention faculties but also indicators of processing speed and working memory, it is impossible to 
fully separate these closely linked functions. Despite attentional dysfunction being particularly 
robust and well described finding in schizophrenia (Nuechterlein, Barch et al. 2004, Knowles, 
Weiser et al. 2015) surprisingly the LC NE system remains understudied in this context. Notably, 
many of the aforementioned studies were conducted in the 1980s and the LC-NE system is less 
well studies with modern techniques. The present study was designed with the intention of 
addressing this gap in the literature and attempting to draw together attentional dysfunction as well 
as underlying neurochemistry associated with to the LC NE system. 
1.2 MODELLING SCHIZOPHRENIA 
The study of psychiatric disorders is notoriously difficult, atypical processing is apparent not just at 
the cellular level but also at network level, leading to abnormalities pervasive in many higher 
cognitive functions. In addition to this, the majority of cells of the brain cannot regenerate but 
rather alter their function via experience driven network integration. For these reasons research 
tends to be focused on the study of whole organisms, either in patient trials or animal models as 
opposed to cell cultures. Each mode of research involves drawbacks and benefits which must be 
carefully assessed.  
The fundamental advantage of research in humans is that a diagnosis can be confirmed from the 
collection of a profile of symptoms from the patient themselves (this is not the case in animal 
models). Unfortunately, it is not always simple to obtain a complete history from the individual 
especially given the cognitive symptoms of disorder such as memory and attentional deficits. 
Another disadvantage is that it may be difficult to gather a large sample of schizophrenia patients 
who will have a similar experience of the disorder due to its cyclical nature and the heterogeneity 
of symptoms. Once subjects have been chosen for the study an additional difficulty is ensuring 
compliance with the testing schedule, whilst controlling for as many lifestyle variables as possible. 
Antipsychotic medication is also a confounding factor as it is unethical to take patients off of 
current medication regimes during trials. Additionally, it is not usually possible to conduct research 
in individuals whilst they are experiencing active phase symptoms and for this reason participants 
may have to be excluded from the results. Finally, there are limited methods for studying the 
human brain in-vivo. The collection of declarative and behavioural data, as well as drug studies and 
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fMRI and EEG can provide information regarding the amelioration or deterioration of symptoms 
but provide little information as to the mechanisms which underlie these processes (Kane and 
Leucht 2008).  
As previously mentioned, it is not possible to make a diagnosis of schizophrenia in an animal using 
the existing clinical diagnostic criteria. The positive symptoms are so-called as they are additive to 
typical human experience; as a consequence, there is no way of identifying these hallucinations or 
delusions non-declaratively (Wong and Josselyn 2016). Given that the positive symptoms can be 
pharmacologically alleviated in most cases this means that the need for understanding the negative 
and cognitive symptoms is paramount. Fortunately these aspects of the disorder are easier to model 
in animals and the results of these investigations can be used to better our understanding of the 
human condition. Much of the gross anatomy and cellular physiology is preserved between the 
brains of small mammals and humans; this allows scientists to conduct translational research 
whereby significant results in animal studies can be followed up in similar patient studies (Geyer 
2008). In the context of schizophrenia and other psychiatric disorders behavioural tests for 
cognition such as memory or attention are very useful in this respect as they can be translated 
across animals and humans (Neill, Harte et al. 2014, Pedersen, Sørensen et al. 2014). Since the 
aetiology of schizophrenia is poorly understood it is difficult to mimic all aspects of the disorder at 
once in an animal model. Broadly speaking there are four different methodologies which are used 
to model schizophrenia experimentally, most commonly in rodents. These being early life adversity 
models, drug-induced models, lesioning models targeting particular brain areas or genetic models, a 
selection of which are summarised in Table 1. There are a number of criteria against which these 
models are assessed; an ideal model must demonstrate face, construct and predictive validities 
(Wilson and Terry 2010). Face validity means a model must mimic core symptoms of the disorder; 
positive, negative and cognitive. Construct validity implies the model has the same underlying 
cause as the disorder; this is of course problematic when aetiology is unknown. Predictive validity 
means the model must demonstrate the efficacy of drugs, both current and novel. Schizophrenia 
studies will often use more than one methodology in order to account for the different strengths and 
weaknesses of the models (Gaskin, Alexander et al. 2014). The limitations of using animals are 
fairly evident, not only are there ethical considerations but also concerns relating to whether any 
significant effects will persist when translated from animals into humans.  
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Table 1- Animal models of schizophrenia 
Model 
methodology 






(McIntosh, Ballard et 
al. 2013) 
Prenatal exposure to 
Methylooxymethanol 
acetate (MAM)  
(Li, Gulchina et al. 
2017) 
Prenatal stress  










-Results are not specific to
schizophrenia.







(Chindo, Adzu et al. 
2012) 
PCP 

















-Unlikely to provide information
as to the origins of the disorder
given that the effects of the drug
are irreversible.
-Can give false positives in
testing efficacy of future drug
interventions.
Lesion based Neonatal ventral 
hippocampal lesion  
(Tian, Yang et al. 
2016) 
Mediodorsal 
thalamus lesion  
(Ouhaz, Ba-M'hamed 
et al. 2017) 
-Help to identify brain
regions and systems to
target for intervention.
-Anatomical abnormalities not








(Hikida, Jaaro-Peled et 
al. 2007) 
Reelin gene 





-Can be used with other
methods to investigate
genetic vulnerability.
-Compensatory effects of other
genes can occlude effects.
-Evidence for small
contributions of multiple genes,
hard to recreate experimentally.
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Drug-induced and lesion-based models primarily mimic the symptomatology of schizophrenia and 
allow for the testing of novel therapies. These methodologies however have limited construct 
validity meaning that they are unlikely to deepen the understanding of the development of the 
disorder. Early life adversity models on the other hand allow for the study of environmental factors 
during the time before symptoms fully manifest. An increased understanding of schizophrenia 
using developmental models may one day allow for the provision of preventative therapies in at-
risk individuals before active phase symptoms begin, thus reducing the need for pharmacological 
intervention. This approach may also be relevant to other psychiatric disorders with a 
developmental component such as anxiety, depression (Gershon, Sudheimer et al. 2013).  
1.3 POST-WEANING SOCIAL ISOLATION 
The present study aimed to investigate cognitive symptoms and specifically the attentional system 
in schizophrenia. For this reason an early life adversity model was chosen to investigate how 
rearing conditions can contribute to attentional issues in early adulthood. The selection of a 
minimally invasive paradigm allows for a more physiological induction of deficits, though the 
results may not be as marked as with more extreme animal modelling methodologies. Early life 
stresses contribute to numerous alterations in brain development and are correlated the 
development of neuropsychiatric disorders later in life and generalised deficits in cognitive function 
(Aas, Steen et al. 2012). Studies have shown that chronic stress can lead to decreased function of 
the LC-NE system evidenced as a decreased firing rate (Bravo, Torres-Sanchez et al. 2014).  
The model used in study was the post-weaning social isolation rearing (SIR) model of 
schizophrenia. The rationale for using the SIR model was that, like humans, rats are social animals 
(Vanderschuren and Trezza 2014), their wide ranging social tendencies have been repeatedly 
demonstrated. These tendencies include social play, mutually beneficial cooperative behaviours, 
empathy and the establishment of hierarchy to name a few (Whishaw and Kolb 2005, Saito, Yuki et 
al. 2016). If rats are prevented from engaging in normal socialisation during their development then 
significant changes in neurophysiology will ensue in later life.  
The effects of social isolation have been studied for over 50 years in neuroscientific and psychiatric 
research. SIR has been effective in mimicking behavioural (Wilkinson, Killcross et al. 1994), 
neurochemical (Toua, Brand et al. 2010) and structural symptoms (Bianchi, Fone et al. 2006) of 
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psychiatric disorders (Lapiz, Fulford et al. 2001, Jones, Watson et al. 2011) as well as responding 
effectively to current antipsychotic medications (Ko and Liu 2015). These measured changes are 
translational to the symptoms of the human mental disorder schizophrenia (Mouri, Nagai et al. 
2013) as well as depression which is often comorbid with schizophrenia (Samsom and Wong 
2015).  
The general procedure for SIR is as follows. After weaning, rats are moved from housing with the 
dam and siblings to experimental housing conditions, group housing for the control animals or solo 
housing for the experimental animals. Animals remain in these conditions for a number of weeks so 
that robust differences can be established. Numerous studies have been conducted with minor 
alterations to the methodology to identify how best to implement these changes. A sample of SIR 
studies from the last 20 years are summarised in Table 2 to give some idea of methodological 
variability. SIR has been most often performed using rats as the subject though isolation effects 
have been demonstrated in a variety of species from monkeys (Washburn and Rumbaugh 1991) to 
voles (Peuler, Scotti et al. 2012). The impact of SIR on different rat strains is also well 
documented, each with subtle susceptibilities to different deficits (Weiss, Di Iorio et al. 2000). The 
strains most commonly used are Lister Hooded, Wistar and Sprague Dawley (S-D). With regard to 
inclusion of the sexes in SIR studies, more often than not females are excluded from the literature. 
Justification of this is often not given or simply involves the citation of a previous study which used 
only males (Ryu, Yoo et al. 2009). Schizophrenia has equal prevalence in men and women so this 
reasoning is inadequate (Aleman, Kahn et al. 2003). Sex difference findings in SIR studies may 
help to better understand the role of the endocrine system in the symptomatology of schizophrenia 
(Weintraub, Singaravelu et al. 2010, Sarkar and Kabbaj 2016). Another methodological difference 
between papers is the duration of the isolation period. Studies have investigated the impact of short 
and longer term isolation as well whether resocialisation following isolation is effective (Meng, Li 
et al. 2010). Typically animals spend 8 weeks in housing conditions before behavioural testing 
takes place (Witten, Oranje et al. 2014). In a study on shorter isolation durations it was found that 
behavioural deficits were evident after 4 weeks of isolation but not 24 hours (Seffer, Rippberger et 
al. 2015). One final point of consideration is the number of animals in the social housing group, this 
number seems to be highly variable ranging from two per group (Chang, Liu et al. 2014) up to 
twelve per group (Melendez, Gregory et al. 2004) with an average of around 5 per group 
(Fabricius, Steiniger-Brach et al. 2011).  
SIR studies tend to have a behavioural component in order to demonstrate that symptoms of the 
disorder have been replicated (face validity). SIR studies will often also include some tests for 
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neural function either utilising in-vivo techniques or neurochemical assays post mortem. Studies 
such as these help to elucidate the mechanisms underlying dysfunction associated with the disorder 
which gives rise to the behavioural changes induced. Hence these studies have the potential to 
provide construct validity. The final criterion required for a successful animal model is predictive 
validity. Existing schizophrenia medications have been shown to be effective in reversing isolation 
deficits (McIntosh, Ballard et al. 2013, Ko and Liu 2015). Many novel compounds are also 
currently being tested in the SIR model (Möller, Du Preez et al. 2013), and if significant benefits 
are demonstrated these may be followed with clinical trials. The summation of these validities 
makes SIR a desirable paradigm for modelling schizophrenia. 
1.3.1 BEHAVIOUR 
The present study investigated behavioural and neurochemical changes induced by SIR that are 
associated with the negative and cognitive symptoms of schizophrenia. The most commonly 
reported findings from SIR are hyperactivity, anxiety, neophobia, aggression and deficits in sensory 
motor gating amongst others (Fone and Porkess 2008). In 2004 the MATRICS initiative established 
a framework for this kind of research and identified the following as key domains for research: 
speed of processing, attention/vigilance, working memory, verbal learning and memory, visual 
learning and memory, and reasoning and problem solving. Behavioural tests in SIR studies are 
often designed to test these deficits, though often a single behavioural test will have implications 
for more than one domain. One crucial factor that must be borne in mind when designing SIR 
behavioural studies is that repeated handling of isolated rats can reverse changes induced by the 
paradigm. It has been shown that more than one day of handling per week can delete the effects of 
the model (Holson, Scallet et al. 1991). For this reason it is not advisable to perform numerous tests 
for different dysfunctions in the same animals. It also limits the usefulness of tests with a lengthy 
training period. Optimal behavioural tests for SIR studies are therefore minimally invasive and 
measure the animals’ reaction to situations which can be paralleled in human studies. In literature 
on the SIR model the hyperactivity of isolated animals relative to socialised controls is often 
referred to. The table below summarises the findings of a number of SIR studies and found this 
effect to be largely strain and time dependent. Where it is demonstrated, isolation-induced 
hyperactivity has been shown to be reversible following the application of existing antipsychotic 
treatments such as risperidone and haloperidol (Fabricius, Helboe et al. 2011, McIntosh, Ballard et 
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al. 2013). The attenuation of hyperactivity in isolates has also been demonstrated by novel 
treatments for example cariprazine a partial D2/D3 receptor agonist, which adds to the predictive 
validity of the model and supports translational research (Watson, King et al. 2016). 
Table 2- SIR methodology and locomotor activity 
The table summarises a sample of SIR rat studies from the last 20 years. The following methodological 
parameter are indicated: the sex and strain of the animals, how long they were placed in housing conditions 
for, how long behavioural recordings were made of locomotor activity in an open field and finally whether 
either group demonstrated hyperactivity during this behavioural recording (ns= no significant difference). 







(Rosa, Silva et al. 
2005) 
Male Wistar p21 + 10 weeks 5 mins ns 
(Raz 2013) Male Wistar p56 + 2 weeks 5 mins Isolated rats 
(Gentsch, Lichtsteiner 
et al. 1981) 




(Simpson and Kelly 
2012) 
Male S-D p46 + 3 weeks 5 mins ns 
(Ishikawa, Ogawa et 
al. 2014) 
Male S-D p14 + 7 weeks 5 mins Isolated rats 
(Liu, Wang et al. 
2017) 
Male S-D p21 + 4 weeks +5 
days resocialise 
10 mins Isolated rats 
(Varty, Paulus et al. 
2000) 
Male S-D p21 + 8 weeks 60 mins ns 




S-D p21 + 13 weeks 60 mins ns 
(Cain, Mersmann et al. 
2012) 
Male S-D p21 + 5 weeks 6 x 60 
mins 
ns 




p23 + 6 weeks 60 mins Isolated rats 




p23 + 5 weeks 60 mins Isolated rats 
(Zamberletti, Viganò 
et al. 2012) 
Male Lister 
Hooded 
p21 + 5 weeks 60 mins Isolated rats 




p25 + 8 weeks 60 mins Isolated rats 




p23 + 14 weeks 60 mins Isolated rats 
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Other than hyperactivity in isolated animals, deficits in paired pulse inhibition (PPI) tests are 
another common behavioural finding in SIR (Wilkinson, Killcross et al. 1994, Weiss, Di Iorio et al. 
2000). PPI testing measures the reaction to two stimuli and gives an indication of sensorimotor 
gating and attentive mechanisms (Alsene and Bakshi 2011). The first stimulus is sub-threshold and 
insufficient to induce a startle, whereas the second stimulus is of a larger scale. In normal subjects 
the first stimulus primes the subject so that the response to the second stimulus is attenuated 
compared to if the second larger stimulus was presented without a smaller priming stimulus. This 
attenuated response is not seen in schizophrenia patients indicating adaptive abnormalities. PPI 
deficits evidenced in schizophrenia are similar to findings in isolated rats, this makes it an ideal 
translational paradigm (Swerdlow, Weber et al. 2008). One particular study of interest investigated 
the role of the LC in PPI, though not in the context of SIR. It was found that deficits in PPI were 
evident after the LC was activated pharmacologically. In the same study this effect was reversed in 
the presence of atypical antipsychotics (Alsene and Bakshi 2011). Another translational test for 
sensorimotor gating is latent inhibition which provides an indication of associative learning 
abilities. Similar deficits in this test have been demonstrated in schizophrenia patients (Gray, 
Pilowsky et al. 1995) and isolated male rats (Marriott, Tasker et al. 2014). 
The response to a novel environment is typically different between socialised and isolated animals. 
Isolates tend to display hyperactivity in response to novelty, along with differences in measures of 
anxiety, exploration and investigation. Indications of anxiety are often evidenced as reduced 
exploration and an unwillingness to venture into open areas in open field tests (Hall, Huang et al. 
2000) and the elevated plus maze (Hellemans, Benge et al. 2004). Exploration in response to 
novelty is purported to be a function of the time period chosen for isolation (Arakawa 2005). Some 
studies report neophobia (fear of novelty) (Holson 1986) as one of the effects of social isolation and 
others term differences as an enhanced novelty response. In one study it was found that neophobic 
tendencies could be reversed depending on lighting conditions (Hall, Humby et al. 1997). Taken 
together these results highlight that novelty response is certainly affected in SIR, however this is 
not a unidirectional phenomenon. This highlights that attributing broad descriptions of behaviour 
may be problematic in SIR and the need for reporting findings in a specific context, as novelty can 
refer to any number of stimuli. One fairly consistent novelty finding is that isolated animals take 
longer to habituate to new settings (Paulus, Bakshi et al. 1998, Powell, Swerdlow et al. 2002).  
The novel object recognition test is a test regularly used in SIR studies. This is a useful translational 
test as healthy humans and rats are drawn to explore novel objects as opposed to familiar ones 
(Lyon, Saksida et al. 2012). In schizophrenia in humans and in translational animal models this trait 
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is altered and subjects will not spend significantly longer exploring novel objects (Young, Powell et 
al. 2009). In this test animals are presented with two similar objects for a period of time and after 
an interval one of these original objects will be presented along with a novel object. The response 
to this novel object has implications for salience processing as well as short term memory function 
depending on the inter trial delay. Deficits in the ability to distinguish between the two objects have 
been found in both male (Jones, Brown et al. 2011) and female rat studies (McLean, Grayson et al. 
2010). It has been found that isolated animals have significantly impaired memory performance in 
the NOR test when the inter-trial interval is increased. The ability of isolates to discriminate 
between the novel and familiar object has been shown to be attenuated after time delays of 60 
minutes (Bianchi, Fone et al. 2006) and 4 hours (McLean, Beck et al. 2008). The hippocampus 
plays a critical role in novel object recognition as lesioning causes specific deficits in task 
performance (Ainge, Heron-Maxwell et al. 2006). Sex hormones have also been shown to play a 
role in regulating the function of the hippocampus in NOR tests in female rats. Elevated levels of 
endogenous hormones progesterone and estradiol are correlated to improved performance scores in 
the NOR test (Tuscher, Fortress et al. 2015). 
Social withdrawal is one of the negative symptoms of schizophrenia and this can be tested in 
animal model using ultrasonic vocalisation and social interaction studies. Adult rats emit 
vocalisations at two key frequencies, 50 kHz and 22 kHz which are suggested to be indicative of 
positive and negative affective states respectively (Portfors 2007, Burgdorf, Kroes et al. 2008). 
Vocalisations at the 50 kHz range are thought to be indicative of positive affect, in a study it was 
found that after recordings of 50kHz pro-social calls were played, isolated rats significantly 
decreased their motor activity, indicating an abnormal response to social stimuli (Seffer, 
Rippberger et al. 2015). This effect was evident in longer term isolated rats but not in rats isolated 
for 24 hours, no differences were found in response to playback of 22 kHz recordings. In a similar 
study it was found that male isolates emitted fewer pro social 50 kHz calls in total than their 
socialised counterparts and in addition to this showed no difference in their call response to 
sexually receptive and non-receptive females (Inagaki, Kuwahara et al. 2013). Taken together these 
results imply abnormal response in social environments which may be of relevance to 
schizophrenia. Vocalisations at the 22 kHz range are thought to be indicative of negative affect, a 
study investigating the differences between long and short term isolation showed that 24 hour 
isolation was accompanied by an increase in the number and duration of calls in this frequency 
range. Contrastingly after a longer 2 week isolation the number of calls was reduced (Tomazini, 
Reimer et al. 2006). Another study found that animals which had undergone isolation made more 
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vocalisations at 22 kHz in response to an aggressor (Von Frijtag, Schot et al. 2002). Though the 
number of calls made by isolates does not consistently decrease or increase in these different 
studies, they nonetheless provide useful data on the way in which social function is abnormal after 
SIR. On account of their lack of normal social play isolated rats, have also been found to have 
heightened aggressive responses to other rats (Wongwitdecha and Marsden 1996). The wide 
ranging deficits that are induced by SIR provide incentive for the follow up of behavioural test with 
neurochemical analyses to probe the systems which may underlie these deficits. 
 
1.3.2 NEUROCHEMISTRY  
 
As well as behavioural data there is much evidence to support that SIR is also able to induce 
neurochemical changes in a variety of brain areas. Many studies have found evidence for dopamine 
dysfunction which parallels schizophrenia. These studies target metabolism, turnover, receptor 
populations and overall concentrations of neurotransmitter to provide information on mechanistic 
differences. When an in-vivo microdialysis study was performed, amphetamine-stimulated DA 
release was found to be reduced in isolated rats in the prefrontal cortex but not in the nucleus 
accumbens, this result fits conveniently with the hypofrontality theory of dopamine in 
schizophrenia and reinforces SIR as an appropriate modelling paradigm (Fabricius, Steiniger-Brach 
et al. 2011). In another in-vivo microdialysis study differences in amphetamine-stimulated release 
were found in the prefrontal cortex. Serotonin (5-HT) release was decreased in the prefrontal cortex 
of isolates but no differences were found for DA (Dalley, Theobald et al. 2002). A study 
investigated DA and 5-HT in post mortem tissue obtained from isolated rats. In the hippocampus it 
was found that the concentration of 5-HT was reduced and 5-HT turnover was increased. In the 
ventral striatum 5-HT concentrations were increased in isolated animals. In the hippocampus DA 
turnover was increased but no change in concentration was evident and in the ventral striatum no 
differences were found between the groups for DA turnover or concentration (Brenes and 
Fornaguera 2009). Glutamatergic neurochemistry is less well studied in the SIR model. One study 
explored alterations in glutamate function and found that the ability of a metabotropic glutamate 
receptor agonist to increase extracellular glutamate in isolated animals was attenuated in addition to 
various differences in metabotropic glutamate receptor subtype populations (Melendez, Gregory et 
al. 2004). Additionally a metabotropic glutamate receptor agonist was shown reverse hyperactivity 
and novel object discrimination impairments in isolated animals. In group animals the same agonist 
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reduced novel object discrimination abilities (Jones, Brown et al. 2011). Though there is evidence 
for NMDA receptor dysfunction in schizophrenia, few studies have sought to characterise these 
populations in SIR.  
Genetic and brain imaging studies have also revealed functional and anatomical differences in 
socially isolated rats. Techniques such as magnetic resonance spectroscopy (MRS), magnetic 
resonance imaging (MRI) and positron emission tomography (PET) enable measurements of the 
metabolic activity of the brain. Microarray and reverse transcription polymerase chain reaction 
(RT-PCR) techniques allow for the quantification of gene expression of tissues in-vitro. These 
studies further implicate certain brain regions as being vulnerable to SIR. In particular, it has been 
shown that there is decreased flurodeoxglucose uptake in the hippocampus of isolates which is used 
as a marker of metabolic activity as measured with PET (Bonab, Fricchione et al. 2012). In 
accordance with this, glutamate and glutamine concentrations have also been found to be reduced 
in the hippocampus when measured with MRS (Shao, Yan et al. 2015), these results provide 
potential translational biomarkers for the human disorder. In a RT-PCR study measuring glutamate 
and GABA receptor subunit expression in distinct regions of the hippocampus isolated animals 
were found to have attenuated GABAA receptor expression in the dentate gyrus but increased 
glutamate NMDA and kainate receptor expression in the CA1 and CA3 regions of the hippocampus 
(Iwata and Yamamuro 2016). Using microarrays it has been found that the PFC demonstrates 
decreased immediate early gene expression (Levine, Youngs et al. 2007) which is linked to the 
disruption of learning and memory processes. Additionally it has been shown that in post-mortem 
tissue there is an overall reduction in PFC volume associated with SIR which corresponds to 
changes seen in schizophrenia though this is not accompanied by a decrease in neuron number 
(Day-Wilson, Jones et al. 2006). This PFC volume reduction has also been demonstrated utilising 
MRI (Schubert, Porkess et al. 2009). 
With regard to NE and SIR, the relationship between the two has been relatively well studied in the 
context of ethanol intake rather than schizophrenia. These studies still provide relevance for 
schizophrenia however because of the high comorbidity of alcohol abuse disorder and 
schizophrenia. It was demonstrated in a microdialysis study that ethanol administration causes an 
increase in extracellular DA and NE in the nucleus accumbens (an area associated with addictive 
behaviours) in isolated animals (Karkhanis, Locke et al. 2014). In this study there was no difference 
found in DA and NE levels prior to alcohol administration. Dopamine beta hydroxylase (DBH), the 
enzyme which converts DA to NE, was stained in various brain areas in an SIR study. It was found 
that the density of DBH axons was greater in in the infra-limbic region of the PFC in isolates 
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(Kuramochi and Nakamura 2009). NE levels were found to be reduced in the ventral striatum in 
isolates (Brenes, Rodríguez et al. 2008) when assayed with HPLC. A reduction in the density of 
noradrenergic neurons in the both the dorsal and ventral prefrontal cortex was evident in isolates, 
no differences were found in the hippocampus (Ishikawa and Ishikawa 2013). In-vitro 
measurements revealed no differences in basal NE release in isolates or in response to high 
potassium stimulation in the hippocampus (Fulford and Marsden 1997). The same test in the 
presence of idazoxan, an α2-adrenoceptor antagonist, caused a greater increase of NE release in 
isolates than in socialised animals. This study commented that isolation may have enhanced α2-
autoreceptor function on the presynaptic terminal. This lab also performed in-vitro and in-vivo 
assays on a number of other neurochemical systems in the SIR model which demonstrates the 
variable susceptibility of different neurotransmitters and brain regions to the paradigm. Elevated 
and prolonged presynaptic dopamine transmission in the nucleus accumbens was evident in isolates 
following a foot shock exposure during an in-vivo microdialysis study (Fulford and Marsden 1998) 
this result was found to be replicable (Hall, Wilkinson et al. 1998). The release of presynaptic 5-HT 
was also increased in the nucleus accumbens of isolated rats (Fulford and Marsden 1998). This 
work was supported with a similar in-vivo study addressing the interaction of dopamine and 5-HT 
in the nucleus accumbens through the inhibition of dopamine synthesis by a pharmacological agent 
(Fulford and Marsden 2007). It is worth noting that the insertion of the microdialysis probe in these 
in-vivo experiments is likely to have caused significant stress to both groups which may have 
masked additional effects of the isolation paradigm (Fulford and Marsden 1998, Fulford and 
Marsden 1998). A separate study measured NE uptake as well as adrenoceptor binding profiles in a 
variety of brain regions (Kraeuchi, Gentsch et al. 1981). In the hypothalamus, uptake of NE into the 
synaptosomes was increased in isolates. A β-adrenoceptor binding ligand was used in the same 
areas and in the thalamus and medulla-pons binding was reduced in isolates, when an α-
adrenoceptor binding ligand was used; binding was shown to be increased in the medulla-pons in 
isolates.  
An additional study used an α-adrenoceptor antagonist (ORM-10921) in an SIR study to assay its 
ability to improve scores in variety of behavioural test. ORM was found to improve the scores of 
isolated animals in PPI testing and recognition memory tests (Uys, Shahid et al. 2016). These 
studies implicate altered adrenoceptor function in SIR which may be relevant to schizophrenia. No 
concentration differences were found when NE and 5-HT were measured post mortem using HPLC 
in the hippocampus, however the turnover of 5-HT was significantly increased in isolates, 
neurotransmitter concentrations were not found to be correlated to activity in the forced swim test 
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(Brenes, Rodríguez et al. 2008). In a follow up study the same group measured NE and 5-HT this 
time in the ventral striatum and prefrontal cortex, no significant differences were found in the 
prefrontal cortex but in the ventral striatum NE was significantly reduced in isolates (Brenes, 
Padilla et al. 2009). 
Previously SIR studies have utilised ELISAs to investigate the abundance of BDNF (an indicator of 
stress and depressive mechanisms) in the SIR model. In the hippocampus of isolated male S-Ds it 
was found that BDNF levels were reduced compared to socialised animals, (Scaccianoce, Del 
Bianco et al. 2006, Pisu, Garau et al. 2016). A separate study found this effect in isolates females 
(and not males) but only in the CA3 hippocampus region (not CA1)(Weintraub, Singaravelu et al. 
2010). In the prefrontal cortex BDNF levels were elevated in isolated male Wistar rats (Shao, Han 
et al. 2013), a visually similar (non-significant) trend was seen in male S-Ds (Scaccianoce, Del 
Bianco et al. 2006), no differences were found in the nucleus accumbens and striatum in these 
studies. Another group found no differences between isolated and socialised rats when testing with 
ELISA for corticosterone levels (also associated with stress) in blood plasma in male S-Ds (Zhang, 
Wang et al. 2014). It is clear that SIR is able to induce not only behavioural deficits but also 
changes in neurochemistry. This body of research is being consistently added to which will allow 
for a more holistic understanding of the neural systems which are vulnerable during development. 
 
1.4 RATIONALE  
 
The implications of schizophrenia on society and the individual are severe. There is a pressing need 
for improved treatment options particularly for cognitive and negative symptoms. Such 
improvements would allow those with a diagnosis of schizophrenia to continue to work and live 
independently and facilitate societal reintegration. The neural substrates of these symptoms must be 
investigated in order to develop effective treatments for their alleviation. There is extensive 
literature regarding the attentional system and its regulation by the LC-NE system in healthy 
individuals. There is also substantial evidence that one of the cognitive symptoms of schizophrenia 
is abnormal attentional processing. So far in the literature there have been few attempts to draw 
together the dysfunction of the attentional system and its regulation by LC-NE in the context of 
schizophrenia, specifically using the SIR model. Behavioural studies of attention in models of 
schizophrenia are not always followed up with neurochemical analyses. The present study was 
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designed to address this gap in the literature and provide novel evidence which may be of clinical 
relevance. The study will also provide additional data on social function which pertains to the 
negative symptoms of schizophrenia. This study will include equal numbers of male and female 
rats in order to investigate sex differences; this is relevant as females may respond differently to 
SIR (Sutcliffe, Marshall et al. 2007, Hong, Flashner et al. 2012), and are often excluded from 
studies.  
Recently in psychiatry there has been a move away from the rigid categorisation of disorders and 
research pertaining only to a single mental disorder. This is due to the lack of consistently 
efficacious treatments across populations as well as the high prevalence of cross-over diagnoses 
and also because current definitions are not necessarily facilitating treatment but perhaps, rather 
adding to stigmatisation. In 2002 in Japan the diagnostic term for schizophrenia was changed from 
‘split mind disorder’ to ‘integration disorder’ in order to address societal prejudice and reflect a 
more modern understanding of schizophrenia (Sato 2006). Therefore, although this project is 
investigating a particular system (attention) in the context of a particular disorder (schizophrenia) 
this research may be relevant to many other people beyond those with a diagnosis of schizophrenia. 
This work will therefore reinforce the validity of SIR as a model for schizophrenia or, if the results 
do not translate into the human disorder, provide valid data about the effects of isolation on the 
attentional system in a non -schizophrenic context (Samsom and Wong 2015). 
 
1.5 AIMS AND HYPOTHESIS  
 
The aim of this study was to use the SIR model to provide a better understanding of the 
undertreated cognitive and negative symptoms of schizophrenia. In particular the attention 
dysfunction in schizophrenia was of interest when planning this study. The experiments were 
designed with the primary aim of probing attention from a behavioural and neurochemical 
perspective and to utilise existing knowledge on the attentional system of the brain in the context of 
schizophrenia. The secondary aim of the study was to measure social function. This study also 
aimed to address how the SIR paradigm might differentially affect males and females. 
This study hypothesised that NE dysfunction underlies attentional issues associated with the 
disorder of schizophrenia. It is also hypothesises that early life adversity in the SIR paradigm will 
be able to serve as a model of these systems. In line with the primary aims of the study we expected 
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to find behavioural deficits in isolated animals such as hyperactivity and abnormal attention 
towards novelty in line with existing literature. We hypothesised that attentional abnormalities in 
isolated animals may be accompanied by attenuation in the functional release of NE or total NE 
concentration in certain brain areas. In line with the secondary aims of the study we hypothesised 
that social isolation may affect calling behaviours. Finally, we expected to find behavioural and 




The primary aim, to assess the behavioural and neurochemical aspects of the attentional system in 
the SIR model and progress understanding of the cognitive symptoms of schizophrenia, was carried 
out with the following objectives: 
1.1) Use in-vivo novel object recognition testing to assess attentional processing and 
measure response to novelty (environment and objects), locomotor activity, exploratory and 
anxiety-like behaviour in socialised and isolated, male and female animals. 
1.2) Use in-vitro superfusion technique to assess relative functional release of NE when 
stimulated with glutamate in locus-coeruleus projection areas hippocampus and prefrontal 
cortex in socialised and isolated, male and female animals. 
1.3) Use in-vitro superfusion technique to assess relative functional release of NE when 
stimulated with glutamate in presence of CNQX and MK-801 (ionotropic glutamate 
receptor antagonists for AMPARs and NMDARs respectively) in locus-coeruleus projection 
area hippocampus in socialised and isolated, male and female animals. 
1.4) Use in-vitro superfusion technique to assess relative functional release of NE when 
stimulated sequentially with glutamate and then GABA (or vice versa) followed by high 
potassium stimulation in locus-coeruleus projection areas hippocampus and prefrontal 
cortex in socialised and isolated, male and female animals. 
1.5) Use in-vitro ELISA and BCA assay to quantify absolute concentrations of glutamate 
and NE in locus-coeruleus projection areas hippocampus and prefrontal cortex in socialised 
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and isolated, male and female animals, expressed as concentration of neurotransmitter per 
wet weight of tissue and as concentration of neurotransmitter per total protein.  
 
The secondary aim, to assess social dysfunction in the SIR model in order to progress 
understanding of the negative symptoms of schizophrenia, was carried out with the following 
objective: 
2) Use in-vivo ultrasonic vocalisation testing to investigate calling behaviour associated 
with negative affect after exposure to novel environment in socialised and isolated, male 






2.1 EXPERIMENTAL CONDITIONS 
2.1.1 ANIMAL REARING 
 
This project was approved by the University of Cape Town health sciences faculty animal ethics 
committee (UCT HSF AEC), project number: 047-2014 (Figure 69, Figure 70). All experiments 
were carried out in accordance with South African National Standards (SANS: The care and use of 
animals for scientific purposes, 2008). In this project 176 outbred Sprague-Dawley (S-D) rats (male 
n=76, female n=100) were used. The use of animals in this study was necessary in order to model a 
complex mental disorder in a whole organism. All animals were issued from the UCT research 
animal facility. Day of birth was considered as post-natal day one (p1). Litters were culled to six or 
eight pups of a single sex, as determined by gonadal anatomy (Torgrimson and Minson 2005), on 
p7 to ensure optimal nutrition from the dam for each of the pups. A litter of six or eight pups, 
alternating between males and females, was collected each week and brought to the Human 
Biology Satellite animal facility on p21 to be housed until end point. On their day of arrival pups 
were weighed and randomly assigned to housing groups. From each litter of six or eight, three or 
four pups were housed together in a ‘socialised’ setting and the other three or four pups were put 
into individual ‘isolated’ housing. A total of twenty two litters were used in this study. The final 
numbers for the groups were as follows; female socialised (FS) n=50, female isolated (FI) n=50, 
male socialised (MS) n=38 and male isolated (MI) n=38. All animals were housed in the same 
room with 12 hour/12 hour reversed light/dark cycle (06h00-18h00 dark, 18h00 -06h00 light). ‘Rat 
Chow’ food (dry pellets) and tap water were provided ad libitum. Light intensity in the facility was 
maintained at 150-200 lux so as not to damage the rat visual system; albino rats have been found to 
develop phototoxic retinopathy at levels above 325 lux (Bellhorn 1980). The room was well-
ventilated and temperature was maintained at 21-24 °C (checked daily). Welfare monitoring of 
each rat took place every day to check for signs of discomfort, stress and physical deterioration. In 
accordance with AEC guidelines, any animals showing signs of distress were decapitated 
immediately. This was necessary only for one animal (KGFI15) during the course of the project on 
04/06/15 after physical deterioration was evident one week after the animal had arrived in the 
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Satellite facility. The animal was showing signs of severe weight loss compared to littermates at 
p28; this was reported to the UCT HSF as required. Animals were housed in translucent Plexiglas 
cages with wire lids and sawdust for bedding, as it has been shown that wired flooring in the cages 
can act as an additional stressor (Weiss, Feldon et al. 1999). Animal bedding was changed and 
cages cleaned at least once or at most twice weekly according to housing group, body weight of 
each animal was recorded once weekly during cleaning. Cage sizes were as follows; extra small (30 
cm l x 15 cm w x 15 cm h), small (35 cm l x 20 cm w x 15 cm h), medium (40 cm l x 20 cm w x 20 
cm h), large (55 cm l x 35 cm w x 20 cm h). The rats were moved to increasingly large cage sizes 
in line with the stage of growth of the animals and to allow for comfortable perambulation (Table 
3). All animals were housed in large cages prior to behavioural testing during p78-82. End point by 
decapitation occurred during p90-94, (Figure 1). 
 
Table 3- Progressive cage sizes for different housing conditions 
  
Post-natal week Cage size  
Socialised rats (3/4 per cage) 
Cage size 
Isolated rats (1 per cage) 
p21-28 Extra small Extra small 
p28-35 Small Extra small 
p35-42 Small Small 
p42-49 Medium Small 
p49-56 Medium Medium 
p56-63 Large Medium 
p63-End point Large Large 
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2.1.2 EXPERIMENTAL DESIGN 
 
Figure 1- Experimental design 
During the pre-weaning phase Sprague-Dawley (S-D) rats were housed in litter groups with dam. 
During experimental conditioning rats were split into testing groups; female socialised (FS) and 
female isolated (FI), male socialised (MS), male isolated (MI). During behavioural experiments rats 
underwent one of two tests listed and then were placed back into the same housing conditions as 
before. Rats were killed at p90-94 by decapitation and tissue of interest was rapidly harvested, 
following this, one of four possible neurochemical analyses was performed. Superfusion (SF) 
experiments involved stimulating the release of radioactively-labelled norepinephrine (NE) with 
glutamate (Glu). Superfusions were carried out in prefrontal cortex (PFC) and hippocampus (HC) 
tissue with the addition of various other compounds; gamma-amino butyric acid (GABA), potassium 
chloride (KCl) and ionotropic glutamate receptor antagonists CNQX and MK-801. For enzyme 
linked immunosorbent assays (ELISA), brain areas were frozen after decapitation, and were 
subsequently used to quantify glutamate and NE concentrations. Bicinchoninic acid (BCA) protein 
assays were used to measure the protein content in the prefrontal cortex and hippocampus. Of the 
176 total animals, 1 animal perished shortly after arrival in Satellite facility. 175 animals were used 
in behavioural testing; tissue was harvested from all 175 animals however not all of the frozen tissue 
intended for ELISA and BCA experiments was used due to limited space in the assay plates. 
Therefore neurochemistry was performed on 163 animals in total.   
46 
 
2.1.3 POST-WEANING SOCIAL ISOLATION REARING 
 
The post-weaning social isolation method used in this project was based on a protocol characterised 
by collaborators at North-West University, South Africa (Toua, Brand et al. 2010, Möller, Du Preez 
et al. 2011, Möller, Du Preez et al. 2012, Möller, Du Preez et al. 2013). The only modification was 
that both male and female rats were used in the present study. 
At p21, six or eight rats of the same sex and from the same litter were removed from their home 
cage where they received nutrition from the dam. Three or four rats were then placed together into 
‘socialised’ housing (sharing one cage) or the other Three or four rats were placed into ‘isolated’ 
housing (single rat per cage). The social isolation protocol pertains only to physical social isolation 
as visual, olfactory and auditory cues from rats were still present in the facility since all animals 
were housed in the same room. This is more representative of human society as individuals with a 
diagnosis of schizophrenia may be isolated in terms of physical interactions with other people but 
are unlikely to be completely cut off from all societal cues. Cages were separated in the room by 
sex in order to minimise odour cues between male and female mammals which have been shown to 
have an impact on behaviour (Doty 1986). All animals underwent a strict minimal handling 
protocol, as it has been shown that if socially isolated rats are handled regularly, the impact of 
isolation is cancelled (Pritchard, van Kempen et al. 2013). For this reason isolated animal cages 
were cleaned once a week only and socialised animal cages twice weekly. All animals were 
weighed once weekly during the cleaning of cages, on a Thursday. Handling of animals was by 
base of tail only so that animals could become accustomed to being moved by experimenters 
(Gärtner, Büttner et al. 1980, van Driel and Talling 2005) and so that physical contact leading to 
bonding could be minimised. In terms of environmental enrichment, socialised animals in large 
cages were given translucent red tubes as is standard with rat care in our facility, isolated animals 
received no enrichment as it has been shown that enrichment can diminish effects of social 
isolation (Tanaś, Ostaszewski et al. 2015).  
 
2.1.4 BEHAVIOURAL EXPERIMENTS 
 
Each animal underwent behavioural testing during p78-82 consisting either of novel object 
recognition (NOR) testing or ultrasonic vocalisation (USV) testing. Behavioural testing was 
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performed after animals had undergone 8 weeks of socialisation or isolation, this being consistent 
with the time window for behavioural testing by other experimental groups (Möller, Du Preez et al. 
2013, Hong, Lee et al. 2015). At this time the rats were adults having sexually matured at p45-48 or 
p32-34 for males and females respectively (Lewis, Barnett et al. 2002). This time window was 
chosen to parallel the time at which symptoms contributing to a diagnosis of schizophrenia are fully 
realised in humans, early adulthood (Bergen, O'Dushlaine et al. 2014). Animals were brought to 
behavioural suite between 07h00 and 09h00, 60 minutes after start of the dark cycle, so as to not 
impact wakeful grooming and eating, therefore to coincide with the time when rats would naturally 
be more active and display behaviour after sleeping during light hours (Castro-Faúndez, Díaz et al. 
2016). Behavioural tests took place in ≥50 lux red light as it has been shown that rats are more 
behaviourally active in red light than white light conditions (Hall, Humby et al. 1997). The 
temperature in the behavioural suite was kept consistent with the housing facility. Animals were 
transported in their home cage to the behavioural suite outside of the testing room and remained 
here for at least 60 minutes prior to recordings to minimise stress from transportation. This was also 
so that the animal undergoing testing was not influenced by other rats in the room. These 
experiments took place in the level 3 behavioural testing suite of the UCT FHS anatomy building.  
 
2.1.5 NEUROCHEMICAL EXPERIMENTS 
 
At experimental end point (p90-94) rats were killed by rapid decapitation by guillotine and tissue 
was harvested for neurochemical analysis; for either in-vitro superfusion or ELISA. The guillotine 
was chosen as the method of killing so as to keep the condition of the brain as close to 
physiological as possible. Therefore blunt force trauma by concussion and the use of anaesthetics 
was avoided. All tissue was immediately placed post-mortem into ice-cold conditions to reduce the 
breakdown of monoamines (Kontur, al-Tikriti et al. 1994). The brain areas chosen for investigation 
in the neurochemical analyses were the hippocampus and prefrontal cortex. Both of these areas 
receive noradrenergic projections from the locus coeruleus and have been shown to be involved in 
attentional processing. Human EEG studies have also demonstrated a strong link between activity 
of the LC-NE system and PFC and HC regions (Berridge and Foote 1991), this supports the 
translational aspect of this study. These studies will allow for examination of cortical level 
processing as well as limbic system function. These experiments took place in the level 5 
Neuroscience laboratory of the UCT FHS anatomy building.  
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2.2 NOVEL OBJECT RECOGNITION TESTING 
 
The novel object recognition (NOR) test is used in animal research to measure a variety of 
behaviours. NOR testing is minimally stressful/ invasive and does not require lengthy training 
(Grayson, Leger et al. 2015) or positive and negative reinforcement (Antunes and Biala 2012). The 
test is primarily used to assess memory function (Pyndt Jørgensen, Krych et al. 2015) but also has 
relevance to other cognitive faculties such as attentional processing and response to novelty 
(Mansour, Babstock et al. 2003, McLean, Grayson et al. 2010, Rajagopal, Massey et al. 2014). In 
schizophrenia, cognitive function is commonly impaired and largely untreated (Green 2016) and 
since the NOR test is able to provide indicators of cognitive function this makes it a useful tool for 
translational research (Perry, Minassian et al. 2010). This translatability stems from the fact that 
healthy rodents and humans alike will naturally show preference towards exploring novel stimuli 
(environments or objects) as opposed to familiar ones (Ennaceur and Delacour 1988, Fone and 
Porkess 2008). In schizophrenia this preference for novelty has been found to be reduced 
(Bachiller, Lubeiro et al. 2015, Andersen, Campbell et al. 2016) and a similar finding is evident in 
NOR testing; isolated animals have a reduced tendency for exploring novel objects (Bianchi, Fone 
et al. 2006). The test can also provide information about anxiety and movement (Hoffman and 
Basurto 2014) which is also relevant to the symptomatology of schizophrenia. Isolated animals are 
commonly found to be hyperactivity in the initial open field phase of the NOR test (Del Arco, Zhu 
et al. 2004, Ishikawa, Ogawa et al. 2014) which has relevance to disorganised motor behaviour in 
schizophrenia.  
 
The test took place over two consecutive days and involved three phases (Figure 2). Socialised and 
isolated animals were recorded in the arena individually. The total number of animals recorded as 
part of the NOR test was as follows; FS n=34, FI n=33, MS n=30 and MI n=30. Due to technical 
difficulties not all data were suitable for analysis; final numbers used for each trial phase are 
reported below. The protocol used in the NOR test followed that of our collaborators at North-West 
University (Möller, Du Preez et al. 2013, Uys, Shahid et al. 2016). On the first day, each animal 
underwent phase 1 ‘open field exploration’ for 10 minutes in an empty arena. On the second day, 
the animal underwent phase 2 ‘object familiarisation’ for 10 minutes whereby two identical objects 
were introduced to the arena. Finally, after an interval of 60-90 minutes, phase 3 ‘novel object 
recognition’ took place for 5 minutes where one familiar object was swapped for a novel object. 
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The apparatus was cleaned with 70 % ethanol and wiped down with water after each rat was tested 
so as to minimise olfactory confounds. In the present study, the arena consisted of an open-topped 
black box (60 cm x 60 cm arena and height of 50 cm). A videorecorder was fixed on a frame above 
the arena to capture the movement of the animal. The videos were later analysed offline using 
Noldus Ethovision (version 7.0). Movement was tracked with centre-point detection of the rat for 
more general exploratory parameters and nose-point detection for more specific investigatory 
parameters. Statistical tests were performed on parameters recorded from the first minute of each 
video to give an insight into the immediate novelty response. Statistical tests were also performed 
on parameters recorded from the first five minutes of each video to give an idea of short term 
attentional processing. Analysis of the full ten minutes of phase 1 was also performed. Analysis of 
all time bins was beyond the scope of this project. 
 
 
Figure 2- Novel object recognition test apparatus 
Three phases of NOR test.  
1: Centre-point detection tracking (red dot), measuring distance travelled (cm), time spent (s) within 
and number of entries into the inner-zone (IZ). 1
st
 minute, 5 minutes and 10 minutes analysed. 
2 and 3: Centre-point detection tracking (red dot) measuring distance travelled (cm), time spent (s) 
within and the number of entries into the quadrants (Q1, Q2, Q3, Q4). Nose-point detection tracking 
(blue dot) measuring time spent (s) with, the number of approaches to, and latency (s) to the first 
approach of the objects (O1, O2). 1
st
 minute and 5 minutes analysed.   
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2.2.1 PHASE 1- OPEN FIELD EXPLORATION  
 
On the first day of testing, after spending 60 minutes in the home cage in the behavioural suite as 
detailed above each animal underwent phase 1open field testing (Figure 2.1) FS n=24, FI n=23, MS 
n=25 and MI n=25. During the open field test the arena was completely empty, no objects were 
present, and each rat was recorded moving around this open space for 10 minutes. This provided a 
measure of the rat’s reaction to a novel environment outside of the home cage for the first time 
since conditioning and to allow the rat to become familiar with the arena before objects were added 
in later phases. At the end of this time the recording was stopped and the animal was returned to its 
home cage.  
Phase 1 was considered as a habituation session for the latter stages of the NOR task (Antunes and 
Biala 2012). This phase exposed animals to a novel environment for the first time since 
experimental conditioning and allowed them to become familiar with the apparatus before objects 
were added in the later phases. Animals were tested individually in the arena. The experimenter 
started the recording, gently placed the rat in the middle of the arena facing the back wall (East) 
and then exited the room. All rats were held at the base of the tail, in line with the protocol of 
minimal handling. The following parameters from phase 1 were recorded based on rat centre-point 
detection; distance travelled (cm), time spent within the inner-zone (s) and the number of entries 
into the inner-zone. The distance was used as a measure of locomotor activity (Prut and Belzung 
2003), and inner-zone measurements were used as an indicator of exploratory behaviour 
(Matsumoto, Uehara et al. 2014) and anxiety, related to fear of open or unfamiliar territory (Das, 
Barhwal et al. 2015). Three temporal analyses were conducted for each of these parameters. The 
analysis of the first minute was performed in order to provide an indication of immediate reaction 
to the novel environment, the analysis of the first 5 minutes and full 10 minutes of the test were to 
give an indicator as to whether response changed over time and how the groups might habituate. 
 
2.2.2 PHASE 2- OBJECT FAMILIARISATION 
 
On the second day, after spending 60 minutes in the home cage in the behavioural suite, each 
animal underwent phase 2 object familiarisation testing (Figure 2.2). FS n=24, FI n=22, MS n=25 
and MI n=24. The testing arena was the same as in phase 1 but in phase 2 two identical objects 
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were added. Object 1 and object 2 (two identical triangular blocks of wood, 5 cm x 5 cm x 3 cm) 
were secured to the base in the top left hand and top right hand corners of the box. The animal was 
left to explore these objects for 10 minutes to allow for familiarisation. At the end of this time the 
recording was stopped and the animal was returned to its home cage. The arena and objects were 
cleaned with 70 % ethanol solution and water and wiped down in between animals. The objects 
were swapped from corner to corner in between every trial to eliminate potential bias.  
The purpose of this stage of testing was to allow the animals to familiarise themselves with the 
objects and show that there was no preference for either. If a difference in preference was 
demonstrated between the two objects this was addressed using a correction factor (Equation 2). 
The following parameters from phase 2 were recorded based on rat centre-point detection; distance 
travelled (cm), time spent in each quadrant of the arena (s), and the number of entries into each 
quadrant. The following parameters from phase 2 were recorded based on rat nose-point detection; 
time spent (s) with the identical objects, the number of approaches to the identical objects and the 
latency to approach each identical object for the first time (s). The latency to enter the quadrants 
was not measured as this was subject to random error since the animals were placed in the centre of 
the testing arena at the intersection of the four quadrants at the start of the experiment. One minute 
and five minute analyses were performed on data.  
When the raw data was analysed, it was found that for some variables, animals were showing a 
preference for one of the objects or quadrants and these results were consistent in both the one 
minute and five minute analyses (Appendix Table 40), these data were then corrected to adjust for 
bias (Equation 2). During testing all efforts were made to standardise the apparatus including 
cleaning and swapping the objects in between trials, and by using overhead lighting to eliminate 
shadows. There may however have been stimuli remaining in the room which the rats were 
sensitive to (but the experimenters could not detect), for example a smell or subtle visual cue. 
Another researcher in the same laboratory also found a similar preference for one of the objects 
when analysing phase 2 of the novel object test (data unpublished). It is therefore recommended 
that the equipment be moved to another room for future study in order to determine the source of 
the bias.   
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2.2.3 PHASE 3- NOVEL OBJECT RECOGNITION 
 
This phase of testing also took place on the second day. After phase 2 each rat was returned to its 
home cage for 60-90 minutes. After this time had elapsed each animal underwent phase 3 novel 
object recognition testing (Figure 2.3) FS n=24, FI n=23, MS n=25 and MI n=24. During phase 3 
testing object 1 was replaced with a rectangular block of wood (5 cm x 2 cm x 2 cm), serving as a 
novel object and object 2 was kept the same as in the previous trial, serving as a familiar object. 
The animal was left to explore these objects for 5 minutes. The arena and objects were wiped down 
with 70 % ethanol solution and then water and in between animals. 
The purpose of this phase of testing was to determine whether the animals showed a preference for 
the novel object. Previous studies have demonstrated that socialised animals spend significantly 
longer with the novel object whilst isolated animals show no preference for either of the objects 
(Bianchi, Fone et al. 2006). The parameters recorded were the same as those in phase 2. In this 
phase a discrimination index was calculated to quantify preference for the novel object. The 
difference in time spent in Quadrant 1 and Quadrant 2 (s) was divided by the total time spent in 
these two quadrants (Equation 1) (Tian, Pan et al. 2015). A discrimination index was also 
calculated in this way for the time spent (s) with Object 1 and Object 2. One minute and five 




2.3 IN-VITRO SUPERFUSION  
 
In-vitro superfusion experiments involved incubation of brain tissue with a radioactively-labelled 
neurotransmitter, which was taken up into the synaptic terminals. The tissue was perfused with 
artificial cerebrospinal fluid (Krebs buffer) to maintain neural function and then stimulated 








neurotransmitter. Relative release of this neurotransmitter was quantified by measuring the level of 
radioactivity in fractions collected from the tissue run-off. The amount of radioactivity found in 
these fractions provided a proportional indication of how much radioactively-labelled 
neurotransmitter had been released. The in-vitro superfusion method described herein has been 
characterised in this laboratory over a number of years (Howells and Russell 2008, Warton, 
Howells et al. 2009, Sterley, Howells et al. 2013, Sterley, Howells et al. 2013, Sterley, Howells et 





H]DA) in several rat strains (e.g. spontaneous hypertensive rats, Wistar rats 
and S-D rats) and brain areas (e.g. hippocampus, prefrontal cortex and nucleus accumbens). 
Stimulation media have included glutamate, GABA and potassium as well as the incorporation of 
various other receptor agonists and antagonists. NE release is stimulated via the action of glutamate 
on AMPA and NMDA receptors in the hippocampus and prefrontal cortex (Howells and Russell 
2008). Glutamate release is also known to be stimulated via the activation of adrenoceptors (Chen, 
Li et al. 2006). Additionally GABA serves to reduce the activity of NE neurons when applied to the 
LC (Szabo and Blier 2001). The relationship between these neurotransmitter systems is yet to be 
investigated within the context of the SIR model. One isolated and one socialised rat of the same 
sex and of the same age (i.e; from the same litter) were used in each superfusion experiment. This 
was to ensure the developmental stage was consistent between both brains. Superfusion 
experiments were carried out at 20-25 °C. On the day of testing each rat was weighed and rehoused 
in a clean individual cage and brought up to the laboratory for 60 minutes prior to experimentation 
in accordance with laboratory procedure. Three different superfusion protocols were used in this 
project to investigate the effects of social isolation rearing on neurochemistry under various 
conditions. Basic experimental set up for all superfusions was as follows. 
Animals were killed by rapid decapitation with a guillotine between 09h00 and 10h00 so as to keep 
the time window similar to that used in the behavioural experiments. The brains were immediately 
and swiftly removed from skulls. First, scissors were used to cut through the skin between the ears 
and then rongeurs were used to carefully break away the superior surface of the skull, exposing the 
brain. Any remaining meninges were broken through using the end of a small spatula. The skull 
was then held at an angle, so that the brain could be easily scooped out, and dropped into ice-cold 
carbogenated Krebs slush buffer (118 mM NaCl, 4.7 mM KCl, 1.0 mM NaH2PO4.H2O., 1.2 mM 
MgCl2.6H2O, 25 mM NaHCO3, 11 mM D(+)-Glucose monohydrate, 1.3 mM CaCl2.H2O (all salts 
from Merck) and 37 μM EDTA(AnalR)). The Krebs solution was bubbled with carbogen; 95 % 
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oxygen, 5 % carbon dioxide (AirLiquide) prior to the addition of the brain tissue in order for it to 
become saturated with the gases and to buffer the solution between pH 7.4-7.5. 
After the tissue had bubbled in the ice-cold Krebs for 15 minutes the relevant brain areas were 
dissected out. The prefrontal cortex dissection involved first manually cutting 3 coronal slices from 
the most anterior part of the brain at 900 µm thickness (Figure 3.1) using a tissue chopper 
(McIlwain); this area represents the prefrontal cortex anterior to the genu of the corpus callosum. 
Any olfactory bulb tissue was discarded and the prefrontal cortex slices from both hemispheres 
were then sliced again with the tissue chopper at 300 µm thicknesses and then rotated 90° and 
chopped at 300 µm once more (Figure 3.2). Once the prefrontal cortex had been removed the 
hippocampus was dissected. A scalpel was used to score the superficial connections of the 
longitudinal fissure between the brain hemispheres. The cortex of each hemisphere was gently 
teased off using a small spatula to reveal the hippocampus (Figure 3.3). The hippocampus was then 
eased out using the spatula, taking care to ensure the deepest and most dorsal part was not lost. Any 
vasculature or myelination on the surface of the hippocampus was removed with tweezers. This 
was repeated for the other hippocampus and then both hippocampi were chopped perpendicularly 
into 300 µm x 300 µm columns using the tissue chopper (Figure 3.4).  
 
 
Figure 3- Tissue dissection 
Tissue dissection of rat brain: 1. Whole rat brain and 900 µm prefrontal cortex slicing represented by 
grey lines. 2. Prefrontal cortex slices with orientation of 300 µm x 300 µm cross-cutting. 3. Cortex 
peeled back with hippocampus revealed and outlined in grey. 4. Hippocampi with orientation of 300 




Cross-chopped tissue from each brain area was incubated in glass vials with 1 ml carbogenated ice-
cold Krebs buffer containing 5.7 mM L-ascorbic acid (Sigma Aldrich), an antioxidant preventing 
the production of free radicals, in a water bath at 37 °C for 10 minutes. This was to allow for tissue 
to return to functional homeostatic temperature. From this stage onwards experiments were carried 
out under low intensity (non-fluorescent) lamp lighting so as not to cause excitation of the 
radioactivity. Radioactively-labelled neurotransmitter norepinephrine (2.67 µL DL-,[7-
3
H(N)]- 
norepinephrine hydrochloride, 1 mCi/ml , 12 Ci/mmol Perkin Elmer) was added to each vial and 
incubated with brain tissue in the same water bath for a further 15 minutes to allow for uptake of 
the [
3
H]NE into vesicles.  
Excess solution was pipetted off so as to remove surplus radioactivity which had not been taken up 
into noradrenergic terminals. Tissue was then pipetted into the 16 superfusion columns on top of 
the cotton wool balls, brain areas were split evenly between their respective columns, (2 or 4 
columns per brain area depending on experimental conditions, allowing for repeat data to be 
collected). Inlet tubes submerged in carbogenated Krebs buffer in the 37 °C water bath were 
connected to each column and solution was washed over tissue by means of a peristaltic pump at a 
speed of 0.25 ml / min. Tissue was first perfused with Krebs buffer for 80 minutes to remove any 
remaining radioactivity not taken up into the noradrenergic terminals. Following this, the motor of 
the fraction collector rack was engaged and every 5 minutes the rack was moved up so that the 
columns dripped into a new row of collecting vials, whilst being perfused with either plain Krebs 
buffer or a stimulating solution of Krebs buffer. Ten samples were collected per column, thus 
providing an indication of functional release of [
3
H]NE from the tissue under differing conditions 
summarised in Table 4. 
Once the first 9 samples had been collected the motor was disengaged and the cotton wool ball 
together with the tissue from each column was placed into the 10
th
 sample vial with 1ml 0.1 M 
NaOH. Then 3.4 ml liquid scintillation fluid (Aquasafe 500plus Zinsser Analytic) was added to 
each sample vial to suspend radioactivity, thus permitting efficient counting of the radioactivity by 
optimising photon emission. Radioactivity in degradations per minute (DPM) were recorded by a 
Packard 1900 TRI-CARB liquid scintillation analyser based on a standard decay curve generated 
from quenched tritium standard samples ( Figure 86). Fractional release of [
3
H]NE was calculated 
from the DPMs for each column of tissue. First the DPMs from each 5 minute fraction were 
divided by the total amount of radioactivity in the tissue at the time of release of that fraction (the 
sum of the fraction in question added to all subsequent fractions). This provided the fractional 
release of [
3
H]NE relative to the total radioactivity at the time the fraction was collected. Then, the 
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fractional release value calculated for the preceding baseline fraction was subtracted from each 
stimulation fraction value and multiplied by 100 to give percentage release of [
3
H]NE for each 
stimulation.  
An average was calculated for each of the three stimulations for all columns containing identical 
tissue receiving identical stimulation protocol (Figure 4). Column data were removed from the 
analysis where the first stimulation was lower than the initial baselines, accepted as error within the 
experimental set-up for that column only. 
 
Table 4- SF1, 2, 3 collection vial order and stimulation sequences 
Order of superfusion solution contents for protocols 1, 2, and 3. Each row represents a 5 minute fraction 
where HC = hippocampus, PFC = prefrontal cortex, Glu = glutamate, Ant = ionotropic glutamate antagonist; 






Figure 4- Superfusion fractional release, example of calculation 
Representative graphs from a superfusion experiment. Graph 1 shows fractional release of [
3
H]NE 
from each 5 minute fraction as a percentage of the total radioactivity present in the tissue at the time 
of release in four repeat columns (containing the same brain area undergoing the same stimulation 
protocol). Graph 2 shows percentage release of [
3
H]NE from stimulations 1,2 and 3 calculated from 
stimulation peak and preceding baseline values in graph 1. For each corresponding column of tissue; 
the baseline 2 value was subtracted from the stimulation 1 value and multiplied by 100, the baseline 
3 was subtracted from the stimulation 2 value and multiplied by 100, and the baseline 4 was 
subtracted from the stimulation 3 value and multiplied by 100. An average for each stimulation was 
then calculated from the four columns for each brain area and stimulation protocol.  
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2.3.1 SF 1- GLUTAMATE-STIMULATED [3H]NE RELEASE 
IN HIPPOCAMPUS AND PREFRONTAL CORTEX 
 
The first group of superfusion experiments measured relative release of [
3
H]NE from prefrontal 
cortex and hippocampus when stimulated with glutamate-containing Krebs buffer FS n=12, FI 
n=12, MS n=10 and MI n=10. Stimulations 1, 2 and 3 consisted of superfusion with Krebs buffer 
containing 250 μM L-Glutamic Acid (Sigma Aldrich). The purpose of these experiments was to 
probe how NE release might differ between sex and housing groups upon excitation with 
glutamate. This concentration was previously determined in our laboratory as sufficient to elicit 
[
3
H]NE release in superfusion experiments (Howells and Russell 2008, Mc Fie, Sterley et al. 2012). 
During these stimulations all inlet tubes were moved from the plain Krebs buffer into the 
glutamate-containing Krebs buffer for the first 1 minute then back to the plain Krebs buffer for the 
remaining 4 minutes of the fraction (Table 4), (Table 5). The first 7 superfusion experiments were 
completed and analysed in the beta counter, the samples were then disposed of due to limited 
radioactive storage space. Subsequently it was noted that the beta counter was not recording DPMs 
consistently. Alterations were made so that the room in which the counting took place was 
completely dark and the vials for counting were of optimal size. For this reason the first 7 
experiments were excluded from the final analysis. This meant that the total number of animals 
whose data were analysed was FS n=7, FI n=7, MS n=8 and MI n=8. 
 
Table 5- SF1, column order 
Row A- Column number 
Row B- Brain tissue (HC = hippocampus, PFC= prefrontal cortex)  





2.3.2 SF 2- GLUTAMATE-STIMULATED [3H]NE RELEASE 
IN HIPPOCAMPUS IN PRESENCE OF MK-801 AND/OR 
CNQX 
 
The second group of superfusion experiments measured relative release of [
3
H]NE in the 
hippocampus only, when stimulated by glutamate in the presence of ionotropic glutamate AMPAR 
and NMDAR antagonists CNQX (6-cyano-7-nitroquinoxaline-2, 3-dione) and MK-801 
(Dizocilpine) respectively FS n=7, FI n=7, MS n=7 and MI n=7. This was to provide information 
on the functionality of these glutamate receptors and their contributions to NE function. 
Stimulations 1, 2 and 3 consisted of superfusion with glutamate-containing Krebs buffer (same as 
in superfusion 1 protocol) with the addition of either 1) nothing as a control condition, 2) 1 μM 
CNQX, 3) 10 μM MK-801 or 4) 1 μM CNQX and 10 μM MK-801 in combination (Howells and 
Russell 2008). During these stimulations all inlet tubes were moved from the plain Krebs buffer 
into one of the four abovementioned Krebs buffer solutions for the first 1 minute then back to the 
plain Krebs buffer for the remaining 4 minutes of the fraction (Table 4, Table 6). Two superfusion 
experiments were excluded because the data showed that there was no effect of stimulation FS n=6, 
FI n=6, MS n=6 and MI n=6. This was likely due to a blockage of the inlet tube; inlet tubes were 
routinely replaced when blockages were detected. Only one brain area could be assayed in this part 
of the study due to the number of columns available for repeats. The hippocampus was chosen over 
the prefrontal cortex as in testing it was found that relatively more [
3
H]NE was released in the 
hippocampus upon stimulation with glutamate.  
 
Table 6- SF2, column order 
Row A- Column number 
Row B- Brain tissue (HC = hippocampus) 
Row C- Animal housing conditions (Iso = isolated, Soc = socialised) 





2.3.3 SF 3- GLUTAMATE, GABA AND KCL-STIMULATED 
[3H]NE RELEASE IN HIPPOCAMPUS AND PREFRONTAL 
CORTEX 
 
The third group of superfusion experiments measured relative release of [
3
H]NE in the prefrontal 
cortex and hippocampus when tissue was stimulated first by Krebs buffer containing glutamate and 
then γ-aminobutyric acid (GABA) or vice versa and then for the third stimulation with Krebs buffer 
containing a high concentration of KCl, FS n=18, FI n=18, MS n=7 and MI n=7. The purpose of 
these experiments was to assess the role of excitatory and inhibitory neurotransmitters on NE 
activity. Glutamate-containing Krebs buffer was prepared by the same method as stated in the 
superfusion 1 protocol. Other stimulating Krebs buffer solutions were; 100 μM GABA (Sigma 
Aldrich)-containing Krebs buffer and high concentration KCl-containing Krebs buffer (98 mM 
NaCl, 25 mM KCl, 1.0 mM NaH2PO4.H2O., 1.2 mM MgCl2.6H2O, 25 mM NaHCO3, 11 mM D(+)-
Glucose monohydrate, 1.3 mM CaCl2.H2O), (all salts from Merck) and 37 μM EDTA (AnalR). 
These concentration had been determined by previous work in our laboratory (Sterley, Howells et 
al. 2013). The volumes of the salts were adjusted accordingly to achieve these different molarities. 
The high concentration KCl-containing Krebs buffer was used to evoke depolarization-induced 
release of neurotransmitter as an indicator of neurotransmitter reserves. During baseline fraction 
collections, all inlet tubes were submerged in Krebs buffer and during stimulations, inlet tubes were 
moved into glutamate/GABA/high concentration KCl-containing Krebs buffer for the first 1 minute 
then back to the plain Krebs buffer for the remaining 4 minutes of fraction collection. During the 
first stimulation half of the inlet tubes were moved from plain Krebs buffer into glutamate-
containing Krebs buffer and the other half were moved into GABA-containing Krebs buffer. For 
the second stimulation inlet tubes were moved into whichever glutamate-containing or GABA-
containing Krebs buffer they had not been in for the previous stimulation. For the third and final 
stimulation all inlet tubes were moved into high concentration KCl-containing Krebs buffer, (Table 
4, Table 7). Once experiments not showing effective stimulations had been removed the total 




Table 7- SF3, column order 
Row A- Column number 
Row B- Brain tissue (HC = hippocampus, PFC = prefrontal cortex) 
Row C- Animal housing conditions (ISO = isolated, SOC = socialised) 
Row D- First stimulation Krebs buffer solution composition (G = glutamate, GA = GABA) 
Row E- Second stimulation Krebs buffer solution composition (G = glutamate, GA = GABA) 
Row F- Third stimulation Krebs buffer solution composition (K = high concentration KCl) 
 
 
2.4 ELISA DETERMINATION OF NE AND 
GLUTAMATE CONCENTRATIONS IN 
HIPPOCAMPUS AND PREFRONTAL CORTEX  
 
Competitive enzyme-linked immunosorbent assay (ELISA) kits were used for quantitative 
determination of NE and glutamate in tissue homogenates of prefrontal cortex and hippocampus 
tissue (LDN immunoassays and services: Noradrenaline Research ELISA, Glutamate ELISA). For 
full instructions refer to appendix (Figure 93, Figure 94, Figure 98 and Figure 99). 
The principle of a competitive ELISA is to measure endogenous concentrations of 
peptides/proteins/antibodies/hormones. In the present study concentrations of glutamate and NE 
were investigated using ELISAs. Antigens to the specific neurotransmitter (antibody) are bound in 
solid state to the wells of the ELISA plate. Thus, when brain tissue homogenate is added, the 
antigen pre-coating on the plate will compete for binding sites, i.e. the respective neurotransmitter 
bind to their respective antigen. Then, any antigen-antibody complexes not bound to the solid phase 
will be washed away. Following this a secondary antibody is added which binds to the solid phase 
antigen-antibody complexes left in the wells. The secondary antibody is conjugated to a molecule 
which can be detected using a chromogenic substrate when read at 450 nm. In a competitive assay 
the mean optical densities calculated will be inversely proportional to the analyte concentration. 
62 
 
Therefore a low signal detected in the solid-phase antigen-antibody complexes indicates a high 
level of sample/control/standard antigen-antibody complexes have been washed off, thus indicating 
a high level of the antigen of interest has been detected.  
In previous studies NE levels were found to fluctuate around 200 ng/g (concentration NE / wet 
weight tissue) in the hippocampus and cortex of S-D rats when determined by HPLC (Jiang, Li et 
al. 2014). These rats had also been subject to sodium taurocholate injections in the bile-pancreatic 
duct, however this was found not to affect the neurotransmitters assayed in brain tissue and was 
therefore a suitable starting point when choosing the concentrations to use in this study. Another 
group using HPLC determined levels of NE in the hippocampus and prefrontal cortex at 233 and 
252 ng/g respectively in control groups of Wistar rats (Del Pino, Martínez et al. 2011). HPLC has 
also been used to measure glutamate in the hippocampus and prefrontal cortex in S-D rats with 
concentrations found to be 6.5 and 11.2 mg/g respectively (Liu, Tang et al. 2011).  
Four ELISAs were performed in order to quantify NE in the hippocampus, NE in the prefrontal 
cortex, glutamate in the hippocampus and glutamate in the prefrontal cortex. Animals were brought 
up to the laboratory 60 minutes prior to experimentation. Each animal was rapidly decapitated 
using a guillotine and the head was immediately and briefly submerged in liquid nitrogen in order 
to reduce deterioration of the tissue during dissection. The brain was removed by the same 
procedure as stated in the superfusion set up. The most anterior portion of the frontal cortex (5mm) 
was sliced off coronally using a scalpel blade (Figure 3.1). Both hippocampi were dissected out 
whole using the same technique as detailed in the superfusion set up, without cross chopping 
(Figure 3.3, Figure 3.4). Each brain area was placed in its entirety into a cryo-vial, snap frozen and 
stored in liquid nitrogen until such time as they were used in the assay.  
ELISAs were carried out at 20-25 °C. On the day of the experiment the tissue was thawed on ice. 
The tissue from the hippocampus and prefrontal cortex of each animal were weighed. Sample 
buffer was added according to the weight of the tissue so that homogenates of 200 mg/ml could be 
made for each sample. The sample buffer contained 1 mM EDTA (AnalR) and 4mM sodium 
metabisulfate (Merck) and 0.01 N HCl (Merck) to prevent catecholamine degradation and to 
provide optimal pH and solubility. The tissue was homogenised in buffer by sonication for 10-15 
seconds so that sound waves could break up tissue membrane and vesicular compartments to allow 
the neurotransmitters of interest in all parts of the cell to bind to the kit antigens.  
A preliminary concentration optimisation assay was performed for each of the two ELISA kits. One 
tissue homogenate from each brain area was diluted to a number of concentrations ranging from 1 
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mg/ml to 200 mg/ml. This range was chosen based on previous studies and detailed above. ELISAs 
were carried out as per the manufacturer’s instruction (detailed below). The different 
concentrations were assayed against standard and control samples supplied with the kit. This was to 
ascertain which concentrations would provide an optimal reading on the linear section of the 
standard spline curve generated. Optimal concentrations chosen based on this first determination 
were 5 mg/ml and 10 mg/ml to ensure that data were readable on the graph for both NE and 
glutamate experiments (Figure 95, Figure 100). Two different concentrations were chosen due to 
slight variability between the hippocampus and prefrontal cortex 
Once the optimal concentrations had been decided a separate ELISA was carried out on all samples 
for each neurotransmitter, brain area combination. Sample sizes were as follows Hippocampus NE: 
FS n=6, FI n=6, MS n=6 and MI n=6, prefrontal cortex NE: FS n=6, FI n=6, MS n=6 and MI n=6, 
hippocampus glutamate: FS n=10, FI n=10, MS n=10 and MI n=10 and prefrontal cortex glutamate 
FS n=6, FI n=6, MS n=6 and MI n=6. For each ELISA 5 mg/ml and 10 mg/ml concentration were 
prepared for each sample by diluting thawed homogenates with sample buffer. These were used as 
repeats.  
For the NE ELISAs the extraction plate phase was performed first. This involved pipetting 10 μl of 
the standards, controls, and samples into each well and then adding a further 90 μl distilled water 
and 25 μl of TRIS-EDTA buffer to each well. Importantly, each homogenate was vortexed for 10 
seconds immediately before being added to the plate. This ensured that the heavier tissue had not 
separated from the buffer. The plate was placed in a plate shaker for 60 minutes at 600 revolutions 
per minute (rpm). Following this the plate was inverted to remove all liquid. Next, 1 ml wash buffer 
was added to each well and it was returned to the shaker for 5 minutes, the plate was then inverted 
and this step was repeated. Acylation of the plates involved adding 150 μl acylation buffer and 25 
μl acylation reagent to the wells and shaking for 20 minutes then inverting the plate. The plate was 
then washed twice more with wash buffer as previously described. Following this 100 μl HCl was 
added to each well and the plate was shaken for 10 minutes. These steps optimise the pH of the 
supernatant for the subsequent enzymatic conversion. 
The following steps involved the microtiter plate. From the extraction plate 90 μl of the supernatant 
was pipetted in to the microtiter plate making sure to maintain the same sample order between 
plates. Then 25 μl of a pre-prepared enzyme solution was added to the wells and the plate was 
shaken for 1 minute then incubated for two hours at 37 °C.  
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The final stages were carried out in the NE microtiter strips. The NE microtiter strips were pre-
coated with an NE antigen so that the anti-NE antibody would bind to the plate. From the microtiter 
plate 100 μl from each well was pipetted into the NE microtiter strips plate. Then 50 μl of NE 
antiserum was added to every well and the plate was shaken for 1 minute. This was a rabbit anti-
NE antibody which bound to NE in the sample and on the plate. NE in the sample competed with 
NE on the microtiter strips plate. The plate was then incubated in the fridge (4 °C) overnight to 
ensure maximal binding site occupation. In the morning the plate was inverted and was washed 4 
times by adding 300 μl wash buffer to each well and then inverting. This removed any anti-NE 
antibody that was not bound to NE on the plate. Next, 100 μl of the enzyme conjugate was added 
and the plate was shaken for 30 mins. This was a goat anti-rabbit immunoglobulin which would 
bind to the rabbit antibody. The 4-step wash procedure was then repeated. Next, 100 μl of the 
chromogenic substrate was added to all wells and the plate was shaken for 25 minutes. This step 
tagged the NE bound to the plate with a chromogenic molecule which could be detected in the plate 
reader at 450 nm. Lamp lighting was used from this phase onwards so as not to excite the substrate. 
Finally 100 μl stop solution was added to end any reactions and the plate was read at a wavelength 
of 450 nm.  
The principle of the glutamate ELISAs was the same as for the NE ELISA and the procedures were 
largely the same. Briefly, 100 μl of the samples, standards and controls were added to the extraction 
plate along with 100 μl of diluent and the plate was shaken for 10 minutes. Then 25 μl from each 
well of the extraction plate was pipetted into the wells of the reaction plate. An additional 10 μl 
NaOH, 50 μl equalising reagent and 10 μl of D-reagent were then added to each well and the plate 
was shaken for two hours. Then 75 μl Q-buffer was added to each well and the plate was shaken for 
a further 190 minutes.  
For the ELISA itself, 25 μl from each extraction plate well was pipetted into the glutamate 
microtiter strips plate and 50 μl glutamate antiserum was added. The plate was then incubated in 
the fridge (4 °C) overnight to ensure maximal binding site occupation. The plate was washed and 
inverted 3 times using 300 μl wash buffer and then 100 μl of the enzyme conjugate was added to 
each well and the plate was shaken for 30 mins. The 3-step washing procedure was then repeated, 
ensuring no unbound glutamate antibody remained in the wells. Next 100 μl of the chromogenic 
substrate was added to all wells and the plate was shaken for 25 minutes, again, lamp lighting was 
used from this step onwards. Finally 100 μl stop solution was added to end any reactions and the 
plate was read at a wavelength of 450 nm. 
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The plate reader gave the optical density value of each well. These optical density values were 
subtracted from an average of the background values (the first standard with no neurotransmitter at 
all). These values were entered into the online ELISA calculation tool elisaanalysis.com for each of 
the four brain area and neurotransmitter combinations. Standard curves were generated and the 
corresponding concentrations of each sample were calculated according to this standard curve 
(Figure 96, Figure 97, Figure 101 and Figure 102). The regression algorithm used was a 4-paramter 
logistic regression. The resulting neurotransmitter concentrations from the original 5 mg/ml and 10 
mg/ml (tissue per volume of buffer) samples were divided by 5 and 10 respectively and an average 
was taken of the two values. The final concentrations were expressed as neurotransmitter per wet 
weight of tissue.  
 
2.4.1 BCA PROTEIN ASSAY 
 
The bicinchoninic acid protein assay (Pierce
TM 
BCA Protein Assay Kit) is used to determine the 





) (Figure 103, Figure 104). This reduction is known as the biuret reaction and takes 
place due to the presence of protein in an alkaline environment (Smith, Krohn et al. 1985). One the 
reduction has taken place the Cu
1+
 chelates with the BCA leading to a measureable colour change. 
The BCA assay was used as a follow-up to the ELISA so that neurotransmitter concentrations 
could be expressed per wet weight of tissue and also per total protein. Frozen tissue in sample 
buffer from ELISAs at 200 mg/ml concentrations was thawed and made up to 5 mg/ml 
concentrations in RIPA (Radio immunoprecipitation assay) buffer containing 150 mM NaCl 
(Merck), 1 % Triton-X 100 (Merck), 0.1 % Sodium Dodecyl Sulfate (Sigma), 20 mM Tris 
(hydroxymethyl) aminomethane (pH7.5) (Merck), 1 % Sodium Deoxycholate (Sigma). This assay 
was performed on lysates from hippocampus-NE, prefrontal cortex-NE and hippocampus-
glutamate ELISA experiments. Unfortunately homogenates from the first day of testing (prefrontal 
cortex-glutamate ELISA) were not frozen immediately so were not suitable for further BCA tests. 
BCA assays were performed following microplate procedure. First 25 μl of each standard and 
sample were pipetted into the wells and 200 μl of working reagent was added then the plates were 
placed on a plate shaker for 30 seconds then incubated at 37 °C for 30 minutes. Finally, 
absorbances were measured on a plate reader set to 562nm. Standard curves were made and the 
corresponding concentrations of each sample were calculated according to this standard curve 
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(Figure 105, Figure 106 and Figure 107). Concentrations from the BCA assay were converted into 
the same units as ELISA values, in order to express results as neurotransmitter per total protein 
ELISA concentrations were divided by BCA concentrations.  
 
2.5 ULTRASONIC VOCALISATION TESTING 
 
The aim of this part of the study was to provide insight into the impact of social isolation on 
communicative behaviour to address negative symptomatology of schizophrenia by analysing 
ultrasonic vocalisation recordings from each animal. Rats emit vocalisations at ultrasonic 
frequencies; these vocalisations have a communicative function in social context and also indicate 
affective state (Portfors 2007). Calls in the 22 kHz frequency band with durations between 300 ms- 
3000 ms provide an indication of fear, anxiety or negative affect and are present in aversive 
environments (Litvin, Blanchard et al. 2007, Ouda, Jílek et al. 2016). Studies from socially isolated 
rats have typically shown that isolated animals emit significantly fewer calls in the 300ms – 
3000ms 22 kHz range than their socialised counterparts (Nunes Mamede Rosa, Nobre et al. 2005, 
Inagaki and Mori 2013). This reduction in calls can be interpreted as an indication of abnormal 
communication in isolated animals and social withdrawal.  
In the present study recordings were taken in the 22 kHz range. During testing one isolated animal 
and one socialised animal of same sex and age were each recorded from using two separate bat 
detectors (Figure 5) FS n=16, FI n=16, MS n=8 and MI n=8. The protocol was replicated from 
previous studies by our lab (Dimatelis, Vermeulen et al. 2016). One animal was placed in each of 
the two transparent Plexiglas cylinders (height 70 cm, diameter 28 cm), 3 cm apart so that during 
the experiment the animals could see each other, thus providing stimulus for communication, no 
other rats were present in the room at the time of recording. Each cylinder was cleaned with 70 % 
ethanol and then water after every experiment and lined with fresh sawdust, as hormonal scent cues 
have been shown to impact calling behaviour, in addition to this, only one sex of rat was tested per 
day (Geyer and Barfield 1978). A directionally sensitive bat detector (Mini-3, Ultra Sound Advice) 
was hung halfway down each cylinder, aimed downwards towards the cylinder floor and the rat 
being tested, so that it detected only the vocal emissions from the animal directly below it and not 
from the rat in the adjacent cylinder. These recordings were processed through UltraVox software 
(Noldus Information Technology, Wageningen, Netherlands). Vocalisations provided an indicator 
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of response to a novel environment given that it was the first time animals were not in their home 
cage. Animals were gently placed in Plexiglas cylinders and a 10 minute recording was initiated by 
the experimenter who then exited the behavioural suite. Software recorded call duration (ms) at 22 
kHz range. Call durations of 300 ms- 3000 ms were analysed and shorter or longer lengths removed 
from analysis, as these call durations at 22 kHz are associated with anxiety (Anderson 1954, 
Brudzynski 2005, Portfors 2007, Inagaki and Mori 2013). Mean call durations and total number of 
calls were the two parameters statistically analysed. An initial malfunction of the equipment meant 
that data from 7 animals had to be removed from the analysis, this malfunction was addressed and 
recordings for all other animals were made FS n=14, FI n=16, MS n=5 and MI n=6. Following this, 
it was noted that the two bat detectors seemed to be recording with different sensitivities (i.e.: 
Channel A seemed to be making consistently more recordings than Channel B). To ensure that this 
did not bias the data, socialised and isolated animals were alternated between the two different 
recorders and chambers. This difference in the recording equipment was analysed and corrected for 
by applying a scale factor so that results obtained from the detectors were comparable (Appendix: 





Figure 5- Ultrasonic vocalisation test apparatus 
During each experiment, two separate recordings were made of ultrasonic vocalisations from one 
socialised and one isolated rat at the 22 kHz range. One rat from each housing condition was placed 
into each of the transparent Plexiglas cylinders. Recordings of the calls from each rat were made by 




2.6 STATISTICAL ANALYSES  
 
All statistical analyses were carried out using Dell Statistica data analysis software system, version 
13. Dell Inc. (2015). All graphs were designed with Microsoft Excel (2010). Data were tested 
firstly for main housing effects 
*
 between socialised and isolated animals within sex groups (i.e.: I 
vs. S for parametric tests or MS vs. MI / FS vs. FI for nonparametric tests), then for sex differences 
#
 (i.e.: M vs. F for parametric tests or MS vs. FS / MI vs. FI for nonparametric tests) and then any 
experimental differences 
^
 (Channel A vs. B / Quadrant 1 vs. 2 etc.). Comparisons across housing 
and sex (i.e.: MS vs. FI / MI vs. FS) are included in appendices but not results section. Each data 
set was tested for normal distribution using Shapiro-Wilk W test where p>0.05 met criterion for 
normal distribution. If the data set were of normal distribution parametric factorial or repeated 
measures analysis of variance (ANOVA) was performed with sex (male, female) and housing 
(isolated, socialised) as categorical variables followed by Bonferroni post-hoc testing of significant 
effects. Parametric data are reported with their mean and standard deviation (SD). 
If the data set did not fit the criterion for normal distribution and easily converted to a normal 
distribution using standard data transform functions then an appropriate nonparametric analysis was 
selected; Kruskal Wallis test, Friedman test, Wilcoxon test or Mann Whitney U test (with 
correction for multiple comparisons where appropriate). For nonparametric analyses, grouping 
variables were flattened into sex_housing, to create groups; female_isolated (FI), female_socialised 
(FS), male_isolated (MI) and male_socialised (MS). Nonparametric data are reported with their 






3.1 BODY WEIGHT  
 
Statistical tests were applied to body weight data (Figure 6) (n=175, 50 FS, 49 FI, 38 MS, 38 MI). 
At p42-49 differences were found between the groups (H(3, N=175) =30.27 p<0.0001), comprising of 
a main effect of housing where MI was heavier than MS, p=0.0487, and sex differences where MI 
was heavier than FI, p=0.0078, and MS was heavier than FS, p=0.046. At p49-56 differences were 
found between the groups (H(3, N=175) =58.99 p<0.0001), comprising of sex differences where MI 
was heavier than FI, p<0.0001 and MS was heavier than FS, p<0.0001. For all of the following 
weeks differences were found between the groups; p56-63 (H(3, N=175) =109.6 p<0.0001), p63-70 
(H(3, N=175) =125.5 p<0.0001), p70-77 (H(3, N=175) =129.1 p<0.0001), p77-84 (H(3, N=175) =130.8 
p<0.0001) and p84-91 (H(3, N=175) =131.4 p<0.0001). These results showed sex differences such that 
MS was heavier than FS and MI was heavier than FI, p<0.0001, for all results. Full statistical tables 




Figure 6- Body weight 
Body weight recorded weekly from post-natal day 21 through to post-natal day 92 for each 
sex_housing group; female socialised (FS n=50) and female isolated (FI n=49), male socialised (MS 
n=38), male isolated (MI n= 38). Differences are indicated as follows: 
*
Main effect of housing (MI 
vs. MS), 
# 
Sex difference (MS vs. FS / MI vs. FI), where first group listed in pair was heavier. 
Differences FS vs. MI, FI vs. MS not shown. Data are presented as median ± IQR, see text for 
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3.2 NOVEL OBJECT RECOGNITION TEST 
3.2.1 PHASE 1- OPEN FIELD EXPLORATION ANALYSIS 
 
Three temporal analyses were performed on the phase 1 data including; the first minute, the first 
five minutes and the full ten minutes (Figure 7).  
 
 
Figure 7- NOR P.1, Example traces 
Sample analyses showing the cumulative exploration of two rats over the time course of the 
open field test as tracked with centre-point detection by Noldus software.   
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3.2.1.1 P.1- FIRST MINUTE  
 
Data from the first minute of the open field exploration trial (phase 1) were analysed, (n=97, 24 FS, 
23 FI, 25 MS, 25 MI). All phase 1 variables were tracked using centre-point detection (Figure 2.1). 
The following parameters were analysed; distance travelled in the arena (cm), time spent within the 
inner-zone (s) and number of entries into the inner-zone. Full statistical tables can be found in 
appendix A.2.1.1. 
For the distance travelled (cm) (Figure 8), a main effect of housing was found (F(1, 93) =7.363, 
p=0.0079), where socialised animals travelled further than isolated animals, p=0.0080. Sex 
differences (F(1, 93) =10.82, p=0.0014), were also found where females travelled further than males, 
p=0.0012. Neither housing nor sex differences were found for the time spent in the inner-zone (s) 
(Figure 9). For the number of entries made into the inner-zone (Figure 10), a sex difference was 
found (H(3, N=97) =17.00, p=0.0007), where socialised males made more entries into the inner-zone 
than socialised females, p=0.0208, and isolated males made more entries into the inner-zone than 
isolated females, p=0.0387.  
 
 
Figure 8- NOR P.1 1 MIN, Distance travelled (cm) 
Distance travelled (cm) during open field exploration (phase 1) for each sex and housing group; 
female socialised (FS n=24), female isolated (FI n=23), male socialised (MS n=25) and male 
isolated (MI n=25). 
*




























travelled further than isolated animals, p=0.0080. 
#
A sex difference was found, p=0.0014, where 
females travelled further than males (p=0.0012). Data are presented as mean ± SD. 
 
Figure 9- NOR P.1 1 MIN, Time spent in the inner-zone (s) 
Time spent in the inner-zone (s) during open field exploration (phase 1) for each sex_housing group; 
female socialised (FS n=24) and female isolated (FI n=23), male socialised (MS n=25) and male 
isolated (MI n=25). Neither housing nor sex differences were found. Data are presented as median ± 
IQR with min and max values 
 
Figure 10- NOR P.1 1 MIN, Number of inner-zone entries 
Number of entries into the inner-zone during open field exploration (phase 1) for each sex_housing 
























































male isolated (MI n=25). 
#
A sex difference was found, p=0.0007, where MI were found to enter the 
inner-zone more frequently than FI, p=0.0387, and MS were found to enter the inner-zone more 
frequently than FS, p=0.0208. Data are presented as median ± IQR with min and max values. 
 
3.2.1.2 P.1- FIVE MINUTES 
 
Data from the first five minutes of the open field exploration trial (phase 1) were combined and 
analysed, (n=96, 24 FS, 23 FI, 25 MS, 24 MI). All variables from phase 1 were tracked using 
centre-point detection (Figure 2.1). The following parameters were analysed; distance travelled in 
the arena (cm), time spent within the inner-zone (s) and number of entries into the inner-zone. Full 
statistical tables can be found in appendix A.2.1.2. 
Neither housing nor sex differences were found for distance travelled (cm) (Figure 11). Neither 
housing nor sex differences were found for the time spent (s) in the inner-zone (Figure 12). For the 
number of entries made into the inner-zone (Figure 13), a sex difference was found (F(1, 92) = 8.207, 
p=0.0052), where males made more entries into the inner-zone than females, p=0.0055.  
 
 
Figure 11- NOR P.1 5 MIN, Distance travelled (cm) 
Distance travelled (cm) during open field exploration (phase 1) for each sex and housing group; 



























isolated (MI n=24). Neither housing nor sex differences were found. Data are presented as mean ± 
SD. 
 
Figure 12- NOR P.1 5 MIN, Time spent in the inner-zone (s) 
Time spent in the inner-zone (s) during open field exploration (phase 1) for each sex_housing group; 
female socialised (FS n=24) and female isolated (FI n=23), male socialised (MS n=25) and male 
isolated (MI n=24). Neither housing nor sex differences were found. Data are presented as median ± 
IQR with min and max values. 
 
Figure 13- NOR P.1 5 MIN, Number of inner-zone entries 
Number of entries into the inner-zone during open field exploration (phase 1) for each sex_housing 
group; female socialised (FS n=24) and female isolated (FI n=23), male socialised (MS n=25) and 



























































male isolated (MI n=24). 
#
A sex difference was found, p=0.0051, where males were found to enter 
the inner-zone more frequently than females, p=0.0055. Data are presented as mean ± SD. 
3.2.1.3 P.1- TEN MINUTES 
Data from the full ten minutes of the open field exploration trial (phase 1) were analysed, (n=97, 24 
FS, 23 FI, 25 MS, 25 MI). All variables from phase 1 were tracked using centre-point detection 
(Figure 2.1). The following parameters were analysed; distance travelled in the arena (cm), time 
spent within the inner-zone (s) and number of entries into the inner-zone. Full statistical tables can 
be found in appendix A.2.1.3. 
Neither housing nor sex differences were found for distance travelled (cm) (Figure 14). For the 
time spent in the inner-zone (s) (Figure 15), a sex difference was found (F(1, 93) = 7.805, p=0.0063), 
where males spent more time in the inner-zone than females, p=0.0062. For the number of entries 
made into the inner-zone (Figure 16), a sex difference was found (F(1, 93) = 11.17, p=0.0011), where 
males made more entries into the inner-zone than females, p=0.0012.  
Figure 14- NOR P.1 10 MIN, Distance travelled (cm) 
Distance travelled (cm) during open field exploration (phase 1) for each sex and housing group; 


























isolated (MI n=25). Neither housing nor sex differences were found. Data are presented as mean ± 
SD. 
 
Figure 15- NOR P.1 10 MIN, Time spent in the inner-zone (s) 
Time spent in the inner-zone (s) during open field exploration (phase 1) for each sex_housing group; 
female socialised (FS n=24) and female isolated (FI n=23), male socialised (MS n=25) and male 
isolated (MI n=25). 
#
A sex difference was found, p=0.0063, where males spent more time in the 
inner-zone than females, p=0.0062. Data are presented as mean ± SD. 
 
Figure 16- NOR P.1 10 MIN, Number of inner-zone entries 
Number of entries into the inner-zone during open field exploration (phase 1) for each sex_housing 


























































male isolated (MI n=25). 
#
A sex difference was found, p=0.0011, where males were found to enter 
the inner-zone more frequently than females, p=0.0012. Data are presented as mean ± SD. 
 
3.2.2 PHASE 2- OBJECT FAMILIARISATION ANALYSIS 
3.2.2.1 P.2- FIRST MINUTE  
 
Data from the first minute of the object familiarisation trial (phase 2) were analysed, (n=95, 24 FS, 
22 FI, 25 MS, 24 MI). In this trial two identical objects (O1, O2) were placed in respective 
quadrants (Q1, Q2). The following parameters were analysed; distance travelled in the arena (cm), 
time spent (s) in quadrants containing identical objects (Quadrants 1+2) vs. quadrants without 
objects (Quadrants 3+4), time spent (s) in each of the quadrants containing identical objects 
(Quadrant 1 vs. Quadrant 2), number of entries into each of the quadrants containing identical 
objects (Quadrant 1 vs. Quadrant 2), time spent (s) with each identical object (Object 1 vs. Object 
2), number of approaches to each identical object (Object 1 vs. Object 2), and latency (s) to the first 
approach of each identical object (Object 1 vs. Object 2). Object variables were tracked by nose-
point detection; all other variables were tracked by centre-point detection, see methodology for 
details (Figure 2.2). Preliminary analysis of the data showed that there was a preference for one of 
the objects or quadrants in the following tests; Quadrant 1 vs. Quadrant 2 (time spent, s), Object 1 
vs. Object 2 (time spent, s) and Object 1 vs. Object 2 (number of approaches). This was taken as a 
bias in the experimental set up, therefore these variables were normalised using a correction factor 
calculated for each animal to compensate for this bias so that the data were comparable (Equation 
2). Full statistical tables can be found in appendix A.2.2.1. 
For distance travelled (cm) (Figure 17), a sex difference was found (F(1, 91) =32.54, p<0.0001), 
where females travelled further than males, p<0.0001. When comparing the time spent (s) in 
object-containing quadrants (Q1+Q2) to the time spent in object-free quadrants (Q3+Q4) (Figure 
18), a difference was found (χ
2
(1, N=95) =43.57, p<0 .0001), where more time was spent in the object-
containing quadrants than in the object-free quadrants. This difference was apparent for all groups; 
FS, p=0.0027, FI, p=0.0006, MS, p=0.0082 and MI p= 0.0007. Neither housing nor sex differences 
were found when comparing the time spent (s) in each of the quadrants containing identical objects 
(Q1 vs. Q2) (Figure 19). Neither housing nor sex differences were found when comparing the 
number of entries into each of the quadrants containing identical objects (Q1 vs. Q2) (Figure 20). 
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Neither housing nor sex differences were found when comparing the time spent (s) with each 
identical object (O1 vs. O2) (Figure 21). Neither housing nor sex differences were found when 
comparing the number of approaches to each identical object (O1 vs. O2) (Figure 22). Neither 
housing nor sex differences were found when comparing the latency (s) to the first approach of 
each identical object (O1 vs. O2) (Figure 23). 
 
 
Figure 17- NOR P.2 1 MIN, Distance travelled (cm) 
Distance travelled (cm) during object familiarisation (phase 2) for each sex and housing group; 
female socialised (FS n=24) and female isolated (FI n=22), male socialised (MS n=25) and male 
isolated (MI n=24). 
#
A sex difference was found, p<0.0001, where females travelled further than 






























Figure 18- NOR P.2 1 MIN, Quadrants 1+2 vs. Quadrants 3+4 (s) 
Time spent (s) during object familiarisation (phase 2) in object-containing quadrants (Q1+2) vs. 
time spent in object-free quadrants (Q3+4) for each sex_housing group; female socialised (FS n=24) 
and female isolated (FI n=22), male socialised (MS n=25) and male isolated (MI n=24). 
^
 A 
difference was found, p<0.0001, where more time was spent in the object-containing quadrants than 
in the object-free quadrants. This result was apparent for all groups; FS, p=0.0027, FI, p=0.0006, 
MS, p=0.0082, MI, p= 0.0007. Data are presented as median ± IQR with min and max values. Q= 
quadrant, 1+2= object-containing quadrants, 3+4= object-free quadrants.  
 
Figure 19- NOR P.2 1 MIN, Quadrant 1 vs. Quadrant 2 (s) 
Time spent (s) during object familiarisation (phase 2) in quadrants containing identical objects (Q1 

























































FS                  FI                   MS                     MI 
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male socialised (MS n=25) and male isolated (MI n=24). Neither housing nor sex differences were 
found. Data were corrected, as phase 2 was familiarisation to objects in preparation for placement of 
a novel object in phase 3, time spent in Q1 was made equal to the time spent in Q2 for each animal, 
thus normalising preference for the identical object-containing quadrants at baseline. Data are 
presented as median ± IQR with min and max values. Q= quadrant, 1,2 = quadrants containing 
identical objects. 
 
Figure 20- NOR P.2 1
 
MIN, Quadrant 1 vs. Quadrant 2 (number of entries) 
Number of entries during object familiarisation (phase 2) into quadrants containing identical objects 
(Q1 vs. Q2) for each sex_housing group; female socialised (FS n=24) and female isolated (FI n=22), 
male socialised (MS n=25) and male isolated (MI n=24). Neither housing nor sex differences were 
found. Data are presented as median ± IQR with min and max values. Q= quadrant, 1,2 = quadrants 


































Figure 21- NOR P.2 1
 
MIN, Object 1 vs. Object 2 (s) 
Time spent (s) during object familiarisation (phase 2) with each identical object (O1 vs. O2) for each 
sex_housing group; female socialised (FS n=24) and female isolated (FI n=22), male socialised (MS 
n=25) and male isolated (MI n=24). Neither housing nor sex differences were found Data were 
corrected, as phase 2 was familiarisation to objects in preparation for placement of a novel object in 
phase 3, time spent in O1 was made equal to the time spent in O2 for each animal, thus normalising 
preference for the identical objects at baseline. Data are presented as median ± IQR with min and 

































Figure 22- NOR P.2 1
 
MIN, Object 1 vs. Object 2 (number of approaches) 
Number of approaches during object familiarisation (phase 2) to each identical object (O1 vs. O2) 
for each sex_housing group; female socialised (FS n=24) and female isolated (FI n=22), male 
socialised (MS n=25) and male isolated (MI n=24). Neither housing nor sex differences were found. 
Data were corrected, as phase 2 was familiarisation to objects in preparation for placement of a 
novel object in phase 3, time spent in O1 was made equal to the time spent in O2 for each animal, 
thus normalising preference for the identical objects at baseline. Data are presented as median ± IQR 
with min and max values. O = object, 1,2 = identical objects. 
 
Figure 23- NOR P.2 1
 
MIN, Object 1 vs. Object 2 (latency to approach, s) 
Latency to the first approach (s) during object familiarisation (phase 2) to each identical object (O1 
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male socialised (MS n=25) and male isolated (MI n=24). Neither housing nor sex differences were 
found. Data are presented as median ± IQR with min and max values. O = object, 1,2 = identical 
objects. 
 
3.2.2.2 P.2- FIVE MINUTES 
 
Data from the first five minutes of the object familiarisation trial (phase 2) were combined and 
analysed, (n=95, 24 FS, 22 FI, 25 MS, 24 MI). In this trial two identical objects (O1, O2) were 
placed in respective quadrants (Q1, Q2). The following parameters were analysed; distance 
travelled in the arena (cm), time spent (s) in quadrants containing identical objects (Quadrants 1+2) 
vs. quadrants without objects (Quadrants 3+4), time spent (s) in each of the quadrants containing 
identical objects (Quadrant 1 vs. Quadrant 2), number of entries into each of the quadrants 
containing identical objects (Quadrant 1 vs. Quadrant 2), time spent (s) with each identical object 
(Object 1 vs. Object 2) and number of approaches to each identical object (Object 1 vs. Object 2). 
Object variables were tracked by nose-point detection; all other variables were tracked by centre-
point detection, see methodology for details (Figure 2.2). Preliminary analysis of the data showed 
that there was a preference for one of the objects or quadrants in the following tests; Quadrant 1 vs. 
Quadrant 2 (time spent, s), Object 1 vs. Object 2 (time spent, s) and Object 1 vs. Object 2 (number 
of approaches), this preference was consistent with data from the analysis of the first minute. This 
was taken as a bias in the experimental set up, therefore these variables were normalised using a 
correction factor calculated for each animal to compensate for this bias so that the data were 
comparable (Equation 2). Full statistical tables can be found in appendix A.2.2.2. 
For distance travelled (cm) (Figure 24), a sex difference was found (F(1, 91) = 38.73, p<0.0001), 
where females travelled further than males, p<0.0001. When comparing the time spent (s) in the 
object-containing quadrants (Q1+Q2) to the time spent in the object-free quadrants (Q3+Q4) 
(Figure 25), a difference was found; (F(1, 91) = 225.8, p<0.0001) where more time was spent in 
object-containing quadrants than in object-free quadrants, p<0.0001. Neither housing nor sex 
differences were found when comparing the time spent (s) in each of the quadrants containing 
identical objects (Q1 vs. Q2) (Figure 26). When comparing the number of entries into each of the 
quadrants containing identical objects (Q1 vs. Q2) (Figure 27), a sex difference was found (F(1, 91) = 
18.90, p<0.0001), where females made more entries into both quadrants (Q1 + Q2) than males 
p<0.0001. Neither housing nor sex differences were found when comparing the time spent (s) with 
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each identical object (O1 vs. O2) (Figure 28). Neither housing nor sex differences were found when 
comparing the number of approaches to each of the identical objects (O1 vs. O2) (Figure 29).  
 
 
Figure 24- NOR P.2 5 MIN, Distance travelled (cm) 
Distance travelled (cm) during object familiarisation (phase 2) for each sex and housing group; 
female socialised (FS n=24) and female isolated (FI n=22), male socialised (MS n=25) and male 
isolated (MI n=24). 
#
A sex difference was found, p<0.0001, where females travelled further than 






















































Figure 25- NOR P.2 5 MIN, Quadrants 1+2 vs. Quadrants 3+4 (s) 
Time spent (s) during object familiarisation (phase 2) in object-containing quadrants (Q1+2) vs. 
time spent in object-free quadrants (Q3+4) for each sex and housing group; female socialised (FS 
n=24) and female isolated (FI n=22), male socialised (MS n=25) and male isolated (MI n=24). 
^
A 
difference was found, p<0.0001, where more time was spent in the object-containing quadrants than 
in the object-free quadrants, p<0.0001. Data are presented as mean ± SD. Q= quadrant, 1+2= object 
containing quadrants, 3+4= object-free quadrants. 
 
Figure 26- NOR P.2 5 MIN, Quadrant 1 vs. Quadrant 2 (s) 
Time spent (s) during object familiarisation (phase 2) in quadrants containing identical objects (Q1 
vs. Q2) for each sex and housing group; female socialised (FS n=24) and female isolated (FI n=22), 
male socialised (MS n=25) and male isolated (MI n=24). Neither housing nor sex differences were 
found. Data were corrected, as phase 2 was familiarisation to objects in preparation for placement of 
a novel object in phase 3, time spent in Q1 was made equal to the time spent in Q2 for each animal, 
thus normalising preference for the identical object-containing quadrants at baseline. Data are 
presented as mean ± SD. Q= quadrant, 1, 2 = quadrants containing identical objects. 






























Figure 27- NOR P.2 5 MIN, Quadrant 1 vs. Quadrant 2 (number of entries)  
Number of entries during object familiarisation (phase 2) into quadrants containing identical objects 
(Q1 vs. Q2) for each sex and housing group; female socialised (FS n=24) and female isolated (FI 
n=22), male socialised (MS n=25) and male isolated (MI n=24). 
#
A sex difference was found, 
p<0.0001, where females made more entries into both quadrants (Q1 + Q2) than males, p<0.0001. 
Data are presented as mean ± SD. Q= quadrant, 1, 2 = quadrants containing identical objects. 
 
Figure 28- NOR P.2 5 MIN, Object 1 vs. Object 2 (s) 
Time spent (s) during object familiarisation (phase 2) with each identical object (O1 vs. O2) for each 
sex and housing group; female socialised (FS n=24) and female isolated (FI n=22), male socialised 
(MS n=25) and male isolated (MI n=24). Neither housing nor sex differences were found. Data were 
corrected, as phase 2 was familiarisation to objects in preparation for placement of a novel object in 























































phase 3, time spent in O1 was made equal to the time spent in O2 for each animal, thus normalising 
preference for the identical object-containing quadrants at baseline. Data are presented as mean ± 
SD. O = object, 1, 2 = identical objects. 
 
Figure 29- NOR P.2 5 MIN, Object 1 vs. Object 2 (number of approaches)  
Number of approaches during object familiarisation (phase 2) to each identical object (O1 vs. O2) 
for each sex and housing group; female socialised (FS n=24) and female isolated (FI n=22), male 
socialised (MS n=25) and male isolated (MI n=24). Neither housing nor sex differences were found. 
Data were corrected, as phase 2 was familiarisation to objects in preparation for placement of a 
novel object in phase 3, time spent in O1 was made equal to the time spent in O2 for each animal, 
thus normalising preference for the identical objects at baseline. Data are presented as mean ± SD. O 
= object, 1,2 = identical objects. 
 
3.2.3 PHASE 3- NOVEL OBJECT RECOGNITION ANALYSIS 
3.2.3.1 P.3- FIRST MINUTE  
 
Data from the first minute of the novel object recognition trial (phase 3) were analysed, (n=96, 24 
FS, 23 FI, 25 MS, 24 MI). In this trial object 1 (O1) in quadrant 1 (Q1) was a novel item whilst 
object 2 (O2) in quadrant 2 (Q2) remained the same as in the previous trial (phase 2). The 
correction factor, calculated for each animal in phase 2 where a behavioural apparatus bias was 
evident (Equation 2), was applied to the corresponding variables in phase 3. The following 
parameters were analysed; distance travelled in the arena (cm), time spent (s) in each of the 
































quadrants containing different objects (Quadrant 1 vs. Quadrant 2), number of entries into each of 
the quadrants containing different objects (Quadrant 1 vs. Quadrant 2), quadrant discrimination 
index, time spent (s) with each identical object (Object 1 vs. Object 2), number of approaches to 
each identical object (Object 1 vs. Object 2), latency (s) to the first approach of each identical 
object (Object 1 vs. Object 2) and object discrimination index. Object variables were tracked by 
nose-point detection; all other variables were tracked by centre-point detection, (Figure 2.3) see 
methodology for details. Full statistical tables can be found in appendix A.2.3.1. 
For distance travelled (cm) (Figure 30), a main effect of housing was found (F(1, 92) =9.210, 
p=0.0031), where socialised animals travelled further than isolated animals, p=0.0029. A sex 
difference was also found for the distance travelled (cm) (F(1, 92) =83.10, p<0.0001), where females 
travelled further than males, p<0.0001. When comparing the time spent (s) in novel object quadrant 
(Q1) to time spent in familiar object quadrant (Q2) (Figure 31), a difference was found (χ
2
(1, N = 94) 
=6.127, p=0.0133), where both FI and MI spent more time in Q1 than in Q2, p=0.008 and p=0.0386 
respectively. Neither housing nor sex differences were found when comparing the number of 
entries into novel object quadrant (Q1) to the number of entries into familiar quadrant (Q2) (Figure 
32). Neither housing nor sex differences were found for the quadrant discrimination index (Figure 
33). When comparing the time spent (s) with the novel object (O1) to time spent with the familiar 
object (O2) (Figure 34), a difference was found (χ
2
(1, N = 94) =19.88, p < 0.0001), where all groups 
spent more time with novel object than with the familiar object; FS, p=0.0240, FI, p=0.0004, MS, 
p=0.0060 and MI, p=0.0011. When comparing number of approaches to the novel object (O1) to 
number of approaches to the familiar object (O2) (Figure 35), a difference was found (χ
2
(1, N = 94) = 
15.69, p < 0.0001), where all groups made more approaches to the novel object than the familiar 
object; FS, p=0.0162, FI, p=0.0015, MS, p=0.0109 and MI, p=0.0115. Neither housing nor sex 
differences were found when comparing the latency (s) to the first approach of the novel object 
(O1) area with the latency to the first approach of the familiar object (O2) area (Figure 36). Neither 





Figure 30- NOR P.3 1 MIN, Distance travelled (cm) 
Distance travelled (cm) during novel object recognition (phase 3) for each sex and housing group; 
female socialised (FS n=24) and female isolated (FI n=23), male socialised (MS n=25) and male 
isolated (MI n=24). 
*
 A main effect of housing was found, p=0.0031, where socialised animals 
travelled further than isolated animals, p=0.0029. 
#
A sex difference was found, p<0.0001, where 
females travelled further than males, p<0.0001. Data are presented as mean ± SD 
 
 
Figure 31- NOR P.3 1 MIN, Quadrant 1 vs. Quadrant 2 (s) 
Time spent (s) during novel object recognition (phase 3) in novel object quadrant (Q1) vs. time 
spent in familiar object quadrant (Q2) for each sex_housing group; female socialised (FS n=24) and 
female isolated (FI n=22), male socialised (MS n=25) and male isolated (MI n=23). 
^
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was found, p = 0.0133, where more time was spent in the novel object quadrant than in the familiar 
object quadrant. This was apparent for the two isolate groups; FI, p=0.008 and MI, p=0.0386. Data 
were corrected such that Q1 data were multiplied by the correction factor calculated in phase 2 for 
each animal (Equation 2), thus adjusting for preference at baseline. Data are presented as median ± 
IQR with min and max values. Q= quadrant, 1= quadrant containing novel object, 2= quadrant 
containing familiar object. 
 
Figure 32- NOR P.3 1 MIN, Quadrant 1 vs. Quadrant 2 (number of entries) 
Number of entries during novel object recognition (phase 3) into novel object quadrant (Q1) vs. 
number of entries into familiar object quadrant (Q2) for each sex_housing group; female socialised 
(FS n=24) and female isolated (FI n=23), male socialised (MS n=25) and male isolated (MI n=24). 
Neither housing nor sex differences were found. Data are presented as median ± IQR with min and 


































Figure 33- NOR P.3 1 MIN, Quadrant discrimination index 
Discrimination index calculated from the time spent in novel object quadrant (Q1) and familiar 
object quadrant (Q2) during novel object recognition (phase 3) (see methodology for calculation), 
for each sex and housing group; female socialised (FS n=24) and female isolated (FI n=22), male 
socialised (MS n=25) and male isolated (MI n=23). Neither housing nor sex differences were found. 
Data were corrected such that Q1 data were multiplied by the correction factor calculated in phase 2 
for each animal (Equation 2), thus adjusting for preference at baseline. Data are presented as mean 
+ SD. 
 
Figure 34- NOR P.3 1 MIN, Object 1 vs. Object 2 (s)  
Time spent (s) during novel object recognition (phase 3) with novel object (O1) vs. time spent with 
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(FI n=22), male socialised (MS n=25) and male isolated (MI n=23). 
^
A difference was found, 
p<0.0001; where all groups spent more time with the novel object than with the familiar object; FS, 
p=0.0240, FI, p=0.0004, MS, p=0.0060 and MI, p=0.0011. Data were corrected such that O1 data 
were multiplied by the correction factor calculated in phase 2 for each animal (Equation 2), thus 
adjusting for preference at baseline. Data are presented as median ± IQR with min and max values. 
O = object, 1= novel object, 2= familiar object. 
 
 
Figure 35- NOR P.3 1 MIN, Object 1 vs. Object 2 (number of approaches)  
Number of approaches during novel object recognition (phase 3) to novel object (O1) vs. number of 
approaches to familiar object (O2) for each sex_housing group; female socialised (FS n=24) and 
female isolated (FI n=22), male socialised (MS n=25) and male isolated (MI n=23). 
^
A difference 
was found, p=0.0001, where all groups made more approaches to the novel object than the familiar 
object; FS, p=0.0162, FI, p=0.0015, MS, p=0.0109 and MI, p=0.0115. Data were corrected such that 
O1 data were multiplied by the correction factor calculated in phase 2 for each animal (Equation 2), 
thus adjusting for preference at baseline. Data are presented as median ± IQR with min and max 
































Figure 36- NOR P.3 1 MIN, Object 1 vs. Object 2 (latency to approach, s)  
Latency to the first approach (s) during novel object recognition (phase 3) to novel object (O1) vs. 
latency to the first approach to the familiar object (O2) for each sex_housing group; female 
socialised (FS n=24) and female isolated (FI n=23), male socialised (MS n=25) and male isolated 
(MI n=24). Neither housing nor sex differences were found. Data are presented as median ± IQR 
with min and max values. O = object, 1= novel object, 2= familiar object. 
.  
Figure 37- NOR P.3 1 MIN, Object discrimination index 
Discrimination index calculated from the time spent with novel object (O1) and familiar object (O2) 
during novel object recognition (phase 3) (see methodology for calculation) for each sex and 




































































n=25) and male isolated (MI n=23). Neither housing nor sex differences were found. Data were 
corrected such that Q1 data were multiplied by the correction factor calculated in phase 2 for each 
animal (Equation 2), thus adjusting for preference at baseline. Data are presented as mean + SD. 
 
3.2.3.2 P.3- FIVE MINUTES 
 
Data from the first five minutes of the novel object recognition trial (phase 3) were analysed, 
(n=94, 23 FS, 23 FI, 25 MS, 23 MI). In this trial object 1 (O1) in quadrant 1 (Q1) was a novel item 
whilst object 2 (O2) in quadrant 2 (Q2) remained the same as in the previous trial (phase 2). The 
correction factor calculated for each animal in phase 2 where a behavioural apparatus bias was 
evident (Equation 2) was applied to the corresponding variables in phase 3. The following 
parameters were analysed; distance travelled in the arena (cm), time spent (s) in each of the 
quadrants containing different objects (Quadrant 1 vs. Quadrant 2), number of entries into each of 
the quadrants containing different objects (Quadrant 1 vs. Quadrant 2), quadrant discrimination 
index, time spent (s) with each identical object (Object 1 vs. Object 2), number of approaches to 
each identical object (Object 1 vs. Object 2) and object discrimination index. Object variables were 
tracked by nose-point detection; all other variables were tracked by centre-point detection, (Figure 
2.3) see methodology for details. Full statistical tables can be found in appendix A.2.3.2. 
For the distance travelled (cm) (Figure 38), a sex difference was found (F(1, 90) = 41.64, p<0.0001), 
where female groups travelled further than male groups, p<0.0001. Neither housing nor sex 
differences were found when comparing the time spent (s) in the novel object quadrant (Q1) to the 
time spent in the familiar object quadrant (Q2) (Figure 39). When comparing the number of entries 
into the novel object quadrant (Q1) to the number of entries into the familiar object quadrant (Q2) 
(Figure 40), a sex difference was found (F(1, 90) = 20.39, p<0.0001), where females made more 
entries into both quadrants (Q1+Q2) than males, p<0.0001. A housing-sex-quadrant interaction was 
also found for the number of entries into the quadrants (F(1, 90) = 5.30, p=0.0235), where the FI 
made more entries into Q1 than MI Q1, p=0.0010 and MI Q2, p=0.0071. FI also made more entries 
into Q2 than MI Q1, p=0.0095. Neither housing nor sex differences were found for the quadrant 
discrimination index (Figure 41). When comparing the time spent (s) with the novel object (O1) to 
the time spent with the familiar object (O2) (Figure 42), a differences was found (χ
2
(1, N= 92) =17.39, 
p<0.0001), where FI and MI both spent more time with O1 than O2, p=0.0045 and p=0.0055 
respectively. When comparing the number of approaches to the novel object (O1) to the number of 
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approaches to the familiar object (O2) (Figure 43), a difference was found (χ
2
(1, N= 92) =9.782, 
p=0.0017), where FS, FI and MS all made more approaches to O1 than O2 where p=0.0264, 
p=0.0155 and p=0.0450 respectively. Neither housing nor sex differences were found for the object 
discrimination index (Figure 44). Novelty preference results are summarised in Table 8. 
 
 
Figure 38- NOR P.3 5 MIN, Distance travelled (cm)  
Distance travelled (cm) during novel object recognition (phase 3) for each sex_housing group; 
female socialised (FS n=23) and female isolated (FI n=23), male socialised (MS n=25) and male 
isolated (MI n=23). 
#
A sex difference was found, p<0.0001, where females travelled further than 




























Figure 39- NOR P.3 5 MIN, Quadrant 1 vs. Quadrant 2 (s) 
Time spent (s) during novel object recognition (phase 3) in novel object quadrant (Q1) vs. time 
spent in familiar object quadrant (Q2) for each sex_housing group; female socialised (FS n=23) and 
female isolated (FI n=22), male socialised (MS n=25) and male isolated (MI n=22). Neither housing 
nor sex differences were found. Data were corrected such that Q1 data were multiplied by the 
correction factor calculated in phase 2 for each animal (Equation 2), thus adjusting for preference at 
baseline. Data are presented as median ± IQR with min and max values. Q= quadrant, 1= quadrant 
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Figure 40- NOR P.3 5 MIN, Quadrant 1 vs. Quadrant 2 (number of entries) 
Number of entries during novel object recognition (phase 3) into novel object quadrant (Q1) vs. 
number of entries into familiar object quadrant (Q2) for each sex and housing group; female 
socialised (FS n=23) and female isolated (FI n=23), male socialised (MS n=25) and male isolated 
(MI n=23). 
#
A sex difference was found, p<0.0001; where females made more entries into both 
quadrants (Q1 + Q2) than males, p<0.0001. 
*.#.^ 
A housing-sex-quadrant difference was also found, 
p=0.0235 (Table 70 for post hoc values). Data are presented as mean ± SD. Q= quadrant, 1= 
quadrant containing novel object, 2= quadrant containing familiar object. 
 
Figure 41- NOR P.3 5 MIN, Quadrant discrimination index 
Discrimination index calculated from the time spent in novel object quadrant (Q1) and familiar 
object quadrant (Q2) during novel object recognition (phase 3) (see methodology for calculation) for 
each sex and housing group; female socialised (FS n=23) and female isolated (FI n=22), male 
socialised (MS n=25) and male isolated (MI n=22). Neither housing nor sex differences were found. 
Data were corrected such that Q1 data were multiplied by the correction factor calculated in phase 2 










































Figure 42- NOR P.3 5 MIN, Object 1 vs. Object 2 (s) 
Time spent (s) during novel object recognition (phase 3) with novel object (O1) vs. time spent with 
familiar object (O2) for each sex_housing group; female socialised (FS n=23) and female isolated 
(FI n=22), male socialised (MS n=25) and male isolated (MI n=22). 
^
 A difference was found, 
p<0.0001, where FI and MI spent more time with novel object than familiar object, p=0.0045 and 
p=0.0055 respectively. Data were corrected such that O1 data were multiplied by the correction 
factor calculated in phase 2 for each animal (Equation 2), thus adjusting for preference at baseline. 




































Figure 43- NOR P.3 5 MIN, Object 1 vs. Object 2 (number of approaches) 
Number of approaches during novel object recognition (phase 3) to the novel object (O1) vs. 
number of approaches to the familiar object (O2) for each sex_housing group; socialised (FS n=23) 
and female isolated (FI n=22), male socialised (MS n=25) and male isolated (MI n=22). 
^ 
A 
difference was found, p=0.0017, where FS, FI and MS made more approaches to the novel object 
than the familiar object, p=0.0264, p=0.0155 and p=0.0450 respectively. Data were corrected such 
that O1 data were multiplied by the correction factor calculated in phase 2 for each animal 
(Equation 2), thus adjusting for preference at baseline. Data are presented as median ± IQR with 


































Figure 44- NOR P.3 5 MIN, Object discrimination index 
Discrimination index calculated from the time spent with novel object (O1) and familiar object (O2) 
during novel object recognition (phase 3) (see methodology for calculation) for each sex and 
housing group; female socialised (FS n=23) and female isolated (FI n=22), male socialised (MS 
n=25) and male isolated (MI n=22). ). Neither housing nor sex differences were found. Data were 
corrected such that O1 data were multiplied by the correction factor calculated in phase 2 for each 
animal (Equation 2), thus adjusting for preference at baseline. Data are presented as mean + SD. 
 
Table 8- NOR P.3, Novelty preference summary 
Groups listed showed preference for the novel quadrant or novel object as evidenced by time spent or how 
many entries or approaches were made. 
 
3.2.4 ALL PHASES- DISTANCE TRAVELLED 
 
Distance travelled during the first minute and the first five minutes was measured in each phase. 


































 1 minute 5 minute 
Time spent (s) Entries/approaches Time spent (s) Entries/approaches 
Novel Quadrant FI MI    
Novel Object FS, FI, MS, MI FS, FI, MS, MI FI, MI FS, FI, MS 
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arena changed after repeated exposures to it. Findings from statistical tests applied to distance 
travelled data are summarised in Table 9 and Table 10. 
 
3.2.4.1 P.1, P.2, P.3- FIRST MINUTE 
 
Data for the distance travelled (cm) in the arena during the first minute were analysed across all 
three phases of the NOR test (n=96, 24 FS, 23 FI, 25 MS, 24 MI). Distance travelled was tracked 
by centre-point detection (Figure 2), see methodology for details. Full statistical tables can be found 
in appendix A.2.4.1. 
For distance travelled (cm) in all three phases of the NOR test (Figure 45), a main effect of housing 
was found (F(1, 90) =9.497, p=0.0027), where socialised animals travelled further than isolated 
animals, p=0.0026. A sex difference was also found for the distance travelled (cm) in all three 
phases (F(1, 90) =73.74, p<0.0001), where females travelled further than males, p<0.0001. A 
difference between the phases was also found for the distance travelled (cm) (F(2, 180) =110.3, 
p<0.0001), where the distance travelled in phase 2 was greater than the distance travelled in phase 
1, p<0.0001 and where the distance travelled in phase 3 was greater than the distance travelled in 
phase 1, p<0.0001. A sex-phase interaction was found for the distance travelled (cm) (F(2, 180) 
=19.74, p<0.0001), such that the distance travelled by females in phase 1 was greater than the 
distance travelled by males in phase 1, p=0.0457, the distance travelled by females in phase 2 was 
greater than the distance travelled by males in phase 2, p<0.0001, the distance travelled by females 
in phase 3 was greater than the distance travelled by males in phase 3, p<0.0001, the distance 
travelled by females in phase 2 was greater than the distance travelled by females in phase 1, 
p<0.0001, the distance travelled by females in phase 3 was greater than the distance travelled by 
females in phase 2, p<0.0001, the distance travelled by males in phase 2 was greater than the 
distance travelled by males in phase 1, p<0.0001, the distance travelled by males in phase 3 was 
greater than the distance travelled by males in phase 1, p=0.0003 and the distance travelled by 
males in phase 2 was greater than the distance travelled by males in phase 3, p<0.0001.Other sex-





Figure 45- NOR All phases 1 MIN, Distance travelled (cm) 
Distance travelled (cm) during first minute of all three phases of the NOR test for each sex and 
housing group; female socialised (FS n=24) and female isolated (FI n=23), male socialised (MS 
n=25) and male isolated (MI n=24). 
*
 A main effect of housing was found, p=0.0027, where 
socialised animals travelled further than isolated animals, p=0.0026. 
#
A sex difference was found, 
p<0.0001, where females travelled further than males, p<0.0001. 
^
A difference between the phases 
was found, p<0.0001, where the distance travelled in phase 2 was greater than the distance travelled 
in phase 1, p<0.0001 and where the distance travelled in phase 3 was greater than the distance 
travelled in phase 1, p<0.0001. 
#.^ 
A sex-phase interaction was found, see text for p values. Data are 



































3.2.4.2 P.1, P.2, P.3- FIVE MINUTES  
 
Data for the distance travelled (cm) in the arena during the first five minutes were analysed across 
all three phases of the NOR test (n=96, 24 FS, 23 FI, 25 MS, 24 MI). Distance travelled was 
tracked by centre-point detection (Figure 2), see methodology for details. Full statistical tables can 
be found in appendix A.2.4.2. 
For distance travelled (cm) in all three phases of the NOR test (Figure 46), a sex difference was 
found (F(1, 88) =38.79, p<0.0001), where females travelled further than males, p<0.0001. A 
difference between the phases was also found for the distance travelled (cm) (F(2, 176) =39.77, 
p<0.0001), where the distance travelled in phase 1 was greater than the distance travelled in phase 
3, p<0.0001 and where the distance travelled in phase 2 was greater than the distance travelled in 
phase 3, p<0.0001. A sex-phase interaction was found for the distance travelled (cm) (F(2, 176) 
=12.95, p<0.0001), such that the distance travelled by females in phase 2 was greater than the 
distance travelled by males in phase 2, p<0.0001, the distance travelled by females in phase 3 was 
greater than the distance travelled by males in phase 3, p<0.0001,the distance travelled by females 
in phase 2 was greater than the distance travelled by females in phase 1, p=0.0010, the distance 
travelled by females in phase 2 was greater than the distance travelled by females in phase 3, 
p<0.0001, the distance travelled by males in phase 1 was greater than the distance travelled by 
males in phase 3 , p<0.0001 and the distance travelled by males in phase 2 was greater than the 
distance travelled by males in phase 3, p<0.0001. Other sex-phase interactions were found but were 
not of statistical relevance (see appendix A2.4.2).  
 
Table 9- Hyperactivity summary within phases 
The table lists sex or housing groups which demonstrated hyperactivity in each of the different phases and 
temporal analyses of the NOR test.  
 1 minute 5 minute 10 minute 
Sex Housing Sex Housing Sex Housing 
Phase 1 Females Socialised     
Phase 2 Females  Females  n/a n/a 




Table 10- Hyperactivity summary across phases 
The table lists sex groups, housing groups or phases where hyperactivity was evident when data from all 3 






1 minute 5 minute 
Sex Housing Phase Sex Housing Phase 
Females Socialised P.1>P.2 
P.1>P.3 





Figure 46- NOR All phases 5 MIN, Distance travelled (cm) 
Distance travelled (cm) during first 5 minutes of all three phases of the NOR test for each sex and 
housing group; female socialised (FS n=24) and female isolated (FI n=23), male socialised (MS 
n=25) and male isolated (MI n=24). 
#
A sex difference was found, p<0.0001, where females travelled 
further than males, p<0.0001. 
^
A difference between the phases was found, p<0.0001, where the 
distance travelled in phase 1 was greater than the distance travelled in phase 3, p<0.0001 and where 
the distance travelled in phase 2 was greater than the distance travelled in phase 3, p<0.0001. 
#.^ 
A 
































3.3 IN-VITRO SUPERFUSION 
3.3.1 SF 1- GLUTAMATE-STIMULATED [3H]NE RELEASE 
IN HIPPOCAMPUS AND PREFRONTAL CORTEX 
 
The first analysis of the Superfusion 1 data compared differences in fractional release of [
3
H]NE 
across three successive glutamate stimulations within one brain area as well as differences between 
prefrontal cortex and hippocampus tissue (n=30, 7 FS, 7 FI, 8 MS, 8 MI). A second comparison 
was then performed to find differences between prefrontal cortex and hippocampus tissue for each 
stimulation, (n=30, 7 FS, 7 FI, 8 MS, 8 MI). Parametric analyses were performed given that the 
primary variables (stimulation 1) were parametric. Full statistical tables can be found in appendix 
A.3.1. 
When data from the hippocampus were analysed a difference was found between the stimulations 
(F(2, 52) = 80.94, p<0.0001), where fractional release of [
3
H]NE resulting from stimulation 1 was 
greater than in both stimulation 2, p<0.0001 and stimulation 3, p<0.0001, (Figure 47). When data 
from the prefrontal cortex were analysed a difference was found between the stimulations (F(2, 52) = 
72.89, p<0.0001), where fractional release of [
3
H]NE resulting from stimulation 1 was greater than 
in both stimulation 2, p<0.0001 and stimulation 3, p<0.0001 (Figure 48). When data from 
stimulation 1 were analysed in both brain areas (Figure 49) a difference was found between the 
brain areas (F(1, 26) = 5.549, p=0.026), where fractional release of [
3
H]NE in the hippocampus was 
greater than in the prefrontal cortex, p=0.0222. When data from stimulations 2 and 3 were analysed 
neither housing nor sex differences were found between fractional release of [
3
H]NE in the 





Figure 47- SF1, HC fractional release of [
3
H]NE 
Glutamate-stimulated fractional release of [
3
H]NE in the hippocampus during Superfusion 1, for 
each sex and housing group; female socialised (FS n=7) and female isolated (FI n=7), male 
socialised (MS n=8), male isolated (MI n=8). 
^
 A difference was found, p<0.0001, where fractional 
release of [
3
H]NE in S1 was greater than S2, p<0.0001and in S3, p<0.0001. Data are presented as 
mean ± SD. S1 = stimulation 1, S2 = stimulation 2, S3 = stimulation 3. 
 










































Figure 48- SF1, PFC fractional release of [3H]NE 
Glutamate-stimulated fractional release of [
3
H]NE in the prefrontal cortex during Superfusion 1, for 
each sex and housing group; female socialised (FS n=7) and female isolated (FI n=7), male 
socialised (MS n=8), male isolated (MI n=8). 
^
A difference was found, p<0.0001, where fractional 
release of [3H]NE in S1 was greater than S2, p<0.0001and in S3, p<0.0001. Data are presented as 
mean ± SD. S1 = stimulation 1, S2 = stimulation 2, S3 = stimulation 3. 
 













































Figure 49- SF1, Stimulation 1 fractional release of [
3
H]NE 
Glutamate-stimulated fractional release of [
3
H]NE in the hippocampus and prefrontal cortex during 
Superfusion 1 stimulation 1 for each sex and housing group; female socialised (FS n=7) and female 
isolated (FI n=7), male socialised (MS n=8), male isolated (MI n=8). 
^
A brain area difference was 
found, p=0.0263, where fractional release of [
3
H]NE resulting from stimulation 1 was greater in the 
hippocampus than in the prefrontal cortex, p=0.0222. Data are presented as mean ± SD. HC= 
hippocampus, PFC= prefrontal cortex. 
  









































3.3.2 SF 2- GLUTAMATE-STIMULATED [3H]NE RELEASE 
IN HIPPOCAMPUS IN PRESENCE OF MK-801 AND/OR 
CNQX 
 
The first analysis of the Superfusion 2 data compared differences in glutamate-stimulated fractional 
release of [
3
H]NE for each drug condition; control (glutamate alone), CNQX, MK-801 or 
CNQX+MK-801 across the three successive stimulations in the hippocampus. The second analysis 
of the Superfusion 2 data compared differences in glutamate-stimulated fractional release of 
[
3
H]NE for each successive stimulation (1, 2 or 3) across the four drug conditions within the 
hippocampus, (n=30, FS 6, FI 6, MS 6, MI 6). Three out of the four primary variables (stimulation 
1) were parametric CNQX, MK-801and CNQX-MK-901 but not control (glutamate alone), 
however, since this condition was identical to the control in Superfusion 1 experiment where it was 
parametric, parametric analyses were used for Superfusion 2. Full statistical tables can be found in 
appendix A.3.2. 
When data from the control condition (glutamate alone,) were analysed (Figure 50), a sex 
difference was found (F(1, 20) = 4.464, p=0.0473), where fractional release of [
3
H]NE was greater in 
females than in males, p=0.0473. A difference was also found between the stimulations (F(2, 40) = 
72.45, p<0.0001), where fractional release of [
3
H]NE resulting from stimulation 1 was greater than 
from stimulation 2, p<0.0001 and from stimulation 3, p<0.0001 for control data. When data from 
the CNQX condition were analysed (Figure 51), a sex difference was found (F(1, 19) = 4.395, 
p=0.0496), where fractional release of [
3
H]NE was greater in females than in males, p=0.0486. A 
difference was also found between the stimulations (F(2, 38) = 60.68, p<0.0001), where fractional 
release of [
3
H]NE resulting from stimulation 1 was greater than from stimulation 2, p<0.0001 and 
from stimulation 3, p<0.0001 and where fractional release of [
3
H]NE resulting from stimulation 2 
was greater than from stimulation 3, p=0.0298 for CNQX data. When data from the MK-801 
condition were analysed (Figure 52), a difference was found between the stimulations (F(2, 40) = 
16.97, p<0.0001), where fractional release of [
3
H]NE resulting from stimulation 1 was greater than 
from stimulation 2, p=0.0004 and from stimulation 3, p<0.0001.When data from the CNQX+MK-
801 condition were analysed (Figure 53), a difference was found between the stimulations (F(2, 40) = 
69.82, p<0.0001), where fractional release of [
3
H]NE resulting from stimulation 1 was greater than 
from stimulation 2, p<0.0001 and from stimulation 3, p<0.0001.When data from stimulation 1 only 
for all drug conditions were analysed (Figure 54), a sex difference was found (F(1, 19) = 8.701, 
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p=0.008), where fractional release of [
3
H]NE was greater in females than in males, p=0.0060. 
When data from stimulations 2 and 3 were analysed neither housing nor sex differences were found 
between the drug conditions (not shown graphically).  
 
 
Figure 50- SF2, Control condition fractional release of [
3
H]NE 
Control condition glutamate-stimulated fractional release of [
3
H]NE in the hippocampus during 
Superfusion 2, for each sex and housing group; female socialised (FS n=6) and female isolated (FI 
n=6), male socialised (MS n=6), male isolated (MI n=6). 
#
A sex difference was found, p=0.0473, 
where fractional release of [
3
H]NE in females was greater than in males, p=0.0473. 
^
A difference 
was found between the stimulations p<0.0001, where fractional release of [
3
H]NE resulting from S1 
was greater than from S2, p<0.0001and from S3, p<0.0001. Data are presented as mean ± SD. S1 = 
stimulation 1, S2 = stimulation 2, S3 = stimulation 3. 





































Figure 51- SF2, CNQX condition fractional release of [3H]NE  
Glutamate-stimulated fractional release of [
3
H]NE in the presence of CNQX in the hippocampus 
during Superfusion 2, each sex and housing group; female socialised (FS n=6) and female isolated 
(FI n=6), male socialised (MS n=6), male isolated (MI n=6). 
#
A sex difference was found, p= 
0.0496), where fractional release of [
3
H]NE in females was greater than in males, p= 0.0486. 
^
A 
difference was found between the stimulations, p<0.0001, where fractional release of [
3
H]NE 
resulting from S1 was greater than from S2, p<0.0001 and from S3, p<0.0001 and fractional release 
of [
3
H]NE resulting from S2 was greater than from S3, p=0.0298. Data are presented as mean ± SD. 
S1 = stimulation 1, S2 = stimulation 2, S3 = stimulation 3. 




































Figure 52- SF2, MK-801 condition fractional release of [3H]NE  
Glutamate-stimulated fractional release of [
3
H]NE in the presence of MK-801 in the hippocampus 
during Superfusion 2, for each sex and housing group; female socialised (FS n=6) and female 
isolated (FI n=6), male socialised (MS n=6), male isolated (MI n=6). 
^
A difference was found 
between the stimulations, p<0.0001, where fractional release of [
3
H]NE resulting from S1 was 
greater than from S2, p=0.0004 and from S3, p<0.0001. Data are presented as mean ± SD. S1 = 
stimulation 1, S2 = stimulation 2, S3 = stimulation 3. 





































Figure 53- SF2, CNQX + MK-801 condition fractional release of [3H]NE 
Glutamate-stimulated fractional release of [
3
H]NE in the presence of CNQX and MK-801 in the 
hippocampus during Superfusion 2, for each sex and housing group; female socialised (FS n=6) and 
female isolated (FI n=6), male socialised (MS n=6), male isolated (MI n=6). 
^
A difference was 
found between the stimulations, p<0.0001, where fractional release of [
3
H]NE resulting from S1 was 
greater than from S2, p<0.0001 and from S3, p<0.0001. Data are presented as mean ± SD. S1 = 
stimulation 1, S2 = stimulation 2, S3 = stimulation 3. 










































Figure 54- SF2, Stimulation 1 fractional release of [3H]NE  
Glutamate-stimulated fractional release of [
3
H]NE for all four drug conditions during stimulation 1 
for each sex and housing group; female socialised (FS n=6) and female isolated (FI n=6), male 
socialised (MS n=6), male isolated (MI n=6). 
#
A sex difference was found, p=0.008, where 
fractional release of [
3
H]NE resulting from stimulation 1 was greater in females than in males, 
p=0.0060. Data are presented as mean ± SD. CT= control (glutamate alone), CN= CNQX, MK= 
MK-801, CM= CNQX+MK-801. 
  








































3.3.3 SF 3- GLUTAMATE, GABA AND KCL-STIMULATED 
[3H]NE RELEASE IN HIPPOCAMPUS AND PREFRONTAL 
CORTEX 
 
Analysis of the Superfusion 3 experimental data compared differences in fractional release of 
[
3
H]NE after sequential stimulations with glutamate then GABA or vice versa. First, fractional 
release of [
3
H]NE in the hippocampus was compared for the following stimulation conditions; 
glutamate stimulation 1, GABA stimulation 2, GABA stimulation 1 and glutamate stimulation 2 
(n=33, FS 11, FI 11, MS 6, MI 5). This comparison was repeated for the corresponding data in the 
prefrontal cortex (n=36, FS 12, FI 12, MS 6, MI 6). Next, fractional release of [
3
H]NE resulting 
from glutamate stimulation 1 was compared between the hippocampus and prefrontal cortex. 
Fractional release of [
3
H]NE resulting from GABA stimulation 1 was compared between the 
hippocampus and prefrontal cortex. Finally, fractional release of [
3
H]NE resulting from KCl were 
compared between groups for each of the 4 stimulation 3 column variables, none of these 
comparisons were significant (included in appendix). Therefore, the 2 KCl stimulation columns 
from each brain area were averaged and compared. Full statistical tables can be found in appendix 
A.3.3. 
When fractional release of [
3
H]NE in the hippocampus was compared for the following stimulation 
conditions; glutamate stimulation 1, GABA stimulation 2, GABA stimulation 1 and glutamate 
stimulation 2 (Figure 55), a main effect of housing was found (F(1, 29) = 4.738, p=0.0377) only, as 
the post-hoc test did not reveal specific group differences. A stimulation difference was also found 
for the hippocampus data (F(3, 87) = 3.893, p=0.0116), where fractional release of [
3
H]NE was 
greater with glutamate stimulation 1 than with GABA stimulation 1, p=0.0144. When fractional 
release of [
3
H]NE in the prefrontal cortex was compared for the following stimulation conditions; 
glutamate stimulation 1, GABA stimulation 2, GABA stimulation 1 and glutamate stimulation 2 
(Figure 56), a stimulation-housing interaction was found (F(3, 96) = 4.161, p=0.0081) only, as the 
post-hoc test did not reveal specific group differences. A housing-sex-stimulation interaction was 
also found for prefrontal cortex data (F(3, 96) = 2.880, p=0.0398) only, as the post-hoc test did not 
reveal specific group differences. When fractional release of [
3
H]NE resulting from glutamate 
stimulation 1 was compared between the hippocampus and prefrontal cortex (Figure 57), a housing-
sex interaction was found (F(1, 31) = 5.203, p=0.0295) only, as the post-hoc test did not reveal 
specific group differences. A difference between the brain areas was also found for glutamate 
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stimulation 1 data (F(1, 31) = 8.050, p=0.0079), where fractional release of [
3
H]NE was greater in the 
hippocampus than in the prefrontal cortex, p=0.0093. When fractional release of [
3
H]NE resulting 
from GABA stimulation 1 was compared between the hippocampus and prefrontal cortex (Figure 
58), a housing-brain area interaction was found (F(1, 29) = 5.625, p=0.0245) only, as the post-hoc test 
did not reveal specific group differences. When fractional release of [
3
H]NE resulting from KCl 
stimulation 3 was compared between the hippocampus and prefrontal cortex (Figure 59), a sex 
difference was found (F(1, 31) = 7.685, p=0.0093), where release in males was greater than in 
females, p=0.0104. A difference between the brain areas was also found (F(1, 31) = 9.715, p=0.0039), 
where KCl-stimulated release of [
3




Figure 55- SF3, HC fractional release of [3H]NE  
Glutamate and GABA stimulated fractional release of [
3
H]NE in the hippocampus during 
Superfusion 3 stimulations 1 and 2, for each sex and housing group; female socialised (FS n=12) 




































































housing was found, p=0.0377, this effect was not supported in post hoc testing. 
^
A stimulation 
difference was found, p=0.0116, where fractional release of [
3
H]NE resulting from glutamate 
stimulation 1 was greater than from GABA stimulation 1, p=0.0144. Data are presented as mean ± 
SD. S1 = stimulation 1, S2 = stimulation 2, Glu = glutamate, GAB = GABA. 
 
 
Figure 56- SF3, PFC fractional release of [3H]NE  
Glutamate and GABA stimulated fractional release of [
3
H]NE in the prefrontal during Superfusion 3 
stimulations 1 and 2, for each sex and housing group; female socialised (FS n=12) and female 
isolated (FI n=12), male socialised (MS n=5), male isolated (MI n=6). A housing-stimulation 
interaction was found, p=0.0081, this interaction was not supported in post hoc testing. A housing-
sex-stimulation interaction was found p=0.0398, this interaction was not supported in post hoc 
testing. Data are presented as mean ± SD. S1 = stimulation 1, S2 = stimulation 2, Glu = glutamate, 







































































Figure 57- SF3, Glutamate stimulation 1 fractional release of [3H]NE 
Glutamate-stimulated fractional release of [
3
H]NE in the hippocampus and prefrontal cortex during 
Superfusion 3 stimulation 1, for each sex and housing group; female socialised (FS n=12) and 
female isolated (FI n=12), male socialised (MS n=5), male isolated (MI n=6). 
^
A difference was 
found between the brain areas, p=0.0079, where fractional release of [
3
H]NE was greater in the 
hippocampus than in the prefrontal cortex, p=0.0093. A housing-sex interaction was found, 
p=0.0295, this interaction was not supported in post hoc testing. Data are presented as mean ± SD. 
HC = hippocampus, PFC = prefrontal cortex. 
 















































Figure 58- SF3, GABA stimulation 1 fractional release of [3H]NE 
GABA-stimulated fractional release of [
3
H]NE in the hippocampus and prefrontal cortex during 
Superfusion 3 stimulation 1, for each sex and housing group; female socialised (FS n=12) and 
female isolated (FI n=12), male socialised (MS n=5), male isolated (MI n=6). A housing-brain area 
interaction was found, p=0.0245, this interaction was not supported in post hoc testing. Data are 
presented as mean ± SD. HC = hippocampus, PFC = prefrontal cortex. 
 












































Figure 59- SF3, KCl stimulation 3 fractional release of [
3
H]NE 
KCl-stimulated fractional release of [
3
H]NE in the hippocampus and prefrontal cortex during 
Superfusion 3 stimulation 3, for each sex and housing group; female socialised (FS n=12) and 
female isolated (FI n=12), male socialised (MS n=6), male isolated (MI n=6). A sex difference was 
found, p=0.0093, where release in males was greater than in females, p=0.0104. A difference 
between the brain areas was found, p=0.0039, where KCl-stimulated release of [
3
H]NE was greater 
in the prefrontal cortex than in the hippocampus, p=0.0042. 
  












































3.4 ELISA AND BCA PROTEIN ASSAY 
 
ELISAs were performed on rat brain tissue homogenates, hippocampus and prefrontal cortex, to 
quantify concentrations of neurotransmitter, NE (n=24, FS 6, FI 6, MS 6, MI 6) and glutamate 
(n=40, FS 10, FI 10, MS 10, MI 10), these were expressed as ng or mg/g wet weight of tissue 
respectively. BCA protein assays were performed from homogenates made for ELISA experiments 
to quantify concentrations of total protein in the tissue. ELISA values were divided by BCA protein 
assay values to give a value for neurotransmitter expressed as pg or mg /g total protein. Full 
statistical tables can be found in appendix A.4. 
When data were analysed for the NE concentration in wet weight of tissue (NE ng/g) in the 
hippocampus (Figure 60), a sex difference was found (F(1, 20) = 4.745, p=0.0415), where the 
concentration of NE was higher in females than in males, p=0.0415. When data were analysed for 
the NE concentration in the total protein (NE pg/g) in the hippocampus (Figure 61), a sex 
difference was found (H(3, N=39) = 7.854, p=0.0491), where the concentration of NE was higher in 
FS than in MS, p=0.0362. When data were analysed for the NE concentration in wet weight of 
tissue (NE ng/g) in the prefrontal cortex (Figure 62), a sex difference was found (F(1, 20) = 5.132, 
p=0.0347), where the concentration of NE was higher in males than in females, p=0.0347. Neither 
housing nor sex differences were found when data were analysed for the NE concentration in the 
total protein (NE pg/g) in the prefrontal cortex (Figure 63). Neither housing nor sex differences 
were found when data were analysed for the glutamate concentration in wet weight of tissue (Glu 
mg/g) in the hippocampus (Figure 64). Neither housing nor sex differences were found when data 
were analysed for the glutamate concentration in the total protein (Glu mg/g) in the hippocampus 
(Figure 65). Neither housing nor sex differences were found when data were analysed for the 





Figure 60- ELISA, HC NE (ng/g wet weight) 
The concentration of norepinephrine (NE ng/g wet weight of tissue) in the hippocampus was 
analysed for each sex and housing group; female socialised (FS n=6) and female isolated (FI n=6), 
male socialised (MS n=6), male isolated (MI n=6). 
#
A sex difference was found, p=0.0415, where 
the concentration of NE was higher in females than in males, p=0.0415. Data are presented as mean 
± SD. 
 
Figure 61- ELISA BCA assay, HC NE (pg/g protein) 
The concentration of norepinephrine (NE pg/g protein) in the hippocampus was analysed for each 
sex_housing group; female socialised (FS n=10) and female isolated (FI n=10), male socialised (MS 
n=10), male isolated (MI n=10). 
#


























































NE was higher in FS than in MS, p=0.0362. Data are presented as median ± IQR with min and max 
values. 
 
Figure 62- ELISA, PFC NE (ng/g wet weight) 
The concentration of norepinephrine (NE ng/g wet weight of tissue) in the prefrontal cortex was 
analysed for each sex and housing group; female socialised (FS n=6) and female isolated (FI n=6), 
male socialised (MS n=6), male isolated (MI n=6). 
#
A sex difference was found, p=0.0347, where 


































Figure 63- ELISA BCA assay, PFC NE (pg/g protein) 
The concentration of norepinephrine (NE pg/g protein) in the prefrontal cortex was analysed for 
each sex and housing group; female socialised (FS n=6) and female isolated (FI n=6), male 
socialised (MS n=6), male isolated (MI n=6). Neither housing nor sex differences were found. Data 
are presented as mean ± SD. 
 
Figure 64- ELISA, HC Glu (mg/g wet weight) 
The concentration of glutamate (Glu mg/g wet weight of tissue) in the hippocampus was analysed 
for each sex and housing group; female socialised (FS n=10) and female isolated (FI n=10), male 
socialised (MS n=10), male isolated (MI n=10). Neither housing nor sex differences were found. 




















































Figure 65- ELISA BCA assay, HC Glu (mg/g protein) 
The concentration of glutamate (Glu mg/g protein) in the hippocampus was analysed for each sex 
and housing group; female socialised (FS n=10) and female isolated (FI n=10), male socialised (MS 
n=10), male isolated (MI n=10). Neither housing nor sex differences were found. Data are presented 
as median ± IQR with min and max values. 
 
Figure 66- ELISA, PFC Glu (mg/g wet weight) 
The concentration of glutamate (Glu mg/g wet weight of tissue) in the prefrontal cortex was 
analysed for each sex and housing group; female socialised (FS n=6) and female isolated (FI n=6), 
male socialised (MS n=6), male isolated (MI n=6). Neither housing nor sex differences were found. 























































3.5 ULTRASONIC VOCALISATIONS  
 
Data were corrected to ensure results from the two bat detectors were comparable, see methodology 
and appendix for details, (n=41, 14 FS, 16 FI, 5 MS, 6 MI). When corrected mean call duration (s) 
and total call data were analysed neither housing nor sex differences were found (Figure 67), 
(Figure 68). Full statistical tables can be found in appendix A.5. 
 
 
Figure 67- USV, Mean call duration (ms) 
Mean call durations (ms) during USV recordings for each sex and housing group; female socialised 
(FS n=14) and female isolated (FI n=16), male socialised (MS n=5), male isolated (MI n=6). Neither 
housing nor sex differences were found. Data were corrected; see USV methodology section 2.4.2 





























Figure 68- USV, Total call number 
Total call number during USV recordings for each sex_housing group; female socialised (FS n=14) 
and female isolated (FI n=16), male socialised (MS n=5), male isolated (MI n=6). Neither housing 
nor sex differences were found. Data were corrected; see USV methodology section 2.4.2 for 
details. Data are presented as median ± IQR with min and max values. 
  


























The primary purpose of this study was to investigate the cognitive symptoms of schizophrenia with 
particular focus on the attentional system. The experiments were designed to reveal behavioural 
deficits, specifically attentional dysfunction, induced by SIR model of schizophrenia and then to 
probe how aberrations in related neurochemical system, the locus-coeruleus norepinephrine system, 
might underlie attentional abnormalities. A secondary aim was to investigate negative 
symptomology tested social function resulting from SIR. Analyses were conducted to determine 
whether social or isolated housing differentially affected the behavioural and neurochemical tests 
applied. These analyses also investigated how SIR might affect males and females differently. This 
discussion will follow the structure of the results, first addressing all behavioural and 
neurochemical tests for attention and then move onto social function. In each section any housing 
differences found will be discussed and this will be followed by a discussion on sex differences 
found. 
The only physical parameter recorded, body weight, was found to differ by housing and sex, this 
was found to compliment the literature in part. In the current study differences between the housing 
groups became apparent from the fourth week (p42-49) after the implementation of experimental 
housing conditions. At this time point isolated males weighed more than socialised males. The 
divergence of median body weights of the male groups was continued to the end of testing though 
it was not statistically significant. Isolation housing in females did not result in any significant 
differences in body weight. Sex differences were also found from week p42-49 such that socialised 
males were heavier than socialised females and isolated males were heavier than isolated females, 
these results were sustained for all weeks subsequent until the end point. A difference in the body 
weight of male and female rats is a normal physiological phenomenon which is independent to SIR 
(Ferreira, Foley et al. 2012).  
An increase in the body weight of isolated male rats has been previously documented after around 4 
weeks of SIR experimental conditioning (Sahakian, Burdess et al. 1982, Menich and Baron 1984, 
Weintraub, Singaravelu et al. 2010, Nakhate, Kokare et al. 2011). One such study found that 
isolated male S-Ds weighed more than socialised rats, as early as the second week after the 
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implementation of experimental housing conditions and this difference was sustained for the 
remaining 7 weeks of the study (Simpson and Kelly 2012). One of the key differences was that in 
this study the animals were placed in experimental housing from 6 weeks old as opposed to 3 
weeks old, as applied in the present study. This result reinforces the capability of the model to 
impact a change in body weight due to housing conditions even when the conditions are 
implemented later in life. The literature suggests that the increased body weight of isolated males 
results from lack of stimulation leading to overeating in the absence of playmates coupled with 
lower levels of activity (Menich and Baron 1984, Simpson and Kelly 2012). Other studies have 
failed to find housing differences for body weight (Hellemans, Benge et al. 2004, Weiss, Pryce et 
al. 2004). An example of one of these studies found that there were no differences when comparing 
the body weights of minimally handled socialised male S-Ds to isolated male rats. However 
isolates did weigh more if they had been exposed to an additional stressor (maternal separation) 
(Ryu, Yoo et al. 2009).  
In the present study, there were no housing differences evident between the body weights of the 
female groups. A single SIR study reported housing differences in female S-Ds (Jahng, Yoo et al. 
2012), where isolates weighed more at p49 after 4 weeks of experimental conditioning. Much of 
the methodology of this study was consistent with the present study. The reason that the isolated 
females in the present study did not display increased body weight may have been due to the 
presence of males in the housing facility. The presence of male vocalisation and olfactory cues may 
have induced stress in the female rats which impacted their eating habits. It has been shown that 
stressed female S-Ds gain less weight than non-stressed females (Bowman, Ferguson et al. 2002). 
Overall the results for body weight during experimental conditioning in the present study are fairly 
consistent with existing SIR literature. Male isolates were found to show differences in their weight 
from the fourth week of isolation, this result was reflected in existing literature; however this 
difference did not remain statistically significant throughout experimental conditioning. When 
comparing our female isolates no differences were found, this was in contrast to the only paper 
found which addressed the effects of isolation on female body weight. This lack of difference in 





4.1 NOVEL OBJECT RECOGNITION TESTING 
 
Analysis of the NOR test was performed on data from the first minute and cumulative five minutes 
of each of the three phases, open-field exploration, object familiarization, and novel object 
recognition. In addition and only for phase 1, the open-field exploration, a cumulative ten minute 
analysis was performed, as this phase ran for 10 minutes while phase 2 and phase 3 only ran for 5 
minutes. Analysis of the first minute provides insight to the immediate reaction to novelty whilst 
analysis of the total five minutes provides an insight into familiarisation to this novelty and thus 
attention (Brenes, Padilla et al. 2009). For the purpose of this discussion, the results from the first 
minute and five minutes of data from each phase will be compared in order to explore how 
behavioural response changed with time. Results obtained for the distance travelled (cm), the only 
variable recorded throughout all phases of testing, will be discussed for each individual phase and 
then compared across all three phases.  
 
4.1.1 PHASE 1- OPEN FIELD EXPLORATION 
 
The first phase of the NOR test consisted placing each rat in an open field and recording their 
movement around this space for 10 minutes. This first phase of testing represents the first time the 
animals were outside of their experimental housing conditions. It therefore provides critical 
information about the animals’ response to a truly novel situation. Locomotor activity was 
compared between groups as well as entries to, and time spent within the centralised ‘inner-zone’ 
of the open field to provide a measure of anxiety-like behaviour (Das, Barhwal et al. 2015). Three 
temporal analyses were performed (first minute, first cumulative five minutes and full ten minutes). 
One housing difference was found during this phase where socialised rats travelled further in the 
open field during the first minute of testing. A number of sex differences were also found; in the 
first minute females were hyperactive and made fewer entries to the inner-zone. In the first five 
minutes and full ten minutes, females similarly made fewer entries to the inner-zone. During the 
full ten minutes males were found to spend longer in the inner-zone. 
During the first minute analysis a housing difference was evident for the distance travelled 
demonstrating that socialised animals travelled a greater distance than isolated animals. There is 
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little in the literature to support this finding as most studies analyse longer-term locomotor activity 
(at least five minutes) in the open field. In one study a minute-by-minute analysis was performed 
on 10 minutes of open field data (Brenes, Padilla et al. 2009). Briefly, male S-Ds were isolated 
from p28-60. At p60 the S-Ds underwent elevated plus maze testing and at p62 animals underwent 
open field testing. The minute analysis of the open field test revealed the following; isolated 
animals and socialised animals were found to travel similar differences at one minute, four minute 
and six minute time bins and for all other time points isolates were found to be hyperactive as well 
as in the overall ten minute analysis. The fact that rats underwent a behavioural test prior to open 
field means that subsequent measurements in the open field are not a true representation of the first 
time outside of the home cage, i.e. not their first experience of a novel environment. It may have 
been the case that the isolates would have demonstrated freezing behaviour similar to the results of 
the present study if they had not been exposed previously to a novel environment and subjected to 
less handling. Additionally the isolation period of the S-Ds was half as long as in the present study 
which may also have contributed to the different results of the groups. Another minute-by-minute 
analysis of locomotor activity during the NOR test, this time in Lister Hooded and Wistar, male and 
female rats revealed that there were there were no differences in exploratory activity in the first 
minute (Ennaceur, Michalikova et al. 2005), though these strains have been shown to have different 
activity levels to S-Ds (Weiss, Di Iorio et al. 2000). In the aforementioned study all animals were 
housed in groups of three, were handled once a day and underwent an anxiety test prior to NOR 
testing. Therefore our study presents a novel finding with regards to the first minute locomotor 
activity analysis. This fact that isolates covered a shorter distance implies that there was initial 
(very short term) enhanced innate freezing response. Freezing responses are used as an indicator of 
fear (Yusufishaq and Rosenkranz 2013). Previous work in the SIR model has used freezing 
responses to investigate conditioned fear as opposed to innate fear. It has been shown that isolated 
rats have a decreased freezing response following fear conditioning which is in contrast to the 
increased innate freezing response of the present study. Though this may seem conflicting, taken 
together these results imply abnormal attribution of salience at both ends of the spectrum which fits 
with the heterogeneity of symptoms in schizophrenia. 
After the initial reduction in locomotor activity during the first minute of the first phase no further 
differences were found in the five or ten minute analyses. This implies that after initial exposure 
(first minute), isolates quickly went on to travel similar distances to the socialised animals. In 
previous SIR studies, the most commonly reported locomotor activity finding is that isolates are 
hyperactive compared to socialised animals and this result is used to exemplify abnormal motor 
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activity associated with schizophrenia (Hall 1998, Lapiz, Fulford et al. 2003, Fone and Porkess 
2008). Activity is commonly measured as distance travelled or number of crossings between areas 
in the open field over a period of at least 10 minutes. The present study found no evidence of 
isolation-induced hyperactivity during a 10 minute, 5 minute or 1 minute analysis of the distance 
travelled in the novel arena. This does however, fit with previous findings from S-D SIR studies 
where hyperactivity is less-robustly induced than in other strains (Table 2). A study utilising a 
similar SIR methodology also found no differences in locomotion in S-D males over a 5 minute 
time course (Simpson and Kelly 2012). Many studies reporting hyperactivity used male Lister 
Hooded rats (Jones, Brown et al. 2011, Watson, Marsden et al. 2012, Zamberletti, Viganò et al. 
2012). Lister Hooded rats are reported as producing more reliable changes in locomotor activity 
than S-D rats (Weiss, Di Iorio et al. 2000). Whilst sex and strain can create a bias in reporting SIR 
hyperactivity certain other methodological factors also determine the result. Critically, in the 
context of this this study, the time over which the recording takes place is of interest as most 
studies are conducted over longer durations, i.e. do not address the first minute of activity in the 
open-field. 
In the present study when activity within the inner-zone was tested no differences were found 
between the housing groups. A previous study found that isolated male S-Ds made significantly 
fewer entries to the open field inner zone and also spent significantly less time in the inner-zone 
(Das, Barhwal et al. 2015). In this study isolated animals were housed in isolation chambers so that 
they were not exposed to any sensory cues from other animals, unlike in the present study where all 
rats were housed in the same room in open-topped cages. This may have led to a more robust 
induction of anxiety which was reflected in the open field test. It would be pertinent to test the 
latency to the first entry into the inner-zone. However, in the present study, the animal was placed 
in the centre of the arena (IZ) by the experimenter at the start of testing, so performing a statistical 
analysis on this would not have been valid. Previous studies have repeatedly demonstrated a slower 
emergence of isolates into an open area (Arakawa 2005). 
With regard to the sex differences evident in the open field test. Females were hyperactive 
compared to males in the first minute but not during five minute and ten minute analyses. This 
female hyperactivity has been previously demonstrated in S-Ds in the SIR model for the first three 
minutes of an open field trial and in the subsequent three minutes of the trial the locomotor activity 
of the males and females equalised (Beck and Luine 2002). This is in agreement with the finding of 
the present study, as female hyperactivity is a common finding in control groups from other studies. 
Open field recordings lasting 6 minutes in S-Ds revealed female hyperactivity (Dubovický, 
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Skultétyová et al. 1999) and also showed that females take longer to habituate to new 
environments. Another study showed female hyperactivity during 3 minute recordings of Wistar 
rats (de Cabo de la Vega, Pujol et al. 1995) and in 20 minute recordings of Wistar rats (Nasello, 
Machado et al. 1998). The latter study also found that males had longer periods of inactivity. 
Female Fischer and Lewis rats tested over 3 minutes seemed to be hyperactive compared to males 
though this result did not reach significance and the rats in this study were extensively handled 
(Stöhr, Schulte Wermeling et al. 1998). Males made more entries to the inner-zone in all three 
temporal analyses and spent significantly longer in the inner-zone in the five and ten minute 
analyses. This is indicative of a sex-specific confidence in exploration away from the ‘safer’ edges 
of the arena which has been demonstrated in other studies, i.e. a reduction in anxiety-like behaviour 
(Beck and Luine 2002).  
The findings from this phase demonstrate that isolates are in fact hypoactive in their very short term 
response to novelty. This provides further evidence to support motor abnormalities in SIR 
modelling which may have implications for schizophrenic symptomatology. It seems that isolates 
initially freeze and then go on to equalise in activity compared to socialised animals. It has been 
demonstrated that isolated animals take longer to habituate to a new environment (Powell, 
Swerdlow et al. 2002). Perhaps it is this failure of isolates to habituate which may underlie their 
relative hyperactivity in the longer term as is reported in other studies.  
 
4.2.2 PHASE 2- OBJECT FAMILIARISATION 
 
This phase of testing was intended not only as a chance for the animals to familiarise themselves 
with the two similar objects but also to demonstrate that there should be no preference between the 
two identical objects.  
No housing differences were found in the one minute or five minute analyses of this phase. Female 
hyperactivity was evidenced as a greater distance travelled in both temporal analyses and 
additionally in the five minutes females made more entries into the quadrants containing the objects 
than males. All groups spent more time in the two quadrants containing the objects than in the two 
empty quadrants in both temporal analyses.  
The female hyperactivity was consistently evident in both the first minute and five minute data 
analyses reinforcing the sex effect which was discussed in the context of phase 1; this was 
137 
 
reinforced by the increased quadrant crossings in total made by the females during the five minutes. 
The test to compare the time spent in the object-containing quadrants versus the empty quadrants 
was used as a proof of concept to determine if all animals detected these objects as salient. This 
proof was sustained in both temporal analyses indicating that the rats acted in a way which allows 
for parallels to be drawn to human studies (Clark, Geffen et al. 1987).  
 
4.2.3 PHASE 3- NOVEL OBJECT RECOGNITION  
 
This phase of testing addressed the primary aim of the study and provided information on the 
attentional responses of the isolated animals. Responses to a novel object were recorded based on 
more explorative centre-point detection and more investigatory nose-point detection. 
A number of housing differences were evidenced in this phase of testing. In the first minute 
analysis isolates spent longer in the quadrant where the novel object was located whereas socialised 
groups did not show a quadrant preference. All groups did however make a greater number of 
approaches and spent longer with the novel object than with the familiar object. In the five minute 
analysis isolates spent longer with the novel object and the socialised animals showed no 
preference. In the five minute analysis all groups except isolated males made more approaches to 
the novel object. With regard to the distance travelled, once again, isolates were found to be 
hypoactive in the first minute of the phase. Females were found to be hyperactive compared to 
males in both temporal analyses and females also made more quadrant entries in total than males 
over the five minutes. The results of the tests for novelty preference are summarised in Table 8. 
In the first minute isolate groups spent more time in the quadrant where the novel object was 
situated than in the quadrant containing the familiar object. This effect was not sustained in the five 
minute analysis. During the first minute all groups spent more time with the novel object itself as 
measured by nose-point detection. In the five minute analysis only the isolated groups spent more 
time with the novel object. The result implies that during the first minute the isolates responded to 
the novelty of the object as well as its surrounding area whereas the socialised animals are able to 
direct their attention to the novel object specifically. This may be relevant to schizophrenia as 
similarly impaired performances in attentional orienting and distractibility studies are a common 
finding. This is evidenced as a reduction in the task-relevant event-related potential P3 amplitude 
during imaging studies (Laurens, Kiehl et al. 2005). This is in line with a study which demonstrated 
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increased exploration of novel objects by isolates (Sahakian, Robbins et al. 1977) though this was 
measured as number of entries to the quadrants as opposed to the time spent. Other groups have 
found the opposite to be true, male and female adult S-Ds were both found to spend less time with 
novel objects compared to socialised animals, however the isolation period used in this study was 
only for 10 days prior to behavioural testing (Douglas, Varlinskaya et al. 2003).  
By the time five minutes had elapsed it appeared that the socialised animals had habituated to the 
novel object and it was no longer salient compared to the familiar one. The isolates on the other 
hand continued to show preference for the novel object but were not spending an increased time in 
its surrounding area. Longer habituation periods are typical of isolates (Powell, Swerdlow et al. 
2002) and our data supports this. 
Novel object studies often do not state the specific point on which the tracking of the animal was 
based; this study provides simultaneous information about close-up ‘investigation’ as well as more 
general ‘exploration’ stimulated by novelty. This allows for an improved differentiation between 
these two terms which are sometimes used inconsistently between studies. Of course there are 
drawbacks to using an automated system for behavioural analysis as Ethovision can only detect 
distance of the rat (either centre-point or nose-point) from the object as an indicator of activity. 
However, since this was kept consistent between all recordings it was considered preferable to 
manual observations which would have been subject to more variable human bias. Most often in 
the literature the NOR test is used to provide data on memory function when the inter-trial interval 
is varied. Studies have shown that after isolates lose their ability to discriminate between the novel 
and familiar object more easily than socialised animals as the inter-trial interval is increased 
(McLean, Grayson et al. 2010). The present study reinforces the use of the NOR testing to provide 
data on attentional function by making comparisons between time periods and also using different 
body tracking parameters. The discrimination indices did not reach the level of significance in any 
of the tests (one minute, five minutes, novel object or novel quadrant) however they do show a 
trend for increased novelty preference by the isolates. The novelty data implies that SIR was able to 
induce an effect on the way in which isolates directed their attention compared to socialised 
animals. A difference in the response was seen in both one minute and five minute analyses with 
each of these time periods demonstrating a distinct effect of the housing condition.  
No differences were found when the latencies to approach the objects for the first time were tested. 
Visually, (Figure 36) all groups seemed to approach the novel object sooner than the familiar object 
though this was not significant. A previous study demonstrated that isolated males took 
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significantly longer to contact the novel object than socialised males and no differences between 
the female groups were found (Douglas, Varlinskaya et al. 2003).  
The findings for the distance travelled in phase 3 are consistent with the previously discussed 
findings from phase 1. Isolates showed decreased locomotor activity in the first minute and females 
were hyperactive in both the one minute and five minute analyses. Females also made more total 
quadrant entries than males which was consistent with the result in phase 2. 
 
4.2.4 ALL PHASES DISTANCE TRAVELLED 
 
Total distances travelled by each group were compared between the three phases for both the first 
minute and cumulative five minutes. These tests were to give an indication of how activity changed 
after repeated exposures to the testing arena, thus providing information on habituation (Table 9 
and Table 10). 
In the analysis of the distance travelled in the first minute between all phases it was found that 
isolates were hypoactive compared to socialised animals, the same result was not true of the five 
minute analysis. In both temporal analyses females were shown to be hyperactive compared to 
males. When the distances between the phases during the first minute were compared it was found 
that all animals were hypoactive in phase 1 compared to phases 2 and 3. Contrastingly, in the five 
minute analysis it was found that all animals were hypoactive in phase 3 compared to phases 1 and 
2.  
This study repeatedly demonstrated a housing effect induced by SIR which is underreported in the 
literature. Isolates display hypoactivity as their immediate response to a novel environment. This 
result demonstrates that a variety of information which can be drawn from a single measurement as 
simple as distance travelled. The one minute analysis provides an indicator of novelty response 
whereas the more commonly used 5-10 minute analyses give an idea of habituation (Brenes, Padilla 
et al. 2009). Studies over a course of hours on the other hand can be used to gain information about 
baseline activity (Gentsch, Lichtsteiner et al. 1981).  
The most consistent finding when the distances travelled were analysed within and between phases 
was that females were hyperactive compared to males. The only time that his was not the case was 
during phase 1, open-field exploration, for the five and ten minute analyses. 
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When the total distances travelled were compared across the three phases of the test a similar trend 
was evident for all groups for both the one minute and five minute analyses. During the first minute 
of testing it was found that the distance travelled during phase 1 was significantly less than the 
distance travelled in both phase 2 and phase 3. This is indicative of initial freezing behaviour of all 
groups during the first exposure to the novel environment and increased exploratory activity in the 
first minute of subsequent phase 3 when the objects were introduced. Contrastingly, during the 
cumulative five minutes of testing it was found that the distance travelled during phase 3 was 
significantly less than the distance travelled in both phase 1 and phase 2. This implies that the 
inactivity or freezing in response to the novel environment was short-lived and the animals 
increased their exploration as the phase continued. The reduced distance travelled during the five 
minute analysis of phase 3 may be due to habituation to the arena and the objects and perhaps 
fatigue or boredom as phase 2 and 3 were performed on the same day within 90 minutes of each 
other.  
 
4.3 IN-VITRO SUPERFUSION 
4.3.1 SF 1- GLUTAMATE-STIMULATED [3H]NE RELEASE 
IN HIPPOCAMPUS AND PREFRONTAL CORTEX 
 
It was found that in both the hippocampus and prefrontal cortex that the first glutamate stimulation 
induced a significantly larger release of [
3
H]NE than the second and third stimulations, supporting 
past papers (Howells and Russell 2008, Howells, Bindewald et al. 2009). It has been speculated 
that the decreased [
3
H]NE release in response to glutamate is due to a decrease in [
3
H]NE pool 
within the terminal varicosities and internalization of AMPA receptors resulting from the hyper 
stimulation (Howells and Russell 2008). It was also found that the first glutamate stimulation in the 
hippocampus caused a larger release of [
3
H]NE than in the prefrontal cortex, similarly shown in 
(Howells, Bindewald et al. 2009). 
No housing differences were found between the groups in the first superfusion experiment, 
glutamate stimulated release of [
3
H]NE from hippocampal and prefrontal cortex tissue. No other 
SIR studies have measured glutamate-stimulated release of [
3
H]NE in the hippocampus and 
prefrontal cortex. With the lack of finding, however with support from the literature that attentional 
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dysfunction is apparent in SIR and therefore there should be changes affected in the locus-
coeruleus NE system termini, further experiments were developed to interrogate this.  
 
4.3.2 SF 2- GLUTAMATE-STIMULATED [3H]NE RELEASE 
IN HIPPOCAMPUS IN PRESENCE OF MK-801 AND/OR 
CNQX 
 
To further interrogate the role of glutamate stimulated release in the SIR model, investigations to 
the role of glutamate ionotropic receptors in the release of [
3
H]NE within the hippocampus were 
formed. Four different stimulation conditions were used; glutamate alone as a control, glutamate in 
combination with CNQX (an AMPA receptor antagonist), glutamate in combination with MK-801 
(an NMDA receptor antagonist) and glutamate in combination with both CNQX and MK-801. 
No housing differences were evident in these superfusion experiments. A sex effect was evident for 
the release of [
3
H]NE resulting from control condition stimulations and when glutamate was in 
combination with CNQX. The release of [
3
H]NE in females was greater than in males for these 
conditions. An overall increase in the [
3
H]NE release in females was evident when the first 
stimulations of all four stimulation conditions were compared. These sex differences found in part 
agree with previous work from our laboratory, it was found that [
3
H]NE release in the hippocampus 
of female S-Ds was greater than in males in response to stimulated with glutamate (Sterley, 
Howells et al. 2013).  
As with the first superfusion experiments the release of [
3
H]NE resulting from the first stimulation 
was greater than the release of [
3
H]NE resulting from the second and third stimulations. This was 
the case for all of the four stimulation conditions. In the CNQX condition there was also found to 
be a difference between release of [
3
H]NE resulting from the second and third stimulations. The 
third stimulation caused a significantly smaller release of [
3
H]NE than the second. In work 
published from the same laboratory utilising the same method and concentrations it was found that 
CNQX caused a significant decrease in glutamate stimulated [
3
H]NE release and that MK-801 
caused a significant increase in [
3
H]NE release (Howells and Russell 2008). When used in 
combination CNQX and MK-801 lead to an overall decrease in [
3
H]NE release. From these results 
it was reported that glutamate-stimulated [
3
H]NE release was AMPA but not NMDA receptor 
dependent. These results were however obtained from spontaneously hypertensive rats (SHR). A 
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strain characterisation revealed that S-Ds are less responsive overall to glutamate-stimulated 
[
3
H]NE release (Howells and Russell 2008, Sterley, Howells et al. 2013). This low responsiveness 
may account for the lack of difference in the present study. There was also a low n for this part of 
the experiment which may have occluded any real differences In order to further study receptor 
types mediating glutamate stimulated [
3
H]NE release in-vitro in S-Ds, investigation utilising more 
sensitive techniques, like HPLC, may be required. The fact that CNQX caused a decrease in 
response between stimulations 2 and 3 provides some indication of its inhibitory effects consistent 
with the previously discussed work in this laboratory. However it may be that a greater 
concentration of CNQX is required in S-Ds in order to show a significant effect compared to 
control glutamate only stimulations. 
These experiments were designed to address a gap in the literature; it is therefore difficult to 
speculate on the lack of housing results. A few SIR studies which have attempted to address 
ionotropic glutamate receptor contribution to NE function in the hippocampus and prefrontal 
cortex. One study which may be of relevance used Western blotting to measure glutamate receptor 
subtypes in the prefrontal cortex of female S-Ds. The results showed that the GluN1 NMDA 
receptor subtype and GluA1 AMPA receptor subtype had been downregulated in isolated animals 
(Hermes, Li et al. 2011). In an SIR gene microarray study of the prefrontal cortex in male S-Ds 
Homer 1 was upregulated, this gene is involved in post-synaptic NMDA receptor clustering 
(Levine, Youngs et al. 2007).  
 
4.3.3 SF 3- GLUTAMATE, GABA AND KCL-STIMULATED 
[3H]NE RELEASE IN HIPPOCAMPUS AND PREFRONTAL 
CORTEX 
 
Having found no difference in the role of ionotropic glutamate receptor function within the 
hippocampus, the next investigation served to interrogate the interaction, priming capacity, of 
glutamate and GABA stimulated release of [
3
H]NE from hippocampal and prefrontal cortex tissue. 
It has been previously demonstrated that the interplay of these two systems can mediate NE release 
(Andreasen and Lambert 1991). These experiments were intended to characterise the interplay 
between GABA and glutamate, respectively the mammalian brains major excitatory and inhibitory 
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neurotransmitters . These stimulations were followed by a high concentration potassium stimulation 
to trigger the release of [
3
H]NE from presynaptic reserves.  
A housing difference was found when the first and second stimulation conditions were compared in 
the hippocampus. This effect was not sustained in post-hoc testing. In the hippocampus it was also 
found that the first glutamate stimulation resulted in a greater release of [
3
H]NE than the first 
GABA stimulation, this difference was not found for prefrontal cortex. The first glutamate 
stimulation was found to cause a greater response in the hippocampus than in the prefrontal cortex. 
No differences were found between the brain areas in response to the first GABA stimulation. A 
sex difference was found in response to the KCl stimulation where the response in males was 
greater than in females. It was also found that [
3
H]NE release resulting from KCl stimulations was 
increased in the prefrontal cortex compared to the hippocampus. A number of interactions were 
also found in these experiments which were not significant in post hoc testing.  
When the hippocampal tissue was stimulated with glutamate and then GABA or GABA and then 
glutamate an overall housing difference was evident where [
3
H]NE release by socialised animals 
was greater than in isolated animals. This result demonstrates that the global release of NE in the 
hippocampus of isolates may be reduced. The fact that this result was not obtained when 
stimulating with glutamate alone but after a combination of stimulations with glutamate and GABA 
may provide a more realistic model for in-vivo neurochemical function. This result is therefore a 
novel finding from this study as GABAergic function in relation to the NE system is understudied 
in the context of SIR. This result seems to be in agreement with the housing-brain area interaction 
evidenced when the GABA stimulation 1 data was compared, though again this was not followed 
through to post hoc tests. From the graphs it appears that GABA-stimulated [
3
H]NE release less 
effective in the hippocampus of isolates than in socialised animals. In the past it has been 
demonstrated that though GABA is typically thought of as an inhibitory it is able to stimulation NE 
release during in-vitro hippocampal studies (Mc Fie, Sterley et al. 2012). This may be due to the 
effect of disinhibition of GABAergic signalling at interneuron level (Barik and Wonnacott 2006). 
This was also the case in our study where GABA was able to evoke [
3
H]NE release in both brain 
areas. GABA mediated NE release in the hippocampus is thought to be exclusively via GABAA 
receptors (Raiteri, Raiteri et al. 2002). This study labelled the hippocampus of male S-Ds with 
[
3
H]NE and found that release was GABA concentration dependent. They posited that a GABA 
heterocarrier enabled this NE release. Another study used in-vivo microdialysis to ascertain the 
effects of ionotropic glutamate receptor agonists and antagonists on extracellular NE levels in the 
hippocampus in the presence of a GABAA antagonist- bicuculline. It was found that bicuculline 
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was able to effectively antagonise the ability of NMDA to cause a decrease in basal extracellular 
NE levels. The suggested reason for this was that NMDA receptors are located on GABAergic 
interneurons which serve to mediate glutamate-stimulated NE release in the hippocampus through 
reciprocal activation (Dazzi, Matzeu et al. 2011). It may be that the dysregulation of this system 
caused differential results of GABA-mediated of [
3
H]NE release in the isolates in of this study. 
This effect warrants further study to investigate the role of GABA-NE. GABA antagonists have 
been shown to lead to an overall decrease of nicotine-stimulated NE release in another 
microdialysis study in the hippocampus, further strengthening the importance of GABA in NE 
transmission (Fallon, Shearman et al. 2007). One other study further strengthened a role for GABA 
in NE activity in the hippocampus by demonstrating that in hippocampal slices, NE was able to 
stimulate GABAergic neurons causing an increase in the generation of inhibitory post synaptic 
potentials (Andreasen and Lambert 1991). It would be of particular interest to investigate how 
bicuculline might differentially affect [
3
H]NE release in a future superfusion study utilising 
glutamate and GABA-stimulation to see how GABAA transmission in the hippocampus might be 
altered by SIR. 
In the hippocampus it was found that the [
3
H]NE release resulting from the first stimulation with 
glutamate was greater than the [
3
H]NE release resulting from the first stimulation with GABA for 
all groups, though there were no differences in stimulating effect of GABA and glutamate in the 
prefrontal cortex. This lack of difference in the prefrontal cortex may have been due to the lower 
total [
3
H]NE release that was demonstrable in this region. In both the first and the third superfusion 
experiments the total [
3
H]NE release was found to be greater in the hippocampus than in the 
prefrontal cortex. The greater [
3
H]NE release activity in the hippocampus may have made the 
difference between glutamate and GABA-stimulated activity more pronounced, contributing to the 
significant effect.  
In the test between KCl
 
stimulations in the brain areas a sex difference was found such that KCl-
stimulated [
3
H]NE release in males was greater than in females. A difference between the brain 
areas was also evident. KCl-stimulated [
3
H]NE release was greater in the prefrontal cortex, this was 
in contrast to the finding that glutamate-stimulated [
3
H]NE release was greater in the hippocampus. 
This disparity is likely to be facilitated by different receptor populations in the two areas. KCl-
stimulated [
3
H]NE release may be mediated by negative feedback inhibition of α2-adrenoceptors in 
NE neurons which act as autoreceptors (Russell, Allie et al. 2000). This was characterised using a 
similar superfusion technique where KCl-stimulated [
3
H]NE release took place in the presence of 





In the context of the present study a reduced population of α2-adrenoceptors in the prefrontal cortex 
may be responsible for the increased KCl-stimulated [
3
H]NE release compared to the hippocampus. 
In a similar study in the SIR model, the effect of a high K
+
 stimulation on NE was investigated in 
isolated male Lister Hooded rats to characterise noradrenergic function and the Ca
2+
-dependency of 
the response (Fulford and Marsden 1997). The rats were isolated from p21 for 4-6 weeks and then 
decapitated and the hippocampi were submerged in Krebs buffer. In contrast to the present study, 
after slicing, the tissues were centrifuged to form pellets. The pellets were incubated with solutions 
containing either 30 mM K
+
, 10 µM clonidine (an α2-adrenoceptor agonist) or 10 µM idazoxan (an 
α2-adrenoceptor antagonist) for 20 minutes and then centrifuged again. Finally the supernatants 
underwent HPLC to determine NE concentrations. No differences were found with regard to the 
basal or high K
+
 stimulated release of NE in the hippocampus in socialised and isolated rats. Basal 
as well as K
+
 stimulated release of NE in the hippocampus was shown to be Ca
2+
-dependent. The 
α2-adrenoceptor agonist had no differential effects on NE release whereas the α2-adrenoceptor 
antagonist caused a significantly greater increase in NE release in isolates compared to basal 
release than it did in socialised animals. It was postulated that this effect is mediated by increased 
that presynaptic α2-autoreceptor sensitivity in the hippocampus due to isolation. In the present 
study the differences found in NE release in the presence of GABA and glutamate demonstrates the 
interaction of these systems and their aberration following isolation. 
Overall these superfusions were the most revealing of NE function in the context of SIR as they 
revealed a tentative difference such that overall presynaptic NE activity was reduced in the 
hippocampus of isolates in response to sequential stimulations with glutamate and then GABA or 
GABA and then glutamate. This may be mediated by attenuated GABAA receptor expression in the 
dentate gyrus but increased glutamate NMDA and kainate receptor expression in the CA1 and CA3 
regions of the hippocampus as demonstrated in a previous study (Iwata and Yamamuro 2016) in 
combination with increased α2-autoreceptor sensitivity. 
 
4.4 ELISA AND BCA PROTEIN ASSAY 
 
The overall the concentrations of glutamate and NE in the hippocampus and prefrontal cortex tissue 
where investigated to determine whether absolute concentrations of NE were affected by SIR 
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No housing differences were found in relation to neurotransmitter concentrations in the 
hippocampus and prefrontal cortex. HPLC studies have found differences between socialised and 
isolated animals levels of NE in the ventral striatum (Brenes, Rodríguez et al. 2008) but not in the 
nucleus accumbens, the prefrontal cortex or the hippocampus (Brenes, Padilla et al. 2009, 
Kirkpatrick, Marshall et al. 2014). Another study utilising single isotope radioenzymatic assay 
found there to be a reduction in NE in the hypothalamus of isolated animals but not in the 
hippocampus (Dronjak and Gavrilovic 2006).  
The only differences found were NE concentration differences between the sexes. In the 
hippocampus the NE concentration in the wet weight of tissue was greater in females than in males, 
a similar effect was found for the NE concentration in the protein of the hippocampus where values 
for the female socialised group were greater than the male socialised group. The concentration of 
NE in the wet weight of tissue in the prefrontal cortex was greater in males than in females. With 
regard to the sex differences evidenced in the NE concentrations in the hippocampus and prefrontal 
cortex, it is surprisingly difficult to find any evidence (supportive or otherwise) in age and strain-
matched tests in both sexes. In one previous study of NE concentrations using HPLC in the 
hippocampus and prefrontal cortex of Wistar rats, sex differences were not found (Del Pino, 
Martínez et al. 2011). However these data support a differential expression of NE for different 
brain areas by sex, further study is required to understand the role of the differential concentrations 
in NE found.  
There were no differences between the groups for any of the glutamate concentrations measured. 
Given its abundance and importance throughout the nervous system it is not surprising that 
isolation had no effects on the total concentration of glutamate in the hippocampus and prefrontal 
cortex. A similar result was found in another study where a microdialysis probe was placed in the 
prefrontal cortex to collect extracellular fluid in order to quantify glutamate concentrations 
(Melendez, Gregory et al. 2004). It is more likely that alterations in glutamate function happen due 
to receptor plasticity and functionality as evidenced in glutamate receptor studies. Western blots of 
glutamate receptor types in male S-D hippocampus tissue have revealed reduced expression of 
GluN1, GluA1 and GluA2 in isolates, these changes are proposed to attenuate synaptic plasticity 
processes (Wang, Huang et al. 2017). This decrease in AMPA receptor subtypes in the 
hippocampus of male isolated rats has been replicated for GluA1 and GluA2 (Sestito, Trindade et 
al. 2011). However in a study to quantify the mRNA expression of NMDA receptor subunit 
NMDAR1A in isolates in the hippocampus, prefrontal cortex and striatum, no differences were 
found (Hall, Ghaed et al. 2002). In another paper, RNA from the hippocampus and prefrontal 
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cortex of isolated male S-Ds was extracted and analysed with real-time polymerase chain reaction. 
It was reported that in the hippocampus NMDA subtypes GluN2A and GluN2B were increased in 
isolates and in the prefrontal cortex GluN2A subtypes were decreased (Zhao, Sun et al. 2009). A 
decrease in GluA1 has also been demonstrated in the medial prefrontal cortex of isolated male rats 
(Sarkar and Kabbaj 2016). A similar result was found in the prefrontal cortex of isolated female S-
Ds where GluA1 and GluN1 populations were reduced (Hermes, Li et al. 2011). Glutamate 
receptor subunit studies have also been carried out in the prefrontal cortex indicating a reduction of 
the subunits mGluR1, mGluR5 and mGluR2/3 in male isolates and an increase in mGluR1 
(Melendez, Gregory et al. 2004). Further studies are required to further characterise glutamate and 
NE receptor populations in brain areas related to attention in the SIR model. 
 
4.5 LINKING BEHAVIOURAL AND 
NEUROCHEMICAL FINDINGS 
 
So far the scope of the discussion has stayed within the context of single findings within each 
experiment. This section will draw together related findings from the experiments discussed above 
which were designed to probe the attentional system in the SIR model.  
It was found that there was an overall decrease in glutamate and GABA-mediated release of NE in 
the hippocampus of isolates during superfusion. Isolates were also found to demonstrate abnormal 
attentional behaviours, evidenced by the attribution of salience to a novel object as well as its 
surrounding area and slower habitation to novelty compared to socialised animals. It has been 
previously demonstrated that phasic release of NE in LC varicosities is required for optimal 
attentional processing (Howells, Stein et al. 2012). It has been shown that the stimulation of 
glutamatergic neurons by GABA interneuron activity can alter NE release in the hippocampus 
(Dazzi, Matzeu et al. 2011), it has also been shown that adrenoceptors play a role in regulating 
GABA activity in the hippocampus (Andreasen and Lambert 1991). In the superfusions with 
glutamate alone, no effects of the isolation protocol were demonstrated. This implies that abnormal 
negative feedback regulation of glutamatergic transmission by GABA might contribute to an 
overall decrease in NE function in hippocampal circuits which may underlie attentional dysfunction 
seen in isolates. 
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In the present study the hyperactivity of females in the behavioural tests may be explainable by the 
increased NE activity in the hippocampus. It has been demonstrated in a previous studies that 
hyperactivity can be experimentally induced by increasing NE in the hippocampus (Flicker and 
Geyer 1982, Suwabe, Kubota et al. 2000). In the neurochemical experiments a few sex differences 
were apparent. In the superfusion experiments the release of [
3
H]NE was greater in the 
hippocampus of females after; stimulations with glutamate alone, stimulations with glutamate in 
the presence of CNQX and overall when the results from the first stimulation of the four different 
stimulation conditions of the superfusion 2 experiments utilising different glutamatergic antagonists 
were combined. Contrastingly, the release of [
3
H]NE was greater in both the hippocampus and 
prefrontal cortex of males when the stimulation medium was KCl. Differences in the response of 
the brain areas was also evident in the superfusion experiments. Release of [
3
H]NE in response to 
the first glutamate stimulation was found to be greater in the hippocampus than in the prefrontal 
cortex. This was the case in the first and the third superfusion experiments. Further, release of 
[
3
H]NE in response to stimulation with KCl was found to be greater in the prefrontal cortex than in 
the hippocampus. Then the concentration of NE in the hippocampus was found to be increased in 
females while the concentration of NE in the prefrontal cortex was found to be increased in males.  
Taken together these data may have implications for differential NE function in the hippocampus 
and prefrontal cortex of the sexes. It seems that in females there is an elevated NE concentration in 
the hippocampus as evidenced by the ELISA data and this is accompanied by greater release of NE 
in response to glutamatergic stimulation as evidenced by the superfusion data. Additionally it was 
demonstrated in the superfusion experiments that overall glutamate-stimulated release of NE is 
greater in the hippocampus than in the prefrontal cortex. This increased NE activity in the 
hippocampus of females has been shown to be dependent on female sex hormones. In a study of 
ovariectomised female rats decreased norepinephrine levels in the hippocampus were rescuable 
upon housing with estradiol (Bowman, Ferguson et al. 2002). In males an elevated concentration of 
NE was found in the prefrontal cortex in the ELISA study and in the superfusions males had an 
elevated response of [
3
H]NE release when stimulated with KCl . KCl was found to have the greater 
effect on [
3
H]NE in the prefrontal cortex compared to the hippocampus. This is fitting with the 
literature as it was found that K
+ 
-stimulated NE release in the olfactory bulb was decreased in 
castrated rats (Guan and Dluzen 1991), interestingly this effect was not rescuable after the 
administration of testosterone.  
To conclude, with regard to sex differences found, females showed increased NE responsivity and 
concentration in the hippocampus whereas in males showed increased NE responsivity and 
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concentration in the prefrontal cortex. In the context of existing literature this differences are 
posited to be related to sex hormones and additionally it has been suggested that the increased NE 
activity in the female hippocampus may contribute to the finding of female hyperactivity in the 
behavioural experiments of this study. Future studies would likely benefit from including the 
measurement of sex hormones as these may provide the necessary insights to understand the 
hyperactivity seen in females, the differential release of [
3
H]NE, and NE concentration differences.
Additionally future studies are suggested which probe the relationship between glutamate, GABA 
and norepinephrine activity using agonists, antagonists and receptor population studies in brain 
areas related to attention to further understand these dysfunctional system in isolated animals. 
4.6 ULTRASONIC VOCALISATIONS 
These experiments were intended as secondary aim of the study to assess calling behaviour in 
response to a novel environment to provide an insight into one of the negative symptoms of 
schizophrenia; social withdrawal. 
No sex or housing differences were demonstrable between the groups during ultrasonic vocalisation 
tests at 22 kHz. Technical issues with the recording equipment, a low sample number and the 
introduction of a correction factor because of apparent differences in the sensitivities of the 
detectors may have occluded group differences. Another confounding factor in the USV test was 
the presence of two animals (one socialised and one isolated) which were tested at the same time. 
The purpose of this was to stimulate communication, though it is difficult to say how well the 
animals could hear and or see each other since they were in two separate cylinders. This poses the 
question of whether they were communicating to each other or rather simply vocalising in response 
to being in a new environment and whether the results should be interpreted as a novelty response 
or social function. Numerous studies have been performed investigating how rats respond to the 
affect of other rats. Responses to ‘negative’ affect vocalisation at 22 kHz and ‘positive’ affect 50 
kHz have been investigated as part of empathy studies and the results showed that the affect of the 
listening rat was altered after listening to recordings (Saito, Yuki et al. 2016). Therefore, if in the 
present study the rats could indeed hear each other they may have influenced each other’s 
behaviour leading to no differences being found.  
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USV recordings from SIR model animals is not yet commonplace in the literature and variety of 
testing conditions have been used. Results from existing 22 kHz studies in SIR have shown that the 
total number of calls was reduced in isolates when they were placed in a novel environment (Nunes 
Mamede Rosa, Nobre et al. 2005). Another study also found that isolates made fewer calls of 22 
kHz in response to a novel environment and also that the duration of the calls was significantly 
reduced compared to socialised controls (Tomazini, Reimer et al. 2006) .  
From an examination of the existing literature it seems that trying to infer human-like emotional 
states from USV data in rats is somewhat problematic. Where SIR has been found to cause 
differences in USV this should be taken at face value as an ‘abnormal’ response. For this reason, in 
future studies, in order to extrapolate relevant information for human conditions it may be prudent 
to couple USV testing with other behavioural test (e.g. NOR). By combining audio and visual data 
this may help to disentangle how rats vocalise when not in the presence of other rats. This could 
provide more robust integrated behavioural information, for example: whether an increase in the 







In the present study the SIR model was found to induce a number of changes in behaviour and 
neurochemistry. The primary aim of the study was to investigate whether the attentional deficits 
associated with the cognitive symptoms of schizophrenia were evident in isolated animals by 
investigating behaviour related to the function of the locus-coeruleus norepinephrine system. In 
order to assess attention a novel object recognition behavioural test was used. Often this test is used 
to study memory but in the present study it was adapted to provide information on attentional 
processing by measuring close investigatory behaviour and more general exploratory behaviours 
utilising two different types of rat body movement tracking. Additionally, parameters of this test 
were analysed at multiple time points to provide information about how the reactions of the rats to 
novelty changed with time. In the first minute of the test it was found that isolated animals 
attributed salience to the area surrounding a novel object as well as to the object itself. Socialised 
animals on the other hand directed their attention specifically to the novel object. In the cumulative 
five minute analysis of the novel object test isolated animals continued to direct their attention to 
the novel object whereas socialised animals no longer demonstrated this preference indicating 
different habituations to novelty. These results imply that the attentional response to novel stimuli 
is abnormal in isolated animals. Additionally, an overall effect was found in behavioural testing 
where isolates were hypoactive compared to socialised animals in the first minute after they were 
placed into an environment outside the home cage. No differences were found between the groups 
when longer term analyses of locomotor activity were conducted. This very short-term novelty-
induced freezing response by isolates has not yet been reported in the literature and implies an 
abnormal response to environmental novelty which changes with time.  
The neurochemical aspects of this study were designed to address whether the systems which are 
involved in attentional processing had been altered by isolation rearing. These experiments were 
the first of their kind and provided tentative information to suggest that isolated animals has 
decreased NE activity in the hippocampus. This was evidenced in a superfusion study where 
stimulation hippocampal tissue by sequential stimulations with glutamate and GABA were found to 
cause an overall reduction in the amount of [
3
H]NE released by isolates. In this study the overall 
concentration of NE in the hippocampus measured by ELISA was found not to differ between the 
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housing groups. This result warrants further investigation of receptor populations in the 
hippocampus which may be responsible for this reduction in NE activity if it is not simply related 
to a reduction in the total NE concentration. A future study could utilise combinations of 
glutamatergic and GABA receptor agonists to try and ameliorate the reduction of NE activity in the 
hippocampus of isolates. Additional studies with bicuculline- a GABAA antagonist will help to 
identify which type of receptors are involved in aberrant GABAergic processing in isolates. 
It is postulated that dysregulation of negative feedback circuits involving GABAergic interneurons 
synapsing on glutamatergic neurons the in the hippocampus may be responsible for attentional 
deficits evidenced in the isolates of this study. This finding may provide a target for the study (and 
potentially treatment) of the cognitive symptoms of schizophrenia. 
Other interesting results of the study pertained to sex differences. It was found that females had 
increased NE functionality and concentration in the hippocampus whereas in males had increased 
NE functionality and concentration in the prefrontal cortex. In the context of existing literature this 
differences are posited to be related to sex hormones and additionally it has been suggested that the 
increased NE activity in the female hippocampus may contribute to the finding of female 
hyperactivity in the behavioural experiments of this study.  
Overall the present study was able to successfully address its primary aim to assess the behavioural 
and neurochemical aspects of the attentional system in the SIR model. This was achieved by the 
demonstration that both male and female isolated animals showed abnormal attentional responses 
to novel objects in a behavioural paradigm as well as an overall reduction in NE release in response 
to glutamate and GABA stimulations in the hippocampus. Future studies will target GABA 
regulation of hippocampal NE release in order to better understand dysregulated attention in the 
socially isolated rat model of schizophrenia. This may help to provide a better mechanistic 
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Figure 69- AEC documentation 1/2 
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Figure 70- AEC documentation 2/2 
140 animals were obtained from project number 014/047 for this study. An additional 36 animals 
from project number 014/048 were also added as the student initially designated them was unable to 




A.1 BODY WEIGHT 




















Table 13- Body weight, Descriptive statistics 
 
 
Table 14- Body weight, p21-28 statistics 






Table 15- Body weight, p28-35 statistics 




Table 16- Body weight, p35-42 statistics 




Table 17- Body weight, p42-49 statistics 






Table 18- Body weight, p49-56 statistics 




Table 19- Body weight, p56-63 statistics 




Table 20- Body weight, p63-70 statistics 






Table 21- Body weight, p70-77 statistics 




Table 22- Body weight, p77-84 statistics 




Table 23- Body weight, p84-91 statistics 







A.2 NOVEL OBJECT RECOGNITION TEST 
A.2.1 PHASE 1- OPEN FIELD EXPLORATION ANALYSIS 









A.2.1.1 P.1- FIRST MINUTE  
 
 
Figure 73- NOR P.1 1 MIN, Histograms 
 
Table 26- NOR P.1 1
 





Table 27- NOR P.1 1
 
MIN, Distance travelled (cm) statistics 
Parametric factorial ANOVA for all sex and housing groups. Followed by Bonferroni post hoc.  
 
 
Table 28- NOR P.1 1
 
MIN, Time spent in the inner-zone (s) statistics 




Table 29- NOR P.1 1
 
MIN, Number of inner-zone entries statistics 






A.2.1.2 P.1- FIVE MINUTES  
 
 




Table 30- NOR P.1 5
 
MIN, Descriptive statistics 
 
 
Table 31- NOR P.1 5
 
MIN, Distance travelled (cm) statistics 
Parametric factorial ANOVA for all sex and housing groups. 
 
 
Table 32- NOR P.1 5
 
MIN, Time spent in the inner-zone (s) statistics 






 Table 33- NOR P.1 5
 
MIN, Number of inner-zone entries statistics 
Parametric factorial ANOVA for all sex and housing groups. Followed by Bonferroni post hoc.  
 
 





Figure 75- NOR P.1 10 MIN, Histograms 
 
Table 34- NOR P.1 10 MIN, Descriptive statistics 
 
 
Table 35- NOR P.1 10 MIN, Distance travelled (cm) statistics 
Parametric factorial ANOVA for all sex and housing groups. 
 
 
Table 36- NOR P.1 10 MIN, Time spent in the inner-zone (s) statistics 





Table 37- NOR P.1 10 MIN, Number of inner-zone entries statistics 
Parametric factorial ANOVA for all sex and housing groups. Followed by Bonferroni post hoc.  
 
 














Table 40- NOR P.2, Preference summary 
The table lists where an overall preference for the one of the quadrants or objects was demonstrated by all 
groups as evidenced by time spent or how many entries or approaches were made. 
 
A.2.2.1 P.2- FIRST MINUTE  
 
 1 minute 5 minute 
Time spent (s) Entries/approaches Time spent (s) Entries/approaches 
Quadrant 
 
Q2  Q2  
Object 
 
O2 O2 O2 O2 
Equation 2- Calculation of correction factor for phase 2 NOR variables 
The variables from the data sets were corrected to remove equipment bias. Quadrant 1 or 
Object 1 was made equal to the corresponding Quadrant 2 or Object 2 value respectively 
for each animal.  
Using Quadrant 1 and Quadrant 2 (s) as an example: 
𝑄𝑢𝑎𝑑𝑟𝑎𝑛𝑡 02 (𝑠)
𝑄𝑢𝑎𝑑𝑟𝑎𝑛𝑡 1 (𝑠)
= 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 𝑓𝑜𝑟 𝑒𝑎𝑐ℎ 𝑎𝑛𝑖𝑚𝑎𝑙.  
𝑄𝑢𝑎𝑑𝑟𝑎𝑛𝑡 1 (𝑠)  × 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 𝑓𝑜𝑟 𝑒𝑎𝑐ℎ 𝑎𝑛𝑖𝑚𝑎𝑙  
∴ 𝑄𝑢𝑎𝑑𝑟𝑎𝑛𝑡 1 (𝑠) = 𝑄𝑢𝑎𝑑𝑟𝑎𝑛𝑡 2 (𝑠) – no differences 
Statistics were reapplied on these phase 2 corrected data, no differences were evident. The 
correction factor calculated in phase 2 was also applied to phase 3 corresponding 
























Table 42- NOR P.2 1 MIN, Distance travelled (cm) statistics 
Parametric factorial ANOVA for all sex and housing groups. Followed by Bonferroni post hoc.  
 
 
Table 43- NOR P.2 1 MIN, Quadrants 1+2 vs. Quadrants 3+4 (s) statistics 
Nonparametric comparison of multiple dependent sample groups, Friedman test for all sex_housing groups. 
Followed by comparison of two dependant sample groups, Wilcoxon matched pairs test. 
 
 
Table 44- NOR P.2 1 MIN, Quadrant 1 vs. Quadrant 2 (s) statistics 
Nonparametric comparison of multiple dependent sample groups, Friedman test for all sex_housing groups. 





Table 45- NOR P.2 1 MIN, Quadrant 1 vs. Quadrant 2 (number of entries) statistics 
Nonparametric comparison of multiple dependent sample groups, Friedman test for all sex_housing groups.  
 
 
Table 46- NOR P.2 1 MIN, Object 1 vs. Object 2 (s) statistics 
Nonparametric comparison of multiple dependent sample groups, Friedman test for all sex_housing groups. 
Followed by comparison of two dependant sample groups, Wilcoxon matched pairs test. 
 
  
Table 47- NOR P.2 1 MIN, Object 1 vs. Object 2 (number of approaches) statistics 
Nonparametric comparison of multiple dependent sample groups, Friedman test for all sex_housing groups. 





Table 48- NOR P.2 1 MIN, Object1 vs. Object 2 (latency of approach, s) statistics 
Nonparametric comparison of multiple dependent sample groups, Friedman test for all sex_housing groups.  
 
 




















Table 50- NOR P.2 5 MIN, Distance travelled (cm) statistics 
Parametric factorial ANOVA for all sex and housing groups. Followed by Bonferroni post hoc.  
 
 
Table 51- NOR P.2 5 MIN, Quadrant 1+2 vs. Quadrant 3+4 (s) statistics  




Table 52- NOR P.2 5 MIN, Quadrant 1 vs. Quadrant 2 (s) statistics 






Table 53- NOR P.2 5 MIN, Quadrant 1 vs. Quadrant 2 (number of entries) statistics 






Table 54- NOR P.2 5 MIN, Object 1 vs. Object 2 (s) statistics 
Parametric repeated measures ANOVA (objects) for all sex and housing groups. Followed by Bonferroni 
post hoc.  
 
 
Table 55- NOR P.2 5 MIN, Object 1 vs. Object 2 (number of approaches) statistics 
Nonparametric comparison of multiple dependent sample groups, Friedman test for all sex_housing groups. 
Followed by comparison of two dependant sample groups, Wilcoxon matched pairs test. 
 
 




A.2.3 PHASE 3- NOVEL OBJECT RECOGNITION ANALYSIS 
 
Variables listed as ‘corrected’ were adjusted using the correction factor calculated in phase 2 (Table 40) 
(Equation 2). Statistical tests were applied to these ‘corrected’ variables. 
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A.2.3.1 P.3- FIRST MINUTE  
 
 



















Table 59- NOR P.3 1 MIN, Distance travelled (cm) statistics 
Parametric factorial ANOVA for all sex and housing groups. Followed by Bonferroni post hoc. 
 
 
Table 60- NOR P.3 1 MIN, Quadrant 1 vs. Quadrant 2 (s) statistics, corrected data 
Nonparametric comparison of multiple dependent sample groups, Friedman test for all sex_housing groups. 
Followed by comparison of two dependant sample groups, Wilcoxon matched pairs test. 
 
 
Table 61- NOR P.3 1 MIN, Quadrant 1 vs. Quadrant 2 (number of entries) statistics 
Nonparametric comparison of multiple dependent sample groups, Friedman test for all sex_housing groups. 
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Table 62- NOR P.3 1 MIN, Quadrant discrimination index statistics 
Parametric factorial ANOVA for all sex and housing groups.  
 Table 63- NOR P.3 1 MIN, Object 1 vs. Object 2 (s) statistics, corrected data 
Nonparametric comparison of multiple dependent sample groups, Friedman test for all sex_housing groups. 
Followed by comparison of two dependant sample groups, Wilcoxon matched pairs test. 
Table 64- NOR P.3 1 MIN, Object 1 vs. Object 2 (number of approaches) statistics, corrected data 
Nonparametric comparison of multiple dependent sample groups, Friedman test for all sex_housing groups. 
Followed by comparison of two dependant sample groups, Wilcoxon matched pairs test. 
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Table 65- NOR P.3 1 MIN, Object 1 vs. Object 2 (latency of approach, s) statistics 
Nonparametric comparison of multiple dependent sample groups, Friedman test for all sex_housing groups. 
Table 66- NOR P.3 1 MIN, Object discrimination index statistics 
Parametric factorial ANOVA for all sex and housing groups. 
A.2.3.2 P.3- FIVE MINUTES
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Figure 84- NOR P.3 5 MIN, Histograms 1/2 
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Figure 85- NOR P.3 5 MIN, Histograms 2/2 
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Table 67- NOR P.3 5 MIN, Descriptive statistics 
219 
Table 68- NOR P.3 5 MIN, Distance travelled (cm) statistics 
Parametric factorial ANOVA for all sex and housing groups, followed by Bonferroni post hoc. 
 (This variable was non-parametric (p=0.04649) but parametric analyses were used as distance travelled was 
parametric in all other stages of testing). 
Table 69- NOR P.3 5 MIN, Quadrant 1 vs. Quadrant 2 (s) statistics, corrected data 
Nonparametric comparison of multiple dependent sample groups, Friedman test for all sex_housing groups. 
Table 70- NOR P.3 5 MIN, Quadrant 1 vs. Quadrant 2 (number of entries) statistics 
Parametric repeated measures ANOVA (quadrants) for all sex and housing groups. Followed by Bonferroni 
post hoc.  
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Table 71- NOR P.3 5 MIN, Quadrant discrimination index statistics 
Parametric factorial ANOVA for all sex and housing groups.  
Table 72- NOR P.3 5 MIN, Object 1 vs. Object 2 (s) statistics, corrected data 
Nonparametric comparison of multiple dependent sample groups, Friedman test for all sex_housing groups. 
Followed by comparison of two dependant sample groups, Wilcoxon matched pairs test. 
221 
Table 73- NOR P.3 5 MIN, Object 1 vs. Object 2 (number of approaches) statistics, corrected data 
Nonparametric comparison of multiple dependent sample groups, Friedman test for all sex_housing groups. 
Followed by comparison of two dependant sample groups, Wilcoxon matched pairs test. 
Table 74- NOR P.3 5 MIN, Object discrimination index statistics 
Parametric factorial ANOVA for all sex and housing groups. 
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A.2.4 ALL PHASES- DISTANCE TRAVELLED
A.2.4.1 P.1, P.2, P.3- FIRST MINUTE
Table 75- NOR All phases 1
 
MIN, Distance travelled (cm) statistics 
Parametric repeated measures ANOVA (stimulations) for all sex and housing groups. Followed by 
Bonferroni post hoc.  
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A.2.4.2 P.1, P.2, P.3- FIVE MINUTES
Table 76- NOR All phases 5
 
MIN, Distance travelled (cm) statistics 
Parametric repeated measures ANOVA (stimulations) for all sex and housing groups. Followed by 
Bonferroni post hoc.  
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A.3 IN-VITRO SUPERFUSION
Figure 86- Superfusion standard curve 
Standard decay curve generated from quenched tritium samples for superfusion analysis. 
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A.3.1 SF 1- GLUTAMATE-STIMULATED [3H]NE RELEASE
IN HIPPOCAMPUS AND PREFRONTAL CORTEX
Table 77- SF1, Data 
226 
Figure 87- SF1, Histograms 
227 
Table 78- SF1, Descriptive statistics 
Table 79- SF1, HC Stim 1 vs. 2 vs. 3 statistics 
Parametric repeated measures ANOVA (stimulations) for all sex and housing groups. Followed by 
Bonferroni post hoc.  
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Table 80- SF1, PFC Stim 1 vs. 2 vs. 3 statistics 
Parametric repeated measures ANOVA (stimulations) for all sex and housing groups. Followed by 
Bonferroni post hoc.  
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Table 81- SF1, Stim 1 HC vs. PFC statistics 
Parametric repeated measures ANOVA (brain areas) for all sex and housing groups. Followed by Bonferroni 
post hoc.  
Table 82- SF1, Stim 2 HC vs. PFC statistics 
Parametric repeated measures ANOVA (brain areas) for all sex and housing groups. 
. 
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Table 83- SF1, Stim 3 HC vs. PFC statistics  
Parametric repeated measures ANOVA (brain areas) for all sex and housing groups. 
A.3.2 SF 2- GLUTAMATE-STIMULATED [3H]NE RELEASE
IN HIPPOCAMPUS IN PRESENCE OF MK-801 AND/OR
CNQX
Table 84- SF2, Data 
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Figure 88- SF2, Histograms 1/2 
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Figure 89- SF2, Histograms 2/2 
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Table 85- SF2, Descriptive statistics 
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Table 86- SF2, Control condition Stim 1 vs. 2 vs. 3 statistics 
Parametric repeated measures ANOVA (stimulations) for all sex and housing groups. Followed by 
Bonferroni post hoc.  
Table 87- SF2, CNQX condition Stim 1 vs. 2 vs. 3 statistics 
Parametric repeated measures ANOVA (stimulations) for all sex and housing groups. Followed by 
Bonferroni post hoc.  
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Table 88- SF2, MK-801 condition Stim 1 vs. 2 vs. 3 statistics 
Parametric repeated measures ANOVA (stimulations) for all sex and housing groups. Followed by 
Bonferroni post hoc.  
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Table 89- SF2, CNQX + MK-801 condition Stim 1 vs. 2 vs. 3 statistics 
Parametric repeated measures ANOVA (stimulations) for all sex and housing groups. Followed by 
Bonferroni post hoc.  
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Table 90- SF2, Stim 1 Control vs. CNQX vs. MK-801 vs. CNQX + MK-801 statistics 
Parametric repeated measures ANOVA (drug conditions) for all sex and housing groups. Followed by 
Bonferroni post hoc.  
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Table 91- SF2, Stim 2 Control vs. CNQX vs. MK-801 vs. CNQX + MK-801 statistics  
Parametric repeated measures ANOVA (drug conditions) for all sex and housing groups. 
Table 92- SF2, Stim 3 Control vs. CNQX vs. MK-801 vs. CNQX + MK-801 statistics  
Parametric repeated measures ANOVA (drug conditions) for all sex and housing groups. 
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A.3.3 SF 3- GLUTAMATE, GABA AND KCL-STIMULATED
[3H]NE RELEASE IN HIPPOCAMPUS AND PREFRONTAL
CORTEX
Table 93- SF3, Data 
240 
Figure 90- SF3, Histograms 1/3 
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Figure 91- SF3, Histograms 2/3 
242 
Figure 92- SF3, Histograms 3/3 
243 
Table 94- SF3, Descriptive statistics 
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Table 95- SF3, HC Glu Stim 1 vs. GABA Stim 2 vs. GABA Stim 1 vs. Glu Stim 2 statistics 
Parametric repeated measures ANOVA (stimulations) for all sex and housing groups. Followed by 
Bonferroni post hoc.  
Table 96- SF3, PFC Glu Stim 1 vs. GABA Stim 2 vs. GABA Stim 1 vs. Glu Stim 2 statistics 
Parametric repeated measures ANOVA (stimulations) for all sex and housing groups. Followed by 
Bonferroni post hoc.  
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Table 97- SF3, Glu Stim 1 PFC vs. HC statistics 
Parametric repeated measures ANOVA (brain areas) for all sex and housing groups. Followed by Bonferroni 
post hoc.  
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Table 98- SF3, GABA Stim 1 PFC vs. HC statistics 
Parametric repeated measures ANOVA (brain areas) for all sex and housing groups. Followed by Bonferroni 
post hoc.  
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Table 99 SF3, HC KCl Stim 3 (after Glu, GABA) statistics 
Parametric factorial ANOVA for all sex and housing groups. 
Table 100 SF3, HC KCl Stim 3 (after GABA, Glu) statistics 
Parametric factorial ANOVA for all sex and housing groups. 
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Table 101 SF3, PFC KCl Stim 3 (after Glu, GABA) statistics 
Parametric factorial ANOVA for all sex and housing groups. 
Table 102 SF3, PFC KCl Stim 3 (after GABA, Glu) statistics 
Parametric factorial ANOVA for all sex and housing groups. 
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Table 103- SF3, KCl Stim 3 HC vs. PFC statistics 
Parametric repeated measures ANOVA (brain areas) for all sex and housing groups. Followed by 
Bonferroni post hoc. 
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A.4 ELISA AND BCA ASSAY
Figure 93- NE ELISA instruction manual 1/2 
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Figure 94- NE ELISA instruction manual 2/2 
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Figure 95- NE ELISA trial standard curve 
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Figure 96- ELISA, HC NE standard curve 
254 
Figure 97- ELISA, PFC NE standard curve 
255 
Figure 98- Glutamate ELISA instruction manual 1/2 
256 
Figure 99- Glutamate ELISA instruction manual 2/2 
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Figure 100- Glutamate ELISA trial standard curve 
258 
Figure 101- ELISA, HC Glu standard curve 
259 
Figure 102- ELISA, PFC Glu standard curve 
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Figure 103- BCA protein assay instruction manual 1/2 
261 
Figure 104- BCA protein assay instruction manual 1/2 
262 
Figure 105- BCA protein assay, HC NE standard curve 
Figure 106- BCA protein assay, PFC NE standard curve 
263 
Figure 107- BCA protein assay, HC Glu standard curve 
264 
Table 104- ELISA and BCA assay, Data 
265 
Figure 108- ELISA and BCA assay, Histograms 
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Table 105- ELISA and BCA assay, Descriptive statistics 
Table 106- ELISA, HC NE (ng/g wet weight) statistics 
Parametric factorial ANOVA for all sex and housing groups. Followed by Bonferroni post hoc. 
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Table 107- ELISA and BCA assay, HC NE (pg/g protein) statistics 
Nonparametric test comparing multiple independent sample groups, Kruskal Wallis test for all sex_housing 
groups. 
Table 108- ELISA, PFC NE (ng/g wet weight) statistics 
Parametric factorial ANOVA for all sex and housing groups. Followed by Bonferroni post hoc. 
Table 109- ELISA and BCA assay, PFC NE (pg/g protein) statistics 
Parametric factorial ANOVA for all sex and housing groups. 
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Table 110- ELISA, HC Glu (mg/g wet weight) statistics 
Nonparametric test comparing multiple independent sample groups, Kruskal Wallis test for all sex_housing 
groups. 
Table 111- ELISA and BCA assay, HC Glu (mg/g protein) statistics 
Nonparametric test comparing multiple independent sample groups, Kruskal Wallis test for all sex_housing 
groups. 
Table 112- ELISA, PFC Glu (mg/g wet weight) statistics 




Table 113- USV, Data 
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Figure 109- USV, Histograms, raw data 
Table 114- USV, Descriptive statistics, raw data 
Table 115- USV, Mean call duration (ms) statistics 
Nonparametric test comparing multiple independent sample groups, Kruskal Wallis test for all sex_housing 
groups.  
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Table 116- USV, Total call number statistics 
Nonparametric test comparing multiple independent sample groups, Kruskal Wallis test for all sex_housing 
groups 
. 
When nonparametric Kruskal Wallis test was applied to raw data sets neither housing nor sex 
differences were found between groups. It was noted that the Channel A equipment seemed to be 
recording with a greater sensitivity than the Channel B equipment. This was confirmed with a 
Mann Whitney U test. A difference was found (H(3, N=175) = 15.45, p= 0.0015) where channel A was 
greater than channel B for both mean call duration and total call number values (p<0.0001). This 
was thought to be due to the age of the batteries in the different bat detectors. Channel A recordings 
were found to be greater than in Channel B by a factor of 1.42 for mean call duration recordings 
and a factor of 4.58 for total call number. These factors were therefore applied as a correction so 
that the two channels were comparable. Since socialised and isolated animals were swapped 
between Channel A and B detectors for each test, no bias was created and therefore a correction of 
this nature was appropriate. 
Table 117- USV, Channel A vs. Channel B statistics 
Comparing two independent sample groups, Mann Whitney U test. 
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Figure 110- USV, Histograms, corrected data 
Table 118- USV, Descriptive statistics, corrected data 
Table 119- USV, Mean call duration (ms) statistics, corrected data 
Parametric factorial ANOVA for all sex and housing groups.  
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Table 120- USV, Total call number statistics , corrected data 
Nonparametric test comparing multiple independent sample groups, Kruskal Wallis test for all sex_housing 
groups. 
